American Academy of Neurology (AAN)
76^th Annual Meeting in Denver, Colo. (April 13-18, 2024)

• The fragility index of randomized controlled trials for early blood pressure management of intracerebral hemorrhage.
  

  Escamilla-Ocanas C, Morales N, Damani R, Bershad E, Hirzallah M, Siddiqui K, et al.

• Development of an automated algorithm for optic nerve sheath diameter measurement using transorbital ultrasound.
  

  Escamilla-Ocanas C, Morales-Cardona N, Akhbardeh A, Hirzallah M

• Simulation-based brain death determination training for neurology residents.
  

  Escamilla-Ocanas C, Torrealba-Acosta G, Morales-Cardona N, Ramachandran L, Garcia C, Hirzallah M

• Burnout in neurology.
  

  Guo J, Gokcebel S, Grewal P, Alick-Lindstrom S, O'Hana Nobleza C, Kung D, et al.

• Simultaneous occurrence of myositis and myasthenia gravis.
  

  Kass N, Anderson N

• Cerebello-parietal functional connectivity in amnestic mild cognitive impairment due to Alzheimer's disease.
  

  Lin C-Y, Yonce S, Pacini N, Yu M, Bishop J, Pavlik V, et al.

• Severe thiamine deficiency with Wernicke's encephalopathy wet beri beri dry beri beri secondary to cannabinoid induced hyperemesis syndrome.
  

  Manchanda R, McGlennon M, Damani R, Bershad E

• Carotid web stenting after mechanical thrombectomy: How long should we wait? A case report and review of literature.
  

  Morales-Cardona N, Escamilla-Ocanas C, Tanweer O, Shastri R

• Fulminant paraneoplastic neuromyelitis optica spectrum disorder (NMOSD) with triple-negative aquaporin-4-positive breast cancer.
  

  Patel H, Cuascut F, Noorbhai I, Kass J

• A case of immune checkpoint inhibitor (ICI) use in multiple sclerosis.
  

  Patel H, Hutton G

• Increased risk of suicidal ideation in patients with spinocerebellar ataxias.
  [Oral Presentation]
  

  Peppel L, Lai R-Y, Opal P, Schmahmann J, Gomez C, Paulson H, et al.

• The history of the term "catatonia" in cases of encephalopathy.
  

  Perera V, Lenka A, Espay A, Okun M

• Racial disparities in status epilepticus outcomes.
  

  Ramachandran L, Javed F, Khilan MH, Rivera Fullana A, Damani R

• Non-motor effects of bemdaneprocel for Parkinson's disease: 18-month results from a phase 1 study.
  

  Sarva H, Henchcliffe C, Lozano A, Kalia S, Yu KKH, Brennan C, et al.

• Perception of lactation experience among neurology faculty and impact on productivity.
  

  Zheng C, Durica S, O'Hana Nobleza C, Ayub N, Grewal P, Allendorfer J, et al.

American Neuropsychiatric Association (ANPA)
34^th Annual Meeting in Houston, Texas (March 6-9, 2024)

• Cerebello-parietal functional connectivity in amnestic mild cognitive impairment due to Alzheimer's disease.
  

  Lin CR, Yonce S, Pacini N, Yu MM, Bishop J, Pavlik VN, et al.

AD/PD
2024 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders in Lisbon, Portugal (March 5-9, 2024)

• Long-term dementia prevalence in Parkinson's disease: Glass half-full?
  

  Gallagher J, Fedler J, Gochanour C, Dobkin R, Aarsland D, Alcalay R, et al.

• Non-motor effects of bemdaneprocel for Parkinson's disease: Results up to 18 months from a phase 1 study.
  

  Yountz M, Henchcliffe C, Sarva H, Lozano A, Fasano A, Kalia S, et al.

• Dissecting oligogenic mechanisms of lysosomal susceptibility in Parkinson's disease.
  

  Zhao J, Gu M, Yu M, Barros De Paula R, Bellen H, Shulman J

American Stroke Association
2024 International Stroke Conference in Phoenix, Ariz. (Feb. 7-9, 2024)

• Zero degree head positioning in acute large vessel ischemic stroke (ZODIAC).
  [Oral Presentation]
  

  Alexandrov AW, Shearin AJ, Mandava P, Torrealba-Acosta G, Elangovan C, Krishnaiah B, et al.

• Evaluation of post stroke telehealth services in Texas (Vast-1).
  

  Anderson J, Kimmel B, Walder A, Ovalle A, Yanes RS, Silos C, et al.

• Cocaine use on patients with acute ischemic stroke: Classification of subtype, management, and clinical outcomes.
  

  Behera AK, Desai H, Kothari SA, Mendelson SJ

• Code stroke imaging: A multicenter feasibility, pilot study randomizing MRI versus CT for code stroke presenting to the emergency department.
  

  Dula AN, Berstis K, Davis LA, Weng TB, Saber H, Miley J, et al.

• Trends of in-hospital strokes over time: Results from the Greater Cincinnati and Northern Kentucky Stroke study.
  

  Nobel L, Chulluncy Rivas R, Robinson D, Stanton RJ, Kissela BM, Ferioli S, et al.

• Neighborhood socio-economic status as a predictor of all-cause long-term post-stroke mortality.
  

  Nobel L, Robinson D, Stanton RJ, Becker C, Kleindorfer DO, Alwell K, et al.

• Comparison of Dallas ED screening tool to identify stroke (DESTINY) with other stroke screening tools.
  

  Novakovic-White R, Johnson M, Diercks DB, Prasad S, Stone S, Day A, et al.

• The Dallas ED screening tool to identify stroke (DESTINY) validation study.
  

  Prasad S, Novakovic-White R, Johnson M, Diercks DB, Stone S, Day A, et al.

• Changing trends in the epidemiology of subarachnoid hemorrhage: A population-based study.
  

  Robinson D, Stanton RJ, Mistry E, Broderick J, Ding L, Mackey J, et al.

• Analyzing door-to-needle time trends: Tenecteplase vs. alteplase in acute ischemic stroke treatment.
  

  Rodriguez N, Prasad S, Gealogo Brown G, Bandela S, Stone S, Olson DM, et al.

• Stroke metrics reporting to hospital leadership advances thrombolysis and thrombectomy rates in a competitive region: Analysis of SETRAC registry.
  

  Venkatasubba CP, Farquhar G, Ramachandran L, SETRAC Stroke Committee

• Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation: Primary results of the START trial.
  [Oral Presentation]
  

  Warach SJ, Davis LA, Lawrence P, Gajewski B, Wick J, Shi F, et al.

• How well do prehospital stroke triage scores identify patients with intracerebral hemorrhage?
  

  Wechsler PM, Robinson D, Sucharew H, Stanton RJ, Demel S, Mistry E, et al.

IEEE International Solid-State Circuits Conference (ISSCC)
San Francisco, Calif. (2024)

• 17.11 a 9mW ultrasonic through transmission transceiver for non-invasive intracranial pressure sensing.
  

  Topalli G, Fan Y, Cheung MY, Veeraraghavan A, Hirzallah M, Chi T

American Epilepsy Society (AES)
77^th Annual Meeting in Orlando, Fla. (Dec. 1-5, 2023)

• Actigraphic signatures of disability in adults with epilepsy and intellectual disability.
  

  Adhyapak N, Krishna Rao P, Kamen J, Abboud M, Krishnan V

• Cortical spreading depression.
  [Oral Presentation]
  

  Aiba I

• Spreading depolarization in gain-of-function Scn8a mice resembles that of Kcnq2 deficient mice.
  

  Aiba I, Ning Y, Noebels J

• In vivo mesoscale imaging of traumatic brain injury and post-traumatic epileptogenesis.
  

  Bottom-Tanzer S, Corella S, Armbruster M, Noubary F, Shtrahman M, Meyer J, et al.

• Antiseizure medication-induced hypersensitivity reactions in a large healthcare system.
  

  Cadle B, Un Candan F, Haneef Z, Barton C, Brock D, Ali I, et al.

• Voltage clamp and genetic variant pathogenicity: Epilepsy sodium channel variant curation expert panel consensus.
  

  Cohen S, Smith L, Parthasarathy S, Bonkowski E, Hong W, Wiltrout K, et al.

• Outcomes of centromedian thalamic responsive neurostimulation in adults and children with generalized onset seizures: A multicenter cohort study.
  

  Hafeez MU, Hafeez K, Talanki Manjunatha R, Ali I, Curry D, Gavvala J, et al.

• Cell type-specific circuit mechanisms of absence epilepsy.
  

  Jiang X, Maheshwari A, Miao Q, Noebels J, Song S

• Sexually dimorphic behavioral and metabolomic consequences of prenatal valproic acid exposure.
  

  Karedia S, Mazumder AG, Kamen J, Krishnan V

• Approaches to ascertain emotional and psychiatric comorbidities in experimental models of epilepsy.
  [Oral Presentation]
  

  Krishnan V

• Clinicopathologic dissociation: Robust age-dependent Lafora body accumulation in Malin-KO mice without observable changes in home-cage behavior.
  

  Krishnan V, Wu J, Mazumder AG, Kamen J, Bass III J, Maheshwari A, et al.

• State-of-the-art of continuous EEG monitoring in the United States.
  

  Oliveira K, Kayal G, Haneef Z

• Virtual patient management conference for epilepsy surgery in the post-COVID era: An educational perspective.
  

  Pecha T, Shetty S, Kengen A, Gavvala J, Maheshwari A

• Hippocampal oscillations are biomarkers for seizure severity during responsive neurostimulation.
  

  Reyes G, Ferreria L, Haneef Z, Hassan A, Myers J, Sheth S

• Characterizing Hispanic veterans with epilepsy: A national population-based study.
  

  Tantillo G, Haneef Z, Lopez M, Rehman R, Sullivan-Baca E

• Impact of brain stimulation on verbal memory in RNS patients.
  

  Ufomadu P, Alam M, Haneef Z, Stinson J

• Characterizing seizure onset patterns with the Responsive Neurostimulation System.
  

  Vedantam S, Haneef Z, Cleboski S, Gavvala J

Park City Epilepsy Meeting
Park City, Utah (Oct. 15-17, 2023)

• Dichotomy of basket cell recruitment during seizures.
  [Oral Presentation]
  

  Dudok B

9^th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Milan, Italy (Oct. 11-13, 2023)

• Recommendations on NMOSD treatment in Latin America: Consensus-based RAND/UCLA methodology.
  

  Alonso RN, Rivera V, Carnero Contentti EG, Hamuy Diaz de Bedoya VF, Ciampi E, Silva B, et al.

• Development of a questionnarie to measure quality of life in neuromyelitis optica spectrum disorder patients. A validation study from Latin America.
  

  Patricio Correa E, Piedra Andrade JS, Carnero Contentti EG, Torres G, Barrera Madera RA, Ortiz Yepez A, et al.

• Increased intracranial pressure - A rare complication of optic neuritis in myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
  

  Rempe T, Elfasi A, Alkabie S, Alison C, Rodriguez E, Castrodad-Molina R, et al.

• Predictors for a relapsing course of myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
  [Platform Presentation]
  

  Rempe T, Elfasi A, Alkabie S, Rodriguez E, Castrodad-Molina R, Montalvo M, et al.

Movement Disorder Society (MDS)
27^th International Congress of Parkinson's Disease and Movement Disorders in Copenhagen, Denmark (Aug. 27-31, 2023)

• Evoked resonant neural activity in globus pallidus vs. subthalamic nucleus of patients with Parkinson's disease, preliminary results.
  

  Branco L, Swamy C, Tarakad A, Vanegas-Arroyave N, Patel I, Ince N, et al.

• Long-term dementia prevalence in Parkinson disease: Glass half-full?
  

  Gallagher J, Fedler J, Gochanour C, Dobkin R, Aarsland D, Alcalay R, et al.

• An international consensus statement for rehabilitation care in Parkinson's disease.
  [Oral Presentation]
  

  Goldman JG, Volpe D, Ellis TD, Hirsch MA, Johnson J, Wood J, et al.

• Deep brain stimulation in chorea: Four cases and literature review.
  

  Hull M, Parnes M, Tarakad A

• Age at onset and therapeutic efficacy of primidone in essential tremor.
  

  Jackson GR, Sarwar AI, Mandava P, Jamal F

• A phase 2, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ABP-450 (prabotulinumtoxinA) in adults with isolated cervical dystonia.
  

  Jankovic J, Oh C, Liu Y, Comella C

• Presurgical correlates of QOL (PDQ-39) in DBS eligible PD population.
  

  Jimenez-Shahed J, Berg A, York MK, Siddiqui M, Schwalb J, McInerney J

• Apathy and Parkinson?s disease motor phenotypes: A preliminary study.
  

  Lenka A, Gazes Y, Vanegas-Arroyave N

• Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson's disease.
  

  Mack J, Marsh L, Sarwar A, Rodriguez K, King A, Hinojosa-Lindsey M, et al.

• Identifying neural biomarkers of motivated behavior in Parkinson's disease using sensing-capable DBS devices.
  

  Provenza N, Rajesh S, Diab N, Reddy S, Lamichhane B, Sabharwal A, et al.

• Risk factors of sleep disordered breathing in Veterans with Parkinson's disease.
  

  Sarwar AI

• Exploring the effects of spinal cord stimulation for gait disturbances in Parkinson's disease.
  

  Vanegas-Arroyave N, Kwei K, Lee M, Prakash C, Branco L, Tarakad A, et al.

• Apathy, white-matter microstructure, and effort-based decision making in Parkinson's disease.
  

  Vanegas-Arroyave N, Leheron C, He Z, Lee S, Huey E, Gazes Y

Neurocritical Care Society (NCS)
21^st Annual Meeting in Phoenix, Ariz. (Aug. 15-18, 2023)

• The influence of area-level deprivation on comprehensive stroke center access and short-term outcomes in intracerebral hemorrhage management.
  

  Downes M, Chada D, Vasa D, Yang A, Johnson B, Lay C, et al.

• High hypoperfusion index on CT perfusion is associated with an unfavorable discharge disposition on patients with large core infarct.
  

  Escamilla-Ocanas CE, Morales-Cardona NC, Siddiqui K, Venkatasubba Rao CP, Bershad E, Hirzallah M, et al.

• Effects of balanced versus unbalanced hypertonic saline on renal function in neurocritical care.
  

  McGlennon MR, Tucker B, Escamilla-Ocanas CE, Morales NC, Steele EJ, Venkatasubba Rao CP, et al.

• High hypoperfusion intensity ratio associated with prolonged ICU-stay and unfavorable discharge disposition in patients who undergo mechanical thrombectomy.
  

  Morales-Cardona NC, Escamilla-Ocanas CE, Siddiqui K, Venkatasubba Rao CP, Bershad E, Hirzallah M, et al.

• Intensivists' perspectives on CLABSIs and CAUTIs: A survey.
  

  Nelson S, Tsetsou S, Liang J

• Hypoperfusion index and early ischemic changes.
  

  Ramachandran L, Ahmad A, Damani R, Rao C, Siddiqui K, Bershad E, et al.

• Deep venous thrombosis after four factor prothrombin complex concentrate in a neurocritical care unit.
  

  Sanchez Mas E, Ramachandran L, Ahmad A, Achuo E, Damani R, Rao C, et al.

• Correlation of personalized and standard blood pressure thresholds with mortality in patients with intracranial hemorrhage and intraventricular hemorrhage.
  

  Siddiqui K, Ramachandran L, Shrestha B, Atwood H, D'Avignon S, Zuniga E, et al.

• Pooled-analysis derived model identifies CN-105 as a promising therapy to improve 90-day outcomes for patients with intracerebral hemorrhage.
  

  Torrealba Acosta G, James M, Laskowitz DT, Mandava P

• Development of predictive models for 90-day outcomes of patients with aneurysmal subarachnoid hemorrhage.
  

  Torrealba Acosta G, Menon G, Chang CWJ, Laskowitz DT, Mandava P

Gordon Research Conferences (GRC)
Cannabinoid Function in the CNS Conference in Barcelona, Spain (July 16-21, 2023)

• Endocannabinoid signaling at GABAergic synapses in behaving animals.
  [Oral Presentation]
  

  Dudok B

Facioscapulohumeral Muscular Dystrophy (FSHD) Society
30^th Annual International Research Congress on FSHD in Milan, Italy (June 15-16, 2023)

• DUX4, nucleolar stress, apoptosis, and FSHD myopathy.
  

  Serra C, Wagner KR, Wilson A, Lloyd TE

• Fibro-adipogenic progenitors and FSHD myopathy.
  

  Serra C, Wagner KR, Wilson A, Lloyd TE

American Academy of Neurology (AAN)
75^th Annual Meeting in Boston, Mass. (April 22-28, 2023)

• Early-life social determinants of SCA6 age at onset, severity, and progression.
  

  Chen T, Casey H, Lin C-Y, Boyle T, Schmahmann J, L'Italien G, et al.

• Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.
  

  Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

• Parental leave experience for academic neurology faculty at 19 academic centers.
  

  He A, Grewal P, Rodrigues K, Shah S, Alexander H, Yang A, et al.

• Spinocerebellar ataxia 21 and phenotypic variability within a single family.
  

  Hull M, Parnes M, Jankovic J

• Systemic inflammatory response syndrome deteriorates the outcomes of mechanical thrombectomy in acute stroke.
  

  Jafari M, Katlowitz K, De la Garza C, Sellers A, Moore S, Hall H, et al.

• Data-driven phenotypic clustering of Parkinson's disease patients seeking deep brain stimulation.
  

  Jimenez Shahed J, Berg A, York M, Schwalb J, Kirk J, Siddiqui M, et al.

• Gambling associated risk-taking decision in cerebellar ataxia.
  

  Lai R-Y, Desai N, Amlang C, Lin C-Y, Chen T, Minyetty M, et al.

• Instrumental Activities of Daily Living (IADL) as a digital biomarker of cognitive decline in older adults.
  

  Lee M, Mishra RK, York M, Kunik M, Barchard G, Vaziri A, et al.

• Apathy and Parkinson's disease motor phenotypes: A preliminary study.
  

  Lenka A, Gazes Y, Vanegas-Arroyave N

• Respiratory impairment in multiple sclerosis: A single-center study in 371 people with MS.
  

  Murrieta-Alvarez I, Perez CA, Leon-Peña AA, Benítez-Salazar JM, Gallardo-Pérez MM, Olivares-Gazca JC, et al.

• Impact of gender and race on academic achievements for neurology faculty.
  

  Patel S, Grewal P, O'hana Nobleza C, Ayub N, Kung D, Shah S, et al.

• Cognitive function remains associated with global functional impairment in profound dementia due to Alzheimer's disease and dementia with Lewy bodies.
  

  Rampalli I, Pavlik V, Yu M, Bishop J, Lin C

• Precision neurology for dementia.
  

  Shulman J, Vanegas-Arroyave N, Fong J, Elsea S, Lin C, Saade H, et al.

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Annual Forum in San Diego, Calif. (Feb. 23-25, 2023)

• Anti-myelin oligodendrocyte glycoprotein (anti-MOG) meningoencephalitis.
  

  Elfasi A, Alkabie S, Rodriguez E, Timmons G, Montalvo Perero M, Castrodad Molina R, et al.

• Treatment response to different immunotherapies in relapsing myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
  

  Elfasi A, Alkabie S, Rodriguez E, Timmons G, Montalvo Perero M, Castrodad Molina R, et al.

• Frequency of oligoclonal bands and IgG index status in the cerebrospinal fluid of Hispanic patients with multiple sclerosis.
  

  Murrieta-Álvarez I, Pérez CA, Amezcua L

• Flurry of neurologic symptoms - KLHL11 paraneoplastic rhombencephalitis.
  

  Patel HY, Pérez CA

American Stroke Association
2023 International Stroke Conference in Dallas, Texas (Feb. 8-10, 2023)

• Strokes averted by intravenous thrombolysis: A secondary analysis of the BEST-MSU trial.
  

  Bach I, Czap AL, Parker SA, Jacob AP, Mir S, Wang M, et al.

• A patient-level data Euclidean-matched analysis of reperfusion therapies in acute ischemic stroke from the Latin American Stroke Registry (LASE).
  

  Barboza MA, Torrealba-Acosta G, Valdez H, Arauz A, Abanto C, Amaya PF, et al.

• Stroke survivors experience during the COVID-19 pandemic: A phenomenological investigation.
  

  Kimmel B, Anderson J, Walder A, Ovalle A, Venkatasubba Rao CP

• Acute stroke treatment in patients with pre-exiting disability: A secondary analysis of the BEST-MSU trial.
  [Oral Presentation]
  

  Pirlog BO, Jacob AP, Yamal J-M, Parker S, Rajan SS, Bowry R, et al.

• Favorable mechanical thrombectomy outcomes from the Latin American Stroke Registry (LASE) and resilient trial compared to a 90-day functional and mortality predictive model.
  [Oral Presentation]
  

  Torrealba-Acosta G, Barboza MA, Arauz A, Amaya PF, Ameriso SF, Cano V, et al.

• Predictors of occlusion after flow diversion of aneurysms in the internal carotid artery: Pooled analysis of 2 large studies.
  

  Vivanco-Suarez J, Farooqui M, Singer J, Rodriguez Calienes A, Bekelis K, Javed K, et al.

National Aeronautics and Space Administration (NASA)
2023 Human Research Program Investigators' Workshop in Galveston, Texas (Feb. 7-9, 2023)

• Enhancing exploration platforms and analog definition intracranial pressure.
  

  Bershad EM, Hirzallah MI, Williams MA, Malm J, Eklund A

• SPACE-CENT: Studying the physiological and anatomical effects of centrifugation and head down tilt bed rest.
  

  Bershad EM, Marshall-Goebel K, Laurie SS, Greenwald S, Macias BR, Venkatasubba Rao CP, et al.

• The long-term consequences of spaceflight on brain and eye health (SANS LTH).
  

  Bershad EM, Strangman G, Ivkovic V, Kramer L, Hasan K, Rao CP, et al.

• Initial analysis of pre- and post-flight refractive error changes in commercial spaceflight participants.
  [Oral Presentation]
  

  Hernández CS, Gil A, Bershad E, Urquieta E, Hirzallah MI, Wehse A, et al.

• Machine learning for the automation of optic nerve sheath diameter measurement: Current progress and future implications for crew autonomy.
  

  Hirzallah MI, Bose S, Hu J, Maltz JS

• Uncovering methodological inconsistencies in ultrasonographic optic nerve sheath diameter measurement and a path forward using expert consensus.
  

  Hirzallah MI, Lochner P, Hafeez MU, Lee AG, Krogias C, Dongarwar D, et al.

• Investigating long-term structural and functional changes to the eye and brain after spaceflight.
  

  Macias BR, Basner M, Bershad EM, Seidler R, Stahn AC, Pardon LP, et al.

• BRAIN-SANS: Brain-related assessments for investigating the neurophysiology of SANS - 2023 update.
  [Oral Presentation]
  

  Thoolen S, Zhang Q, Ivkovic V, Voss S, Moestl S, Frett T, et al.

• Zero G and ICP: Invasive and noninvasive ICP monitoring and sans biomarker identification.
  

  Williams MA, Bershad EM, Levine BD, Clark J, Furman D, Hu X, et al.

• B complex: A nutraceutical SANS countermeasure.
  [Oral Presentation]
  

  Zwart SR, Macias BR, Melin MM, Bershad E, Smith SM

• Exploring endothelial function risk factors and optic disc edema during strict 6° head-down tilt bed rest.
  [Oral Presentation]
  

  Zwart SR, Macias BR, Melin MM, Bershad E, Smith SM

International Neuropsychological Society (INS)
51^st Annual Meeting in San Diego, Calif. (Feb. 1-4, 2023)

• Psychometric properties of the Verbal Series Attention Test: Preliminary findings.
  

  McCauley SR, York MK, Strutt AM, Stinson JM, Henry SK, Windham VA, et al.

American Epilepsy Society (AES)
76^th Annual Meeting in Nashville, Tenn. (Dec. 2-6, 2022)

• A Bayesian switching linear dynamical system for modeling seizure cycles.
  

  Chiang S, Wang E, Vannucci M, Haneef Z, Moss R, Rao V

• Surgical outcomes in post-traumatic epilepsy: A metanalysis.
  

  Haneef Z, Ferreira L, Tabaeizadeh Fesharak M

• The VA EEG Utilization Project: A national VA operations and quality improvement initiative.
  

  Kellogg M, Smith C, Pugh MJ, Haneef Z, Rehman R, Jones J, et al.

• Assessment of mindfulness in the epilepsy monitoring unit.
  

  Maheshwari K, Chang V, Baig M, Hotait M, Chavez A, Maheshwari A

• Encephalopathy in kv1.1 KO mice is associated with hippocampal BDNF and EGR3.
  

  Mazumder AG, Kamen J, Bass J, Schirmer C, Krishnan V

• Nonlinear dysregulation of glutamate and neural activity facilitates glioma-induced epilepsy.
  

  Meyer J, Yu K, Deneen B, Noebels J

• A digenic mechanism for absence epilepsy.
  

  Miao Q-L, Noebels J

• Emx1-Cre is expressed in peripheral neurons that regulate cardiorespiratory tone.
  

  Ning Y, Noebels J, Aiba I

• mTOR complexes in epilepsy and seizure disorders.
  

  Okoh J, Mays J, Bacq A, Zhou H, Imanbeyev K, Jafar-Nejad P, et al.

• Diagnostic utility of video alone in differentiation of epileptic seizures from paroxysmal non-epileptic events in children.
  

  Raichur P, Burr T, Modiano Y, Barton C, Sah J, Farber D, et al.

• Disparities in morbidity and mortality in adults with status epilepticus in the USA: 2010-2019.
  

  Tantillo G, Dongarwar D, Venkatasubba Rao C, Johnson A, Camey S, Reyes O, et al.

Society of Neuro-Oncology (SNO)
27^th Annual Scientific Meeting and Education Day in Tampa, Fla. (Nov. 16-20, 2022)

• Pathogenic germline mutations in glioma patients.
  

  McDonald MF, Prather LL, Helfer CR, Ludmir EB, Echeverria AE, Patel AJ, et al.

Society for Neuroscience (SFN)
52^nd Annual Meeting in San Diego, Calif. (Nov. 12-16, 2022)

• Dissecting the role of mTOR complexes in epilepsy and seizure disorders.
  

  Okoh JT, Mays JL, Bacq A, Imanbayev K, Zhou H, Jafar-Nejad P, et al.

• Layer- and cell type- specific cortical circuit deficits underlying the absence epilepsy.
  

  Song S, Maheshwari A, Noebels JL, Jiang X

• Transcriptional dysregulation of thalamic t-type calcium channel gene precedes seizure onset in childhood absence epilepsy mouse model tottering.
  

  Thompson S, Sonig A, Noebels J

American Neurological Association (ANA)
147^th Annual Meeting in Chicago, Ill. (Oct. 22-25, 2022)

• Actigraphic correlates of psychiatric disability in patients with focal epilepsy.
  

  Abboud MA, Kamen JL, Gavvala JR, Lin L, Krishnan V

Neurocritical Care Society (NCS)
20^th Annual Meeting in San Antonio, Texas (Oct. 17-21, 2022)

• Patient and cost-benefit of utilizing checklists in the Neurocritical Care Unit.
  

  Escamilla-Ocañas CE, Torrealba-Acosta G, Mandava P, Qasim MS, Gutiérrez-Flores B, Bershad E, et al.

• Methodological inconsistencies in optic nerve sheath diameter measurement using bedside ultrasound - A systematic review of literature.
  

  Hafeez MU, Manchanda R, Hirzallah MI

• A multimodal noninvasive approach to predict radiographic DCI in high grade aneurysmal SAH.
  

  Klavansky D, Baang H, Yoo J, Tsetsou S

• Orthostatic differences in transcranial Doppler in severe COVID-19.
  

  Reynolds SA, Reilly JK, Poor DH, Rural K, Howell D, Mustafa A, et al.

• Critical care provider's perspective of multimodal monitoring in patients with acute brain injury.
  

  Romero R, Reynolds A, Dangayach N, Tsetsou S, Klavansky D

Movement Disorder Society (MDS)
26^th International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain (Sept. 15-18, 2022)

• Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis subtype of cervical dystonia.
  

  Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

• Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with retrocollis subtype of cervical dystonia.
  

  Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

• Spinocerebellar ataxia 21 and phenotypic variability within a family.
  

  Hull M, Parnes M, Jankovic J

• Racial differences in essential tremor.
  

  Jamal F, Noorbhai I, Jackson G, Sarwar A

• Neuroanatomical underpinnings of apathy in Parkinson's disease.
  

  Le Heron C, Huey E, Vanegas-Arroyave N, Gazes Y, Lee S

• Chronotype and cognition in veterans with Parkinson's disease.
  

  Sarwar A

• How does head tremor in cervical dystonia change with head position?
  

  Vu J, Cisneros E, Zhao J, Jankovic J, Factor S, Goetz C, et al.

32^nd International Congress of Clinical Neurophysiology (ICCN)
Geneva, Switzerland (Sept. 4-8, 2022)

• Time to EEG connection after status epilepticus in the neurocritical care unit - A pilot study.
  

  Gutzwiller EM, Kosarussavadi S, Liang J, Singh A, Nelson S, Fields M, et al.

• Neurophysiologic competency certification module for ancillary test reporting in determination of death by neurological criteria — EEG, brainstem and somatosensory evoked potentials.
  [Oral Presentation]
  

  Tsetsou S

Gordon Research Conferences (GRC)
Mechanisms of Epilepsy and Neuronal Synchronization Conference in Barcelona, Spain (July 31 - Aug. 5, 2022)

• Cell type-specific recruitment of hippocampal perisomatic inhibition during seizures in vivo.
  

  Dudok B, et al.

• Dichotomy of basket cell recruitment during seizures.
  [Oral Presentation]
  

  Dudok B, et al.

2022 Alzheimer's Association International Conference (AAIC)
San Diego, Calif. (July 30 - Aug. 4, 2022)

• "Hablemos de Alzheimer": Words Mexican Americans use to talk about Alzheimer's disease genetic testing. Implications for precision medicine education.
  

  Fong JC, Chavez F, Silos K, Castro GC, Arroyo-Miranda ML, Kunik ME, et al.

• A matrisomal proteomics network modulates tau and amyloid-beta toxicity in fly AD models.
  

  Li-Kroeger D, Al-Ramahi I, Marella A, Amoh BK, Smith N, Botas J, et al.

• Reduced vascular disease mortality associated with improved 5-year survival in an AD cohort followed for 25 years.
  [Platform Presentation]
  

  Pavlik VN

• Cell-specific responses to Tau pathology in the aging brain.
  

  Wu T, Guo C, Deger JM, Dhindsa J, Al-Ouran R, Shulman JM

• Retromer subunit, VPS29, regulates vacuolar-type ATPase and lysosomal acidification in the aging brain.
  

  Ye H, Bagchi P, Wu T; Dammer EB, Seyfried NT, Shulman JM

International Neurotoxin Association (INA)
Toxins 2022 6^th International Conference in New Orleans, La. (July 27-30, 2022)

• Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.
  

  Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

American Academy of Clinical Neuropsychology (AACN)
20^th Annual Meeting in Minneapolis, Minn. (June 22-25, 2022)

• Forensic grand rounds: Practical considerations in the evaluation of non-native English speakers.
  

  Irani F, Strutt AM, Yamout KZ

Facioscapulohumeral Muscular Dystrophy (FSHD) Society
29^th Annual International Research Congress on FSHD in Orlando, Fla. (June 16-17, 2022)

• DUX4, the nucleolar stress, and the FSHD myopathy.
  

  Serra C, Wagner KR, Lloyd TE

• Fibro-adipogenic progenitors and the progression of the FSHD myopathy.
  

  Serra C, Wagner KR, Lloyd TE

International Myositis Society
4^th Global Conference on Myositis, Prague, Czech Republic (June 6-9, 2022)

• Role of the cGAS/STING pathway in inclusion body myositis.
  

  Serra C, Wilson A, Ikenaga C, Perry K, Reed N, Roda RH, et al.

ISI Committee on Risk Analysis (ISI-CRA) of the International Statistical Institute (ISI)
9^th International Conference on Risk Analysis (ICRA9) in Perugia, Italy (May 25-27, 2022)

• Experience of stroke survivors during the COVID-19 pandemic (ESS-COV): A phenomenological investigation.
  [Oral Presentation]
  

  Kimmel B, Anderson J

Professional Society for Health Economics and Outcomes Research (ISPOR)
2022 Annual Meeting in Washington, DC (May 16-18, 2022)

• Comparative adherence trajectories across oral disease-modifying agents in multiple sclerosis.
  

  Earla JR, Hutton GJ, Aparasu RR

• Factors associated with prescribing of teriflunomide and dimethyl fumarate versus fingolimod in multiple sclerosis.
  

  Earla JR, Hutton GJ, Aparasu RR

American Academy of Neurology (AAN)
74^th Annual Meeting in Seattle, Wash. (April 2-7, 2022)

• Clinical and demographic characteristics associated with poor posterior circulation stroke outcomes: Greater Cincinnati/Northern Kentucky stroke study.
  

  Chervak L, Demel S, Sucharew H, Jasne A, Woo D, Martini S, et al.

• The American Academy of Neurology Residents as Educators Workgroup Initiative: Nurturing future neurology educators.
  [Oral Presentation]
  

  Furr-Stimming E, Dara A, Rybinnik I, Quick A, Schuyler EA, Biliciler S, et al.

• Erdheim-Chester disease with isolated CNS involvement: A case report and systematic review of literature.
  

  Haque A, Perez C, Reddy T, Gupta R

• Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.
  [Previously Presented]
  

  Jankovic J, Carruthers J, Naumann M, Boodhoo T, Gupta S, Attar M, et al.

• A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
  

  Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

• Determinants of disparate disability accumulation in Black, Hispanic, and White patients with multiple sclerosis.
  

  Orlando C, Lincoln J, Perez C, Agyei P, Elsehety M, Singh SK

• NeuroLytes: Developing clinical reasoning for medical students on the neurology clerkship.
  

  Qasim MS, Moore MZ, Sellers A, Garcia CR, Manchanda R, Noorbhai I, et al.

• Steroid-responsive ecchordosis physaliphora diagnosed as CLIPPERS: A systematic review of literature and case report.
  

  Reddy T, Perez C, Haque A, Samant R, Gupta R

• Responsive neurostimulation vs. vagus nerve stimulation in epilepsy.
  

  Skrehot H, Englot D, Haneef Z

• Implementation of systematic safety checklists in a neurointensive care unit: A quality and improvement study.
  [Oral Presentation]
  

  Torrealba-Acosta G, Escamilla-Ocanas C, Mandava P, Bershad E, Hirzallah M, Venkatasubba Rao C, et al.

• Investigation of neuroplasticity with the responsive neurostimulation (RNS) system during battery failure.
  

  Vallera A, Ward R, Karakas C, Skrehot H, Cleboski S, Haneef Z

• Seizure control during COVID-19: A study using the responsive neurostimulation system (RNS).
  

  Ward R, Karakas C, Skrehot H, Vallera A, Cleboski S, Haneef Z

• Gender discrepancies in neurologist compensation.
  

  Yu MM, Merillat SA, Weathers AL, Evans DA, Wolf RA, Ney JP

Texas Scottish Rite Hospital for Children
44^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 24-25, 2022)

• Impaired large fiber sensory exam with normal NCS.
  [Oral Presentation]
  

  Komal F, Sharp L, Abid F

American Stroke Association
2022 International Stroke Conference in New Orleans, La. (Feb. 9-11, 2022)

• Utility of routine inpatient echocardiography in acute ischemic stroke patients with established stroke etiology: A population study.
  

  Aziz YN, Kandregula K, Sucharew H, Alwell K, Woo D, Demel S, et al.

• Temporal trends in stroke patients who had prior transient ischemic attack and did not present to the emergency room: A population study.
  

  Aziz YN, Kandregula K, Sucharew H, Demel S, Alwell K, Woo D, et al.

• Trends in the clinical phenotype of infective endocarditis related stroke from 2005-2015: A population-based study of the Greater Cincinnati/Northern Kentucky region.
  

  Ridha M, Aziz Y, Ades LMC, Alwell KS, Woo D, Khoury JC, et al.

American Stroke Association
2022 Stroke Nursing Symposia in New Orleans, La. (Feb. 8, 2022)

• Mobile health technology is feasible and effective for self-management support among underserved stroke survivors.
  [Oral Presentation]
  

  Anderson J, Kimmel B, Sansgiry S, Evans-Hudnall G, Ovalle A, Cerra-Stewart C, et al.

National Aeronautics and Space Administration (NASA)
Virtual 2022 Human Research Program Investigators' Workshop (Feb. 7-10, 2022)

• CADRE: Commercial astronaut data repository.
  [Oral Presentation]
  

  Bershad E, Hirzallah M, Damani R, Venkatasubba Rao C, Urquieta E, Wu J, et al.

• SPACE-CENT: Studying the physiological and anatomical cerebral effects of centrifugation and head down tile bed rest: 2021 update.
  

  Bershad E, Marshall-Goebel K, Laurie S, Greenwald S, Pardon L, Macias B, et al.

• A review of optic nerve sheath diameter use in spaceflight and analogues with qualitative analysis and future directions.
  

  Fall D, Lee A, Bershad E, Kramer L, Mader T, Clark J, et al.

• Governance and institutional review board challenges for the Inspiration4 mission?s crew health research program (MESH -i4 and CADRE).
  [Oral Presentation]
  

  Hirzallah M, Urquieta E, Wu J, Basner M, Shelhamer M, Sargsyan A, et al.

• BRAIN-SANS: Brain-related assessments for investigating the neurophysiology of SANS.
  [Oral Presentation]
  

  Thoolen S, Zhang Q, Ivkovic V, Voss S, Moestl S, Frett T, et al.

• Zero G and ICP: Invasive and noninvasive ICP monitoring and SANS biomarker identification.
  

  Williams M, Bershad E, Levine B, Clark J, Furman D, Hu X, et al.

• Exploring endothelial function risk factors and optic disc edema changes during strict 6° head-down tilt bed rest.
  

  Zwart S, Macias B, Melin M, Bershad E, Young M, Smith S

American Clinical Neurophysiology Society (ACNS)
2022 Annual Meeting in Orlando, Fla. (Jan. 26-30, 2022)

• The electroencephalogram of the developing brain.
  [Herbert H. Jasper Award Lecture]
  

  Mizrahi EM

American Society of Neuroimaging / NeuroNet Pro (ASN/NNP)
Joint Annual Meeting 2022 in Scottsdale, Ariz. (Jan. 13-16, 2022)

• Cerebral venous sinus thrombosis masquerading as acute arterial ischemic stroke.
  

  Hafeez MU, Hafeez K, Qasim S, Shastri R

Institute of Electrical and Electronics Engineers (IEEE)
2021 IEEE 18^th India Council International Conference (INDICON) in Guwahati, India (Dec. 19-21, 2021)

• A more generalizable DNN based automatic segmentation of brain tumors from multimodal low-resolution 2D MRI.
  

  Divya B, Parameshwaran Nair R, Prakashini K, Girish Menon R, Litvak P, Mandava P, et al.

Baylor College of Medicine (BCM)
Virtual Neuropsychology Grand Rounds in Houston, Texas (Dec. 9, 2021)

• The Neuropsychology of SARS-CoV2.
  [Oral Presentation]
  

  Hollman CM, Henry SK

American Epilepsy Society (AES)
75^th Annual Meeting in Chicago, Ill. (Dec. 3-7, 2021)

• KCNQ2 G256W, a "moderate severity" developmental encephalopathy allele, modeled in silico, in vitro, and in knockin mice.
  

  Abreo T, Ji Z, Xu M, Dunbar C, Chavez A, Johnson J, et al.

• Spontaneous cortical spreading depolarization in a SCN1A deficient Dravet syndrome mouse model.
  

  Aiba I, Ning Y, Noebels J

• System xc: Friend or foe in KCNA1-null mice?
  

  Aloi M, Noebels J

• Predictive value of magnetoencephalography to guide intracranial implant strategy.
  

  Anand A, Gadot R, Najera R, Smith D, Hegazy M, Gavvala J, et al.

• Opposite recruitment of hippocampal PV- and CCK-expressing interneurons in epilepsy.
  

  Dudok B, Malhotra S, Soltesz I

• Mortality and access to comprehensive epilepsy care among U.S. veterans.
  

  Haneef Z, Rehman R, Husain A

• COVID-19 and epilepsy: Data from Responsive Neurostimulation System (RNS).
  

  Karakas C, Ward R, Cleboski S, Haneef Z

• On the mental status of Stargazer mice.
  

  Krishnan V, Abboud M, Lee S, Bass J, Schirmer C, Mazumder A

• Actigraphic correlates of disability in patients with focal epilepsy.
  

  Lin L, Abboud M, Bass J, Gavvala J, Krishnan V

• Genetic labeling of CCK-expressing interneurons in a chronic mouse model of temporal lobe epilepsy.
  

  Malhotra S, Dudok B, Soltesz I

• On the digital psychopharmacology of antiseizure medications.
  

  Mazumder A, Bass J, Lee S, Schirmer C, Krishnan V

• Making absence epilepsy by combining two epilepsy genes.
  

  Miao Q, Noebels J

• Multi-scale investigation of the pathological nature of interictal spikes.
  

  Nguyen QA, Farrell J, Dudok B, Szabo G, Gschwind T, Hadjiabadi D, et al.

• Fenfluramine directly inhibits cortical spreading depolarization&emdash;A pathophysiologic process linked to SUDEP.
  

  Ning Y, Reeder T, Noebels J, Aiba I

• Provider experience with ketamine for refractory status epilepticus.
  

  Tantillo G, Davis N, Granstein J, Yoo JY, Agarwal P, Reilly K, et al.

• Transcriptional dysregulation of thalamic T-type calcium channel CACNA1G gene precedes seizure onset in childhood absence epilepsy mouse model tottering.
  

  Thompson S, Sonig A, Noebels J

• The effect of sensory deprivation and mutant gene dosage on seizures and background oscillations in a mouse model of absence epilepsy.
  

  Yang R, Sonesra A, Ntamatungiro A, Chavez A, Dunbar C, Agashe S, et al.

Society of Neuro-Oncology (SNO)
26^th Annual Scientific Meeting and Education Day in Boston, Mass. (Nov. 18-21, 2021)

• An innovative virtual multi-institutional, multidisciplinary neuro-oncology tumor board: The NIH-NOB experience during the COVID-19 pandemic.
  

  Rogers J, Acquaye A, Ikiddeh-Barnes U, Benson K, Boris L, Akindona F, et al.

Society of Vascular and Interventional Neurology (SVIN)
Hybrid Annual Meeting in Phoenix, Ariz. (Nov. 17-20, 2021)

• Dural arteriovenous fistula and implications in aneurysmal genesis.
  

  De la Garza C, Shastri R

• Impact of systemic inflammatory response syndrome on acute ischemic stroke patients treated with mechanical thrombectomy.
  

  Jafari M, Katlowitz K, De la Garza C, Sellers A, Moore S, Hall H, et al.

• Covered stent placement for treatment of a dural arteriovenous fistula: Case report and literature review.
  

  Moore S, Hoang AN, Tanweer O

Society for Neuroscience (SFN)
Virtual Annual Meeting (Nov. 8-11, 2021)

• Functional validation of the cytoskeletal protein Plectin in Alzheimer's disease.
  

  Lee TV, Allison K, Seyfried NT, Levey AI, Shulman JM

• Alzheimer's disease risk gene CD2AP modulates synaptic structure and plasticity.
  

  Paveskovic M, Ojelade S, Pekarek B, Kochukov M, Arenkiel B, Shulman J

• Layer- and pathway-specific disruption of perisomatic inhibition in the somatosensory cortex of the stargazer model of absence epilepsy.
  

  Song S-Y, Maheshwari A, Noebels JL, Jiang X

• Hippocampal GABAergic cell type selectively controlling local and extra-hippocampal interneurons during sharp-wave ripples.
  

  Szabo GG, Dudok B, Hou W-H, Farrell JS, Ortiz A, Varga C, et al.

Association of American Medical Colleges (AAMC)
Learn Serve Lead 2021: The Virtual Experience (Nov. 8-10, 2021)

• Inter-professional education on the neurology clerkship involving physical therapy and medical students.
  

  Kung DH, Oyelami V, Brewer W, Hessel S, Bramlett L, Gill A

Gordon Research Conferences (GRC)
Cannabinoid Function in the CNS Conference in Ventura, Calif. (Nov. 6-7, 2021)

• Retrograde endocannabinoid signaling at perisomatic GABAergic synapses during behavior.
  [Oral Presentation]
  

  Dudok B, et al.

Neurocritical Care Society (NCS)
19^th Annual Meeting in Chicago, Ill. (Oct. 26-29, 2021)

• The use of point of care compression ultrasound as a screening tool for lower extremity deep vein thrombosis in the neurocritical care unit.
  

  Cuesta Isabel IJ, Damani R, Bershad E, Venkatasubba Rao CP, Hirzallah M, Desai A, et al.

• Spontaneous spinal subarachnoid hemorrhage with simultaneous intracranial subarachnoid hemorrhage: A case report.
  

  Moore S, Hafeez M, Siddiqui K, Venkatasubba Rao C

American Neurological Association (ANA)
146^th Annual Virtual Meeting (Oct. 14-19, 2021)

• The implication of pyramidal signs in multiple system atrophy.
  [Previously Presented]
  

  Lin CY, Viswanathan A, Chen TX, Kuo SH

Movement Disorder Society (MDS)
Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 17-22, 2021)

• Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of Tourette syndrome.
  

  Billnitzer A, Jankovic J

• Distinct impulsive traits in cerebellar ataxia and Parkinson's disease.
  

  Chen TX, Lin CY, Aumann M, Claassen D, Kuo SH

• A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
  

  Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

• The implication of pyramidal signs in multiple system atrophy.
  

  Lin CY, Viswanathan A, Chen TX, Kuo SH

• Tourette syndrome and driving.
  

  Makhoul K, Jankovic J

• Deep brain stimulation surgery and clinical characteristics of essential tremor in a cohort of veterans.
  

  Noorbhai IZ, Jamal F, Jackson G, Sarwar A

• Whole-exome sequencing in a movement disorders clinic.
  

  Shah C, Robak L, Hill EJ, Jankovic J

• The MJFF global genetic Parkinson's disease research resource.
  

  Vollstedt E-J, Aasly JO, Ahmad-Annuar A, Al Mubarak B, Alcalay RN, Alvarez V, et al.

17^th International Conference of Computational Methods in Sciences and Engineering (ICCMSE)
Crete, Greece (Sept. 4-7, 2021)

• A qualitative approach to evaluate post stroke telehealth (VAST) services in Texas.
  [Oral Presentation]
  

  Kimmel B, Anderson J

2021 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 26-30, 2021)

• U.S. POINTER: Lessons learned about delivery of a multi-domain lifestyle intervention during the COVID-19 pandemic.
  

  Baker LD, Espeland MA, Whitmer RA, Kivipelto M, Antkowiak S, Chavin M, et al.

• Integrating multimodal data to support Alzheimer's disease target prioritization.
  

  Cary GA, Gockley J, Lehallier B, Leal K, Greenwood AK, Shulman JM, et al.

• The Alzheimer's disease risk gene CD2AP modulates mammalian synaptic structure and plasticity.
  

  Paveskovic M, Ojelade SA, Kochukov M, Pekarek B, Arenkiel B, Shulman JM

• Elucidiating cellular contributions to tau-mediated neurodegeneration using Drosophila and single cell transcriptomics.
  

  Wu T, Guo C, Shulman JM

Society of NeuroInterventional Surgery (SNIS)
18^th Annual Meeting in Colorado Springs, Colo. (July 26-29, 2021)

• Strict aspects cutoffs in endovascular therapy selection paradigms may harm patient outcomes.
  

  Abdelkhaleq R, De la Garza C, Kim Y, Khose S, Salazar Marioni S, Sheth S

Human Brain Project (HBP)
Brain Initiative Meeting (virtual) (June 15-17, 2021)

• Alternating recruitment and opposed scaling of distinct hippocampal inhibitory modules during behavior.
  

  Dudok B, et al.

American Academy of Clinical Neuropsychology (AACN)
Virtual 19^th Annual Meeting (June 9-12, 2021)

• Psychiatric and military history do not differentiate psychogenic non-epileptic seizures and epileptic seizures among veterans.
  

  Modiano Y, Karakas C, Haneef Z

Baylor College of Medicine (BCM)
4^th Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (May 20, 2021)

• Multiple sclerosis in a multi-ethnic population in Houston, Texas: A retrospective analysis, 2019-2020.
  

  Mercado V, Dongarwar D, Wiafe KA, Costello P, Fisher K, Salihu HM, et al.

• Effects of narcolepsy during pregnancy on adverse maternal-fetal outcomes.
  

  Wilson A, Dongarwar D, Carter K, Marroquin M, Salihu HM

Professional Society for Health Economics and Outcomes Research (ISPOR)
Virtual 2021 Annual Meeting (May 17-20, 2021)

• Effect of different variance estimation methods with inverse probability treatment weights (IPTW) on comparative effectiveness measure in multiple sclerosis.
  

  Earla J, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR

• Factors associated with prescribing of disease-modifying agents among older adults with multiple sclerosis: A real-world analysis of electronic medical records.
  

  Talwar A, Earla J, Hutton GJ, Aparasu RR

Association for Research in Vision and Ophthalmology (ARVO)
Virtual 2021 Annual Meeting (May 1-7, 2021)

• Optic disc edema and chorioretinal folds develop during strict head-down tilt bedrest with and without artificial gravity.
  

  Greenwald SH, Laurie S, Marshall-Goebel K, Pardon LP, Lee SMC, Stern C, et al.

American Academy of Neurology (AAN)
Virtual 2021 Annual Meeting (April 17-22, 2021)

• Diagnostic outcome of genetic testing on neuromuscular disorders in a tertiary center.
  

  Al Sultani H, Komal F, Shaibani A

• The RIKEE database: Genotype-phenotype patterns in KCNQ channel related disease, based on 784 individuals and pedigrees.
  

  Cooper E, Joshi N, Millichap J, Tsuchida T, Nesbitt G, Taglialatela M, et al.

• Acute bilateral optic neuritis due to Borrelia Burgdorferi in a patient with multiple sclerosis on ocrelizumab.
  

  Gill S, Wyrostek SL, Whiting C, Zand R, Esch M

• Adverse neurological events amongst patients undergoing Extracorporeal Membrane Oxygenation (ECMO).
  

  Hafeez MU, Siddiqui K, Ahmad A, Bershad E, Hirzallah MI, Venkatasubba Rao CP, et al.

• Age of onset and deep brain stimulation in a cohort of essential tremor.
  

  Jamal F, Sarwar A

• A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
  

  Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

• A paradoxical phenomenon: Seizure exacerbation following administration of anti-seizure drugs.
  

  Jaramillo M, Pham T, Kamrudin S, Khanna R, Maheshwari A

• Patient reported baseline measures in RAD-PD reveal marked heterogeneity in a DBS cohort.
  

  Jimenez Shahed J, Berg A, York M, Siddiqui M, Schwalb J, McInerney J

• Patient preference in virtual versus in-person visits in neuromuscular clinical practice, a multicenter survey.
  

  Komal F, Al Sultani H, Habib A, Siddiqi Z, LaBoy S, Biliciler S, et al.

• The implication of upper motor neuron burden in multiple system atrophy.
  

  Kuo SH, Viswanathan A, Chen TX, Lin CY

• Cerebellar Impulsivity-Compulsivity Assessment (CIA): A scale to measure impulsive and compulsive behaviors in cerebellar disorders.
  

  Lin CY, Desai NA, Freedman S, Chen TX, Viswanathan A, Korrapati K, et al.

• Corticobasal degeneration and auditory hallucination.
  

  Lin CY, Viswanathan A, Kang UJ, Vonsattel JP

• NeuroLytes as a novel, virtual, case-based didactics targeted at medical students undergoing Neurology clerkship.
  

  Nascimento F, Moore M, Qasim M, Kung D

• Ten year clinical outcomes of subthalamic nucleus versus pallidal deep brain stimulation for Parkinson's disease: VA/NINDS CSP #468F.
  

  Ostrem J, Luo P, Weaver F, Follett K, Galifianakis N, Lai E, et al.

• Candida parapsilosis mastoiditis causing Gradenigo's and Vernet's syndrome: a case report in an older adult.
  

  Parekh M, Pacheco V

• Sociodemographic and clinical characteristics of patients with multiple sclerosis by race and ethnicity (NARCRMS Registry).
  

  Rivera V, Repovic P, Adeyemi A, Altincatal A, Perez-Bajandas C, Saldana-King T, et al.

• Spontaneous intracranial hypotension presenting as postural headache and cranial VI palsy: A case report.
  

  Shou L, Kengen A, Goldsmith C

• EEG findings in patients undergoing extracorporeal membrane oxygenation (ECMO).
  

  Siddiqui K, Hafeez MU, Ahmad A, Bershad E, Hirzallah MI, Venkatasubba Rao CP, et al.

• North American survey on the effects of the COVID-19 pandemic shutdown on DBS care.
  

  Siddiqui M, De Jesus S, Sarva H, McInerney J, Panov F, York M, et al.

• Resident lumbar puncture clinic at Geisinger Health System: A single program needs assessment for quality improvement.
  

  Wyrostek SL, Whiting C, Houtz C, Avila JD

Baylor College of Medicine (BCM)
Henry J.N. Taub and James K. Alexander Medical Student Research Symposium in Houston, Texas (March 25, 2021)

• Machine learning algorithm for differentiating epileptic and non-epileptic seizures.
  

  Han A, Nakhleh L, Fussner S, Haneef Z

• COVID-19 survey of clinical neurophysiology/epilepsy program directors and fellow trainees in the United States.
  

  Nakhleh L, Gavvala J, Haneef Z

• ADHD Comorbidity in patients with epilepsy and psychogenic non-epileptic seizures in the Epilepsy Monitoring Unit.
  

  Pham C, Maheshwari A

American Stroke Association
Virtual 2021 International Stroke Conference (March 17-19, 2021)

• Racial disparities in blood pressure at time of acute ischemic stroke emergency department presentation within a population.
  

  Aziz YN, Demel SL, Ridha M, Ades LM, Alwell KS, Woo D, et al.

• Google Auto ML based prediction of outcomes in intracerebral hemorrhage - Bringing machine learning to clinicians.
  

  Mandava P, Hegde A, Sandesh O, Menon G

• Outcomes after thrombolysis for ischemic stroke in Costa Rica compare favorably with international cohorts.
  

  Mandava P, Torrealba-Acosta G, Barboza MA, Fernandez-Morales H, Qasim M, Litvak P, et al.

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Virtual 2021 Annual Meeting (Feb. 25-27, 2021)

• The reality of MS epidemiology in LATAM.
  [Oral Presentation]
  

  Rivera V

Texas Scottish Rite Hospital for Children
43^rd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 18-19, 2021)

• Outcomes in neuromuscular genetic testing.
  

  Al Sultani H, Hafeez K, Shaibani A

• Clinicians preference of virtual vs. physical visit.
  [Oral Presentation]
  

  Hafeez K, Al Sultani H, Shaibani A

American Clinical Neurophysiology Society (ACNS)
Virtual 2021 Annual Meeting (Feb. 10-14, 2021)

• The utility of additional depth or subdural electrodes following stereotactic EEG evaluation.
  

  Karimov A, Gavvala J, Goldman A, Haneef Z, Maheshwari A, Sheth S, et al.

International Neuropsychological Society (INS)
Virtual 49^th Annual Meeting (Feb. 2-5, 2021)

• SALUD Strutt MacDonald Equitable Healthcare Model: A comprehensive approach to addressing healthcare disparity in the field of neuropsychology.
  

  MacDonald B, Strutt A

• Predictive utility of MMPI-2-RF in differentiating psychogenic non-epileptic events and epilepsy in a largely male veteran sample.
  

  Modiano YA, Webber T, Cerbone B, Haneef Z, Pastorek N

National Aeronautics and Space Administration (NASA)
Virtual 2021 Human Research Program Investigators' Workshop (Feb. 1-3, 2021)

• SPACE-CENT: Studying the physiological and anatomical effects of centrifugation and head down tilt — Updated results.
  [Oral Presentation]
  

  Bershad EM, Marshall-Goebel K, Laurie SS, Greenwald S, Pardon L, Macias BR, et al.

• Cerebral oxygen delivery and dynamic autoregulation are maintained following 60 days strict head down tilt.
  

  Hoffmann F, Moestl S, Hasan KM, Gerlach D, Marshall-Goebel K, Laurie S, et al.

• Saccade metrics and visual reaction times are not negatively affected by head down tilt bedrest with or without artificial gravity.
  

  Martina S, Nguyen K, Kernagis D, Bershad EM, Clark J

• Effects of repetitive, successive oculometric testing on saccades, smooth pursuit, and visual reaction times for future head down tilt bed rest study applications.
  

  Nguyen K, Martina S, Kernagis D, Clark J, Hinricher N, Backhaus C, et al.

• MRI-based quantification of posterior globe flattening in head-down tilt bedrest subjects, and the effect of centrifugation.
  

  Seiner A, Sater S, Conley Natividad G, Bershad E, Fu A, Macias BR, et al.

• Fluid shifts during short-arm centrifugation: The AGBRESA Study (SPACE-CENT).
  

  Strangman GE, Marshall-Goebel K, Moestl S, Bershad EM

• Hemodynamic fluid shifts during orthostatic tilt — Can NIRS detect impending pre-syncope? The AGBRESA Study (SPACE-CENT).
  

  Strangman GE, Marshall-Goebel K, Moestl S, Bershad EM, Tank J

• Brain related assessments for investigating the neurophysiology of SANS (BRAIN-SANS).
  

  Strangman GE, Zhang Q, Ivkovic V, Voss S, Tank J, Wu J, et al.

• Zero G and ICP: Invasive and non-invasive ICP monitoring and SANS biomarker identification.
  

  Williams MA, Bershad EM, Levine B, Clark J, Malm J, Eklund A, et al.

International Neurotoxin Association (INA)
Virtual Conference (Jan. 16-17, 2021)

• Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.
  

  Jankovic J, Carruthers J, Naumann M, Boodhoo T, Gupta S, Attar M, et al.

• A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
  

  Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

• Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naive subjects: Results from a phase III study.
  

  Mitsikostas DD, Dekundy A, Althaus M, Scheschonka A, Pagan F, Jankovic J

American Epilepsy Society (AES)
74^th Annual Meeting in Seattle, Wash. (Dec. 4-8, 2020)

• Actigraphic correlates of disability in patients with focal epilepsy.
  

  Bass J, Kapadia P, Gavvala J, Krishnan V

• Machine learning can model visual EEG analysis for epileptic and non-epileptic seizure classification.
  

  Fussner S, Nakhleh L, Haneef Z

• EEG education in neurology residency &emdash; EEG knowledge before and after lecture-based didactics.
  

  Gavvala J, Nascimento F, Maheshwari A, Chu J

• Outpatient smartphone video prediction of epileptic vs. non-epileptic seizures in U.S. veterans.
  

  Karakas C, Van Ness P, Gavvala J, Modiano Y, Fadipe M, Fussner S

• Epileptic encephalopathy in KCNA1 KO mice disrupts active state organization.
  

  Krishnan V, Schirmer C, Jankovic M, Kapadia P, Bass J

• Deficits in 5-HT2C receptor signaling coordinately impact seizure risk and behavioral activity.
  

  Massey C, Thompson S, Jankovic M, Bass J, Krishnan V, Noebels JL

• On the digital psychopharmacology of valproic acid in mice: Adult and prenatal exposure.
  

  Schirmer C, Ton L, Tuo A, Jankovic M, Kapadia P, Krishnan V

• Neuromonitoring at the height of a pandemic: EEG findings in patients with COVID-19.
  

  Tantillo G, Jette N, Marcuse L, Navis A

• Right-lateralized posterior parietal theta-gamma coupling during sustained attention in mice.
  

  Yang R, Dunbar C, Sonesra A, Ntamatungiro A, Park S, Ressler K, et al.

Society of Neuro-Oncology (SNO)
25^th Virtual Annual Scientific Meeting and Education Day (Nov. 19-21, 2020)

• IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
  

  Mandel J, Youssef M, Yust-Katz S, Patel A, Jalali A, Ludmir E, et al.

Society of Vascular and Interventional Neurology (SVIN)
Virtual 2020 Annual Meeting (Nov. 18-21, 2020)

• Predictors of functional outcome in post-mechanical thrombectomy patients.
  

  De la Garza C, Torrealba-Acosta G, Hassan AE, Jafari M, Desai A, Sellers A, et al.

• Clinical description of post-mechanical thrombectomy patients treated at a comprehensive stroke center.
  

  De la Garza C, Torrealba-Acosta G, Hassan AE, Moore S, Hall H, Jafari M, et al.

• Cell count ratios as outcome predictors in acute ischemic stroke patients treated with mechanical thrombectomy.
  

  De la Garza C, Torrealba-Acosta G, Hassan AE, Moore S, Hall H, Sellers A, et al.

Joint European Stroke Conference and World Stroke Congress
Virtual Conference (Nov. 7-9, 2020)

• Functional outcome in very elderly acute ischemic stroke patients after IV thrombolysis: Single center experience.
  

  Fernandez-Morales H, Sanchez-Acosta C, Sanchez-Pacheco R, Vargas-Howell R, Perez-Rojas R, Barboza MA, et al.

• Reducing door-to-needle times for acute ischemic stroke in a public hospital in Costa Rica.
  

  Fernandez-Morales H, Sanchez-Acosta C, Sanchez-Pacheco R, Vargas-Howell R, Perez-Rojas R, Torrealba-Acosta G, et al.

• Pulse pressure variability is associated with unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis in a phase III randomized-controlled clinical trial.
  

  Katsanos AH, Tsivgoulis G, Mandava P, Kohrmann M, Soinne L, Barreto A, et al.

• Response to thrombolysis in Costa Rican patients compared with NINDS and CLOTBUST-ER cohorts.
  

  Torrealba-Acosta G, Barboza-Elizondo M, Litvak P, Fernandez-Morales H, Rothlisberger T, Tsivgoulis G, et al.

• Moderators of the efficacy of sonothrombolysis in acute ischaemic stroke patients with large vessel occlusion: A systematic review and international collaborative individual patient data meta-analysis.
  

  Tsivgoulis G, Katsanos AH, Eggers J, Larrue V, Thomassen L, Grotta J, et al.

• Blood pressure excursions are associated with unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis in a phase III randomized-controlled clinical trial.
  

  Tsivgoulis G, Katsanos AH, Mandava P, Kohrmann M, L Soinne, Barreto A, et al.

Houston Neuropsychological Society
Virtual Fall Symposium (Oct. 24, 2020)

• Disparities in global cognition between lower and higher SES older adults.
  

  Henry SK, Stinson J, Strutt AM

American Congress of Rehabilitation Medicine (ACRM)
Virtual 97^th Annual Meeting (Oct. 21-24, 2020)

• Long-term effects of daily sensory neuromodulation on gait function in persons with peripheral neuropathy using a wearable neuroprosthesis.
  

  Oddsson LI, Bisson T, Cohen HS, Iloputaife I, Jacobs J, Khoshnoodi M, et al.

American Neurological Association (ANA)
145^th Annual Meeting in Los Angeles, Calif. (Oct. 4-6, 2020)

• Epileptic encephalopathy in Kcna1 KO mice disrupts active state organization.
  

  Bass J, Schirmer C, Jankovic M, Kapadia P, Krishnan V

• Neurosarcoidosis related vision loss mimicking idiopathic intracranial hypertension.
  

  Lie M, Acosta GT, Melendez-Zaidi A, Sharp L

Neurocritical Care Society (NCS)
Virtual 18^th Annual Meeting (Sept. 22-25, 2020)

• Variations in regional and hospital level factors in relation to clinical outcomes of subarachnoid hemorrhage in the United States.
  

  Desai A, Kazemlou S, Saber H, Cuesta Isabel IJ, Damani R

• Clinically measured scalp EEG activity and detection of cortical spreading depolarizations.
  

  Sivakumar S, Tsetsou S, Patel AB, Stapleton C, Schweitzer J, Sharma G, et al.

• Is door-to-needle time an adequate surrogate in predicting function outcome after IV thrombolysis in acute ischemic stroke?
  

  Torrealba Acosta C, Barboza-Elizondo MA, Escamilla-Ocanas C, Fernandez-Morales H, Damani R

• Predictors of functional outcome in patients with acute ischemic stroke treated with IV thrombolysis, in a public hospital in Costa Rica.
  

  Torrealba Acosta C, Barboza-Elizondo MA, Escamilla-Ocanas C, Fernandez-Morales H, Damani R

• Early systolic blood pressure variability and hyponatremia are associated with cerebral vasospasm in aSAH patients.
  

  Venkatasubba Rao C, Escamilla-Ocanas CE, Torrealba-Acosta G, Qasim M, Hafeez M, Gutierrez-Flores B, et al.

• Early systolic blood pressure variability is associated with a poor neurological outcome at discharge in aSAH patients.
  

  Venkatasubba Rao C, Escamilla-Ocanas CE, Torrealba-Acosta G, Qasim M, Hafeez M, Gutierrez-Flores B, et al.

• Positive fluid balance during NICU stay is associated with decreased survival after aSAH.
  

  Venkatasubba Rao C, Torrealba-Acosta G, Escamilla-Ocanas CE, Qasim M, Hafeez M, Gutierrez-Flores B, et al.

Virtual 18^th International Conference of Numerical Analysis and Applied Mathematics (ICNAAM)
Rhodes, Greece (Sept. 17-23, 2020)

• Goal attainment measures for stroke survivors self-management support interventions: A systematic review.
  [Invited Presentation]
  

  Kimmel B, Anderson J

International Society for Pharmacoepidemilogy (ISPE)
International Conference on Pharmacoepidemilogy (ICPE) All Access 2020 virtual event (Sept. 16-17, 2020)

• Comparative treatment effectiveness of oral fingolimod and injectable disease modifying agents in multiple sclerosis.
  

  Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR

Movement Disorder Society (MDS)
Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 12-16, 2020)

• Impulsivity in cerebellar ataxias: Testing the cerebellar reward hypothesis in humans.
  [Previously Presented]
  

  Amokrane N, Viswanathan A, Freedman S, Yang CY, Kuo SH, Lin CY

• Cognitive differences between men and women with progressive supranuclear palsy.
  

  Bayram E, Jankovic J, Reich S, Marras C, Bordelon Y, Shprecher D, et al.

• Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects: Results from a Phase III study.
  

  Pagan F, Dekundy A, Althaus M, Scheschonka A, Jankovic J, Mitsikostas D

• Is chronotype a biomarker for depression in military veterans with Parkinson's disease?
  

  Sarwar A

• Use of botulinum toxin: Experience in a cohort of essential tremor patients.
  

  Shah C, Jamal F, Sarwar A, Jackson G

8^th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
MS Virtual 2020 (Sept. 11-13, 2020)

• Socio-demographic and clinical characteristics of patients with multiple sclerosis by race and ethnicity (NARCRMS registry).
  

  Rivera V, Repovic P, Adeyemi A, Altincatal A, Perez-Bajandas C, Saldana-King T, et al.

2020 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 27-31, 2020)

• US-POINTER (USA).
  [Platform Presentation]
  

  Baker LD, Espeland MA, Kivipelto M, Whitmer RA, Snyder HM, Carrillo MC, et al.

• A consensus proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
  

  Johnson ECB, Dammer EB, Duong D, Ping L, Zhou M, Yin L, et al.

• Different profiles of cognitive deficits predict progression rate in probable AD.
  

  Sood A, Pavlik VN, Darby E, Chan W, Doody R

American Academy of Clinical Neuropsychology (AACN)
18^th Annual Meeting in Washington, DC (June 10-13, 2020)

• Neuropsychological assessment for primarily Portuguese-speaking Brazilians living in the United States.
  

  Diaz-Santos AL, Henry SK, Strutt AM, Stinson J, McCauley S, York M

• Working with culturally diverse populations: Development of a Farsi-speaking battery.
  

  Henry SK, Strutt AM, Diaz Santos AL, Stinson J

Professional Society for Health Economics and Outcomes Research (ISPOR)
Virtual 2020 Annual Meeting (May 18-20, 2020)

• Comparative adherence trajectories of oral fingolimod and injectable disease modifying agents in multiple sclerosis.
  

  Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu R

• Factors associated with prescribing of oral fingolimod in multiple sclerosis.
  

  Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu R

American Academy of Neurology (AAN)
72^nd Annual Meeting in Toronto, Ontario, Canada (April 25 - May 1, 2020)

• Neurological symptoms in patients with zinc deficiency: A case series with documented blood levels.
  

  Achari M, Escamilla-Ocanas CE, Amjadi N

• Impulsivity in cerebellar ataxias: Testing the cerebellar reward hypothesis in humans.
  

  Amokrane N, Viswanathan A, Freedman S, Yang CY, Kuo SH, Lin CY

• Clinical and neuropsychological correlates of the TETRAS score in DBS patients.
  

  Bellows S, Combs J, Jimenez-Shahed J

• Evaluation of the association between the age of onset and duration of epilepsy, and the neuropsychological and developmental performance, in patients with refractory epilepsy, at the Costa Rica National Children's Hospital Epilepsy Monitoring Unit: a 13-year hospital-based retrospective cohort.
  

  Bogantes Ledezma S, Rodriguez-Roblero MC, Torrealba Acosta G, Segura-Valverde JL, Brian-Gago R

• Postpartum relapse after first on-study pregnancy in RRMS patients treated with alemtuzumab in the phase 2 and 3 clinical development program over 8 years.
  

  Celius EG, Oh J, Achiron A, Compston DAS, Devonshire V, Hellwig K, et al.

• The use of dual therapy vs. triple therapy in patients with atrial fibrillation and acute coronary syndrome: A network meta-analysis of randomized clinical trials.
  

  Desai A, Escamilla-Ocanas C, Asgarisabet P, Damani R

• Inpatient complications and mortality of stroke in Costa Rica: A seven-year hospital-based acute stroke registry of 1319 patients.
  

  Escamilla-Ocanas CE, Torrealba Acosta G, Damani R, O'Brien AT, Liu R, Barboza-Elizondo M, et al.

• Utilization of systematic safety checklists to improve length-of-stay, infection rates, preventable complications and mortality at the Neurointensive Care Unit of the Baylor Saint Luke's Medical Center: A quality improvement study.
  

  Escamilla-Ocanas CE, Torrealba Acosta G, Hirzallah M, Bershad E, Venkatasubba Rao C, Damani R

• Improving learning with a neurology question of the day.
  

  Goldsmith C

• Addressing challenges of clinical comprehensive genetic testing in Parkinson's disease.
  

  Hill E, Deger J, Robak L, Rao S, Saade H, Ripperger B, et al.

• Treatment strategies for glioblastoma in older patients: Age is just a number.
  

  Mandel J, Youssef M, Ludmir E, Patel A, Jalali A, Treiber J, et al.

• Examining the impact of isocitrate dehydrogenase (IDH) gene status on the development of venous thromboembolism in glioma patients.
  

  Mandel J, Youssef M, Yust-Katz S, Patel A, Jalali A, Wu J, et al.

• EEG education in neurology residency &emdash; Baseline EEG knowledge and resident perception.
  

  Nascimento F, Maheshwari A, Chu J, Gavvala J

• A wearable sensory neuroprosthesis to improve gait and balance function in persons with sensory peripheral neuropathy &emdash; the walk2Wellness Trial .
  

  Oddsson L, Bisson T, Cohen H, Iloputaife I, Koehler-McNicholas S, Kung D, et al.

• Treatment patterns in patients with essential tremor.
  

  Shah C, Jamal F, Jackson G, Sarwar A

• Multiple watershed infarcts confirming the existence of a vascular steal phenomenon established around a brain arteriovenous malformation.
  

  Torrealba Acosta G, Diaz Marchan P, Escamilla Ocanas C, Damani R

Society of Behavioral Medicine (SBM)
2020 Virtual Annual Meeting and Scientific Sessions (April 1-4, 2020)

• Synergistic impact of pain interference and depression on quality of life and function of the stroke patients.
  

  Evans-Hudnall G, Bakhshaie J, Anderson J

American Society on Aging (ASA)
Virtual Annual Conference in Atlanta, Ga. (March 24-27, 2020)

• Integrating service learning opportunities into traditional geropsychology curriculum.
  

  Elick E, Scholz M, Longenecker H, Tseng L, Kutnar S, Espinoza-Mendoza R, et al.

Texas Scottish Rite Hospital for Children
42^nd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 20-21, 2020)

• Sjogren's associated with inclusion body myositis.
  

  Abu A, Biliciler S, Nguyen T

American Stroke Association
2020 International Stroke Conference in Los Angeles, Calif. (Feb. 19-21, 2020)

• Post-acute stroke experience survey: Development and pilot testing.
  

  Anderson JA, Kimmel B, Martin K, Ovalle A, Ifeorah C, Jobe E, et al.

• Cerebellar infarction presentations: A population-based study from the Greater Cincinnati/Northern Kentucky Stroke Study.
  

  Kerber KA, Khoury J, Burke J, Meurer W, Alwell K, Moomaw C, et al.

• Behavioral change intervention and predictors of self-management blood pressure control in underserved post-stroke population.
  

  Kimmel B, Fujimoto K, Saliba R, Anderson JA

• No improvement in emergency medical services use by stroke patients from 1999-2015: A population-based study.
  

  Li JL, Sucharew H, Alwell K, Broderick JP, Coleman E, De Los Rios La Rosa F, et al.

• High accuracy of predictive models for SAH using different machine learning approaches.
  

  Litvak P, Medikonda J, Menon G, Mandava P

• Diffusion weighted imaging lesions in patients with acute intracerebral hemorrhage: A pooled analysis of individual patient data from MISTIE-III, ATACH-II, I-DEF, and ERICH.
  

  Murthy SB, Cho S-M, Gupta A, Shoamanesh A, Avadhani R, Gruber J, et al.

• Safety and efficacy of sonothrombolysis in acute ischemic stroke patients with large vessel occlusion: International collaborative individual patient data meta-analysis.
  

  Tsivgoulis G, Katsanos AH, Eggers J, Larrue V, Thomassen L, Grotta JC, et al.

International Neuropsychological Society (INS)
48^th Annual Meeting in Denver, Colo. (Feb. 5-8, 2020)

• Self-reported sleep quality and cortical thickness at 3-months post-mild traumatic brain injury.
  

  Merkley TL, Wilde EA, McCauley SR, Barnes A, Hanten G, Levin HS

• Predictive utility of MMPI-2-RF in differentiating psychogenic non-epileptic events and epilepsy in a largely male Veteran sample.
  

  Modiano Y, Webber T, Cerbone B, Haneef Z, Pastorek NJ

• Neuropsychological and non-motor assessment baseline characteristics of the RAD-PD cohort.
  

  York MK, Kirk J, Berg A, Shih L, Schwalb J, McInerney J, et al.

University of Houston Health Research Institute
Health: A Call to Action Conference in Houston, Texas (Jan. 30-31, 2020)

• Addressing health disparities in specialty care: Strutt MacDonald Service Model for Equitable Healthcare.
  [Platform Presentation]
  

  Strutt AM, MacDonald B

National Aeronautics and Space Administration (NASA)
2020 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 27-30, 2020)

• SPACE-CENT: Studying the physiological and anatomical effects of centrifugation and head down tilt - preliminary results.
  [Platform Presentation]
  

  Bershad E, Marshall-Goebel K, Venkatasubba Rao C, Damani R, Cohen H, Clark J, et al.

• Intracranial effects of artificial gravity: A flow study at 3T.
  [Platform Presentation]
  

  Kramer L, Kramer D, Marshall-Goebel K, Hasan K, Laurie S, Bershad E

• Optic disc edema develops during bed rest in subjects not exposed to elevated ambient CO₂.
  [Platform Presentation]
  

  Laurie S, Macias B, Marshall-Goebel K, Greenwald S, Stern C, Bershad E, et al.

• Successful implementation of oculometric assessment during head down tilt bed rest: Technical considerations.
  

  Martina S, Nguyen, K, Kernagis D, Bershad E, Clark J

• Evolution of eye examinations during bed rest studies: Maintaining ocular health in space and on Earth.
  

  Stern C, Mittelstaedt D, Stupp S, Klink K, Pittius M, Ritter S, et al.

• Changes in refraction during 60 days of -6° headdown tilt bed rest.
  [Platform Presentation]
  

  Stern C, Pittius M, Ritter S, Mittelstaedt D, Klink K, Stupp S, et al.

• Physiological monitoring of fluid shifts during orthostatic tilt.
  [Platform Presentation]
  

  Strangman G, Marshall-Goebel K, Hoffmann F, Moestl S, Tank J, Bershad E

• Zero G and ICP: Invasive and noninvasive ICP monitoring and sans biomarker identification.
  

  Williams M, Bershad E, Levine B, Clark J, Malm J, Eklund A, et al.

American Epilepsy Society (AES)
73^rd Annual Meeting in Baltimore, Md. (Dec. 6-10, 2019)

• High yield of screening for ADHD in the epilepsy monitoring unit.
  

  Dunbar C, Lee M, Maheshwari A

• KB-3061 is a potent activator of wild type KCNQ channels and restores current to KCNQ2 encephalopathy variants in vitro.
  

  Ji Z-G, Moore O, Abreo T, Dworetzky S, Picchione KE, Cooper EC

• Mice lacking 5-HT2C receptors have a lowered spreading depolarization threshold compared to wildtype littermates.
  

  Massey CA, Noebels JL

• Local disinhibition via tetanus toxin injection reshapes neural activity and EEG patterns in mouse neocortex.
  

  Meyer J, Smirnakis SM

• 17^th Annual Judith Hoyer Lecture in Epilepsy: Advances in diagnosis and management of neonatal seizures.
  [Invited Lecture]
  

  Mizrahi EM

• Arx mouse model of x-linked infantile spasms shows augmented wave of early cortical apoptosis without evidence of cellular inflammation.
  

  Siehr MS, Massey CA, Noebels JL

• Pregnancy-related complications and risk of post-partum readmission for seizures.
  

  Tantillo G, Jette N, Yoo JY

• Posterior parietal theta-gamma phase-amplitude coupling as a biomarker for sustained attention in mice.
  

  Yang RZ, Dunbar C, Sonesra A, Park S, Pham T, Maheshwari A

National Academy of Neuropsychology (NAN)
39^th Annual Meeting in San Diego, Calif. (Nov. 13-16, 2019)

• The culturally expressive and responsive (CER) supervision model in neuropsychology.
  

  Strutt AM, MacDonald B, Stinson JM

University of Pittsburgh Medical School
UPMC Critical Care Symposium in Pittsburgh, Penn. (Nov. 11, 2019)

• Radiology 101 for nurses and respiratory therapists.
  

  Hirzallah MI

American Congress of Rehabilitation Medicine (ACRM)
96^th Annual Meeting in Chicago, Ill. (Nov. 5-8, 2019)

• How to prevent older adults from falling? Effectiveness of technological innovations and clinical approaches.
  

  Wang C, Najafi B, Kahya M, Zhou H, York MK

• Neurodegenerative disease NG and geriatric rehabilitation NG mentorship round table discussion.
  

  Wingo B, Heyn P, Hirsch M, York MK, Backus D, Mark V, et al.

• Patient engagement approaches for improving research and clinical care in Parkinson's disease.
  

  York MK, Benge J, Hirsch M, Robledo I, Iyer S

Society for Neuroscience (SFN)
49^th Annual Meeting in Chicago, Ill. (Oct. 19-23, 2019)

• Cav3.1 and 3.2 T-type Ca²⁺ channels collectively contribute to oscillatory excitation of nucleus ambiguus neurons.
  

  Aiba I, Noebels JL

• A genetic cross between Gad2-Cre and loxTB Htr2c mouse strains does not prevent seizures and death in a 5-HT_2C-null SUDEP mouse model.
  

  Massey CA, Noebels JL

• Progression of cortical hypersynchrony and epileptogenesis induced by brain tumors.
  [Platform Presentation]
  

  Meyer JF, Yu K, Hatcher A, Aiba I, Deneen B, Noebels JL

• Mice with adult-onset P/Q calcium channel deletion recapitulates childhood absence epilepsy.
  

  Miao QM, Noebels JL

• Investigating the role of CD2AP, an Alzheimer's disease susceptibility gene, in mammalian synaptic structure and function.
  

  Paveskovic M, Ojelade SA, Pekarek BT, Arenkiel BR, Shulman JM

• Nodes of DMN involved in general intelligence.
  

  Yadav A, Lalwani P, Suri H, Jejurikar R, Purushotham A

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
66^th Annual Meeting in Austin, Texas (Oct. 16-19, 2019)

• Incorporation of electrodiagnostic case reviews to the morning report in a neurology residency program.
  

  Wyrostek SL, Avila JD

Neurocritical Care Society (NCS)
17^th Annual Meeting in Vancouver, British Columbia, Canada (Oct. 15-18, 2019)

• Characteristics of Patients with Deep Venous Thrombosis after Intracerebral Hemorrhage.
  

  Escamilla-Ocañas CE, Amna Ramzan, Ali Ahmad, Gutiérrez-Flores BL, Jobe E, Venkatasubba Rao CP, et al.

• Rates of Infections and Clinical Outcomes after Intracerebral Hemorrhage.
  

  Escamilla-Ocañas CE, Gutiérrez-Flores BL, Jobe E, Bershad EM, Venkatasubba Rao CP, Saleem Y, et al.

• Low serum calcium levels are associated with a worse clinical outcome in ICH.
  

  Escamilla-Ocañas CE, Naveed A, Gutiérrez-Flores BL, Jobe E, Bershad EM, Venkatasubba Rao CP, et al.

• Clinical seizures associated with a worse clinical outcome at hospital discharge in ICH patients.
  

  Escamilla-Ocañas CE, Sorge S, Komal G, Gutiérrez-Flores BL, Jobe E, Bershad EM, et al.

• Clinical seizures associated with a worse clinical outcomes at hospital discharge in aSAH patients.
  

  Escamilla-Ocañas CE, Torrealba-Acosta G, Naveed A, Parekh MA, Gutiérrez-Flores BL, Jobe E, et al.

• Factors Affecting the Development of Acute Renal Failure after Intracerebral Hemorrhage.
  

  Gutiérrez-Flores ML, Hafeez M, Escamilla-Ocañas CE, Jobe E, Damani R, Bershad EM, et al.

• A multimodal non-invasive approach for intracranial hypertension detection: A single-center prospective study.
  

  Tsetsou S, Ronquillo M, Reynolds A, Dangayach N

American Neurological Association (ANA)
144^th Annual Meeting in St. Louis, Mo. (Oct. 13-15, 2019)

• A consensus Alzheimer's disease brain protein co-expression network identifies robust biological alterations associated with early- and late-stage disease.
  

  Johnson ECB, Dammer EB, Duong DM, Yin L, Betarbet R, Shulman JM, et al.

• Biological alterations associated with early- and late-stage disease.
  

  Johnson ECB, Dammer EB, Duong DM, Yin L, Betarbet R, Shulman JM, et al.

• Parkinson's disease susceptibility in carriers of lysosomal storage disorder genes.
  

  Robak L, Shulman J

• Progressive autoimmune cerebellar degeneration in a young healthy man: Not your typical vertigo.
  

  Santos D, Tantillo G, Tse W, Yeshokumar AK

• Norovirus: An unusual case of infantile encephalopathy and status epilepticus.
  

  Tantillo G, Navyamani Kagita VD, Kauffman D, LaVega-Talbott M

• Posterior parietal theta-gamma phase-amplitude coupling as a biomarker for sustained attention in mice.
  

  Yang R, Dunbar C, Sonesra A, Park S, Maheshwari A

Movement Disorder Society (MDS)
23^rd International Congress of Parkinson's Disease and Movement Disorders in Nice, France (Sept. 22-26, 2019)

• The influence of sociodemographic factors on post-DBS impulse control symptom severity in Parkinson's disease.
  

  Combs H, Strutt A, Jimenez-Shahed J, Niemann N, Viswanathan A, York MK

• Age of onset and diagnosis of essential tremor.
  

  Jamal F, Jackson GR, Moore S, Sarwar AI

• Design and implementation of a quality improvement registry for DBS in Parkinson's disease.
  

  Jimenez-Shahed J, d'Haese P-F, Kirk J, York MK, Berg A, Shih L, et al.

• Is sleep disordered breathing a risk factor for REM sleep behavior disorder in military Veterans with Parkinson's disease?
  

  Sarwar AI, Moore S

• Neuropsychiatric symptoms over the initial lustrum of Parkinson disease: Common, increasing, comorbid and varied.
  

  Weintraub D, Caspell-Garcia C, Simuni T, Cho R, Coffey C, Aarsland D, et al.

Lone Star Stroke Research Consortium
Annual Meeting in Austin, Texas (July 19, 2019)

• Tool that measures goal attainment in management of stroke risk factors.
  

  Kimmel B, Anderson J

2019 Alzheimer's Association International Conference (AAIC)
Los Angeles, Calif. (July 14-18, 2019)

• Tau-mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer's disease.
  

  Guo C, Hsieh Y-C, Yalamanchili HK, Abreha M, Al-Ouran R, Li Y, et al.

• Functional dissection of an Alzheimer's disease susceptibility gene network.
  

  Lee TV, Allison KS, Ojelade SA, Lah JJ, Levey AI, Seyfried NT, et al.

• Functional dissection of Alzheimer's disease brain gene expression signatures in humans and mouse models.
  

  Mangleburg CG, Wan Y-W, Al-Ouran R, Lee TV, Allison KS, Logsdon BA, et al.

• Cholinesterase inhibitors have a disease modifying effect in AD relative to CHRFAM7A genotype suggesting an a7NAChR dependent mechanism.
  

  Szigeti K, Chen Z, Ouf A, Reisch J, Pavlik V, Wilding G

Gordon Research Conferences (GRC)
GRC Inhibition in the CNS Conference in Newry, Maine (July 7-9, 2019)

• Recruitment of interneuron classes during spontaneous behavior: CCK cells fill the gaps.
  [Oral Presentation]
  

  Dudok B, et al.

• Temporal dichotomy of the activity of parvalbumin- and cholecystokinin-containing hippocampal interneurons during locomotion and immobility.
  

  Dudok B, et al.

Baylor College of Medicine (BCM)
2^nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019)

• Spanish/cross-cultural fellowship in neuropsychology: A response to the needs of the Houston Hispanic community.
  

  Baena E, Vuong KD, Stinson JM, McCauley SR, York MK, Strutt AM

• Developing culturally competent foreign language neuropsychological assessments: Vietnamese-speaking patients with suspected dementia.
  

  McCauley SR, Strutt AM, Stinson JM, Combs HL, York MK

• Geopolitical considerations of working with medically complex patients: An Urdu speaking case illustration.
  

  Stinson JM, Combs HL, York MK, Strutt AM, McCauley SR

• CCACTUS - Cross-cultural consortium on aging and cognition in Texas, U.S.: The development of a neuropsychology data repository.
  

  Strutt AM, Armendariz V, Vuong KD, Rossetti A

• BCM Cerebro: Neuropsychology outpatient clinic specializing in the care of Spanish-speakers.
  

  Strutt AM, Jose IE, McCauley SR, York MK, Stinson JM

• Development of a cross cultural neuropsychology outpatient clinic at Baylor College of Medicine.
  

  York MK, Stinson JM, McCauley SR, Strutt AM

International Association of Parkinsonism and Related Disorders (IAPRD)
XXIV World Congress on Parkinson's Disease and Related Disorders in Montreal, Canada. (June 16-19, 2019)

• The evaluation of non-motor symptoms in the registry for DBS in Parkinson's disease (RAD-PD).
  

  York MK, Kirk J, Berg A, Shih L, Schwalb J, McInerney J, et al.

American Academy of Clinical Neuropsychology (AACN)
17^th Annual Meeting in Chicago, Ill. (June 5-8, 2019)

• Utility of the Spanish Baylor Profound Mental Status Examination in advanced Alzheimer's disease.
  

  Isaac BK, Gilboa-Fried S, Salmerón Ríos S, Strutt AM

World Parkinson Congress (WPC)
Kyoto, Japan (June 4-7, 2019)

• Patient engagement in the development of OUR DBS: A global patient registry addressing outcomes and unanswered questions for DBS.
  

  Kirk J, York MK, Jimenez-Shahed J, d'Haese P-F, Berg A, Shih L, et al.

European Stroke Organisation (ESO)
5^th Conference in Milan, Italy (May 22-24, 2019)

• Endovascular equipoise shift during a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke.
  

  Alexandrov A, Tsivgoulis G, Kohrmann M, Katsanos A, Soinne L, Barreto AD, et al.

• Constitution (Prakriti) as defined by traditional Indian medicine is a risk factor for stroke.
  

  Luthra A, Harini JA, Medikonda J, Mandava P, Aaron S, Rajesh KN, et al.

• Machine learning to predict subarachnoid hemorrhage outcomes.
  

  Mandava P, Medikonda J, Khan A, Litvak P, Menon G

Professional Society for Health Economics and Outcomes Research (ISPOR)
2019 Annual Meeting in New Orleans, La. (May 18-22, 2019)

• Factors associated with prescribing of oral disease modifying agents in multiple sclerosis.
  

  Earla JR, Hutton GJ, Thornton JD, Aparasu RR

• Healthcare expenditure burden in multiple sclerosis: Marginal costs based on national level data.
  

  Earla JR, Thornton JD, Hutton GJ, Aparasu RR

Psychiatric Associations of Puerto Rico
Second Summit in Río Grande, Puerto Rico (May 2019)

• Conditioned fear extinction, neuropsychological, and psychological aspects of OCD in Latinos.
  

  Santiago-Mejías S, Martinez K

American Academy of Neurology (AAN)
71^st Annual Meeting in Philadelphia, Penn. (May 4-10, 2019)

• Symptomatic cerebrovascular manifestations as presenting symptom for neurosarcoidosis.
  

  Abu A, Patel N, Wu L

• Genome-wide association study meta-analysis for Parkinson disease motor subtypes.
  [Platform Presentation]
  

  Alfradique-Dunham I, Blauwendraat C, Al-Ouran R, von Coelln R, Tan M, Hill EJ, et al.

• Leprosy in two patients with relapsing remitting multiple sclerosis (RRMS) treated with fingolimod.
  

  Balasa A, Hutton GJ

• Immunogenicity of daxibotulinumtoxinA for injection in adults with cervical dystonia from a phase 2 dose-escalation multicenter study.
  

  Brashear A, Truong DD, Comella CL, Jankovic J, Patel AT, Prawdzik G, et al.

• When Occam's razor fails: A McArdle disease diagnosis following idiopathic transverse myelitis.
  

  Chen W, Dunham SR, Sharp L

• RECLAIM-DCP: A randomized, double-blind, placebo-controlled study of deutetrabenazine for the treatment of dyskinesia in cerebral palsy in children and adolescents.
  

  Claassen DO, Mink JW, Parnes M, Gordon MF, Barkay H, Wieman M, et al.

• Fingolimod related cryptococcal meningitis and immune reconstitution inflammatory syndrome in two patients with multiple sclerosis.
  

  Cuascut Lassus FX, Dunham SR, Hutton GJ

• Student satisfaction and NBME outcomes with team based learning on the neurology clerkship, a pilot study.
  

  Dunham SR, Haneef Z, Kung D

• A case of hepatocellular carcinoma presenting with myasthenia gravis.
  

  Fussner S, Garg T, Sharp L

• Capturing Parkinson's disease heterogeneity with quantitative mobility measures.
  [Platform Presentation]
  

  Hill EJ, Alfradique-Dunham I, Mangleburg CG, Ripperger B, Stillwell A, Rao S, et al.

• Vitamin D assessment in veterans with Parkinson's disease.
  

  Jamal F, Jackson GR, Moore S, Sarwar A

• Using a quality improvement framework to examine deep brain stimulation in Parkinson's disease: The RAD-PD initiative.
  

  Jimenez-Shahed J, d'Haese P-F, Kirk J, York MK, Berg A, Shih LC, et al.

• Consistently large amyloid reductions in patients with and without ARIA-E in the gantenerumab SCarlet RoAD and Marguerite RoAD open-label extension studies.
  [Platform Presentation]
  

  Klein G, Delmar P, Rehal S, Adjelkovic M, Abi-Saab D, Bullain SS, et al.

• Bradykinesia, mitochondrial myopathy and progressive ophthalmoplegia associated with a novel DNM1L mutation.
  

  Parnes M, Bashir HH, Jankovic J

• The potential role of estrogen in moderating symptom severity in women with RYR1-related myopathy.
  

  Sharp L, Pleitez MY, Yee R, Hamilton S

• Baseline characteristics from a phase III trial of crenezumab in early (prodromal-to-mild) Alzheimer's disease (CREAD).
  

  Sink S, Ostrowitzki S, Millar L, Warren F, Lin HC, Smith J, et al.

• Anti-GAD65 antibody: A possible link to encephalopathy, aphasia, seizures and lateralized weakness.
  

  Tantillo G, Abrams R, Mishra N, Pedowitz E, Krieger S, Yeshokumar A

University of Pittsburgh
Mitchell P. Fink Scholar Day in Pittsburgh, Penn. (April 16, 2019)

• Feasibility of virtual reality-based video-oculography to detect neurologic deterioration in the intensive care unit.
  

  Hirzallah MI, Kiderman A, Nturibi EM, Balaban C, Molyneux BJ

Parkinson Study Group (PSG)
32^nd Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Phoenix, Ariz. (April 6, 2019)

• Design and implementation of a quality improvement registry for DBS in Parkinson's disease.
  

  Jimenez-Shahed J, d'Haese P-F, Kirk J, York MK, Berg A, Shih L, et al.

14^th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
Lisbon, Portugal (March 26-31, 2019)

• Temporal trends in mortality in an AD clinical cohort.
  

  Pavlik VN, Darby E, Kass JS

North American Neuro-Ophthalmology Society (NANOS)
45^th Annual Meeting in Las Vegas, Nev. (March 16-21, 2019)

• Substantia nigra hyperintensities leads to diagnosis of Leber's hereditary optic neuropathy.
  

  Smith C, Darpel K, Echiverri K

Hispanic Neuropsychological Society (HNS)
3^rd Biannual Conference in New York City, N.Y. (Feb. 23, 2019)

• Soroxchi after traveling to South America: Cognitive and neurobehavioral changes in a patient with bilateral globus pallidus lesions.
  

  Baena E, Strutt AM

Texas Scottish Rite Hospital for Children
41^st Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 21-22, 2019)

• Nuclear gene mutation producing muscle weakness.
  [Oral Presentation]
  

  Komal F, Moretti PM, Shaibani AI

International Neuropsychological Society (INS)
47^th Annual Meeting in New York, N.Y. (Feb. 20-23, 2019)

• Cognition and psychological symptomatology in Tourette's syndrome following deep brain stimulation.
  

  Bhavsar P, Jimenez-Shahed J, Viswanathan A, Strutt AM

• Cognitive and neuropsychiatric correlates of impulse control disorder symptom severity in Parkinson's disease.
  

  Combs HL, Strutt AM, Jimenez-Shahed J, Niemann N, Viswanathan A, York MK

• An examination of the relationship between frustration tolerance and objective executive function performance in a weight loss sample.
  

  Henry SK, Gowey MA, Neumeier WH, Phillips J, Dutton GR

American Stroke Association
2019 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2019)

• Mobile health (mHealth) for secondary stroke prevention is feasible and effective.
  

  Anderson JA, Kimmel B, Tang X, Ovalle A, Ifeorah C, Gina E, et al.

• Effects of VA National Telestroke Program implementation training.
  

  Anderson JA, Schlamb L, Martini S, Plue L, Williams L, Martin H, et al.

• Racial differences in left atrial size among patients with ischemic stroke.
  

  Kamel H, Alwell K, Kissela B, Moomaw CJ, Sucharew HG, Woo D, et al.

• Racial differences in left atrial size among patients with ischemic stroke.
  

  Kamel H, Alwell K, Kissela B, Moomaw CJ, Sucharew HG, Woo D, et al.

• The Goal Attainment Measure (GAM-S) for Secondary Stroke Risk Factors Management: Pilot test and psychometric analysis.
  

  Kimmel B, Anderson J, Swank PR, Swartz MD, Burns J, Shegog R

• Stroke in the young: preliminary results for temporal trends in the age of stroke incidence in a large, bi-racial population.
  

  Kissela MB, Alwell K, Khoury JC, Moomaw CJ, Woo D, Adeoye O, et al.

• Preliminary population-based temporal trends in stroke incidence: Racial disparity and stroke incidence from 1993-2015.
  

  Kleindorfer DO, Alwell K, Khoury J, Moomaw C, Woo D, Adeoye O, et al.

• Patient perceptions of remotely delivered acute stroke care.
  

  Lyerly MJ, Martin HA, Plue L, Anderson J, Damush T, Graham GD, et al.

• Development of outcome models for intracerebral hemorrhage using patient level data from ATACH-II and information theory to identify the best predictors.
  

  Mandava P, Saeed O, Qureshi AI, Kent TA

• Veterans Administration National Telestroke Program: A distributed hub system of acute stroke care.
  

  Martini SR, Anderson J, Murphy K, Plue L, Martin H, Williams L, et al.

• Race and gender differences in mortality due to spontaneous subarachnoid hemorrhage.
  

  Rushworth D, Mathews A, Mandava P

• Predictors of neurological worsening among patients presenting with large vessel occlusions and mild symptoms.
  

  Saleem Y, Kim SJ, Sharashidze V, Nogueira RG, Frankel M, Al-Bayati A, et al.

• Regional variability in the care of subarachnoid hemorrhage (SAH) patients in the United States.
  

  Shah VA, Kazmi SO, Damani R, Hartsell A, Hohmann S, Suarez JI

• Frequent flyers: Retrospective review of repeat stroke codes.
  

  Tantillo G, Wheelwright D, Dhamoon M, Leung K, Tuhrim S, Stein L

• Implementation of informal caregiver and veteran dyadic intervention: Acquiring new skills while enhancing remaining strengths.
  

  Wilder VD, Plue LD, Roudebush RL, Murray L, Kimmel B, Dube A, et al.

• Effective communication and engagement cultivates teamwork among virtual telestroke providers.
  

  Williams LS, Patel H, Martin H, Rattray N, Miech E, Savoy A, et al.

National Aeronautics and Space Administration (NASA)
2019 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 22-25, 2019)

• SPACE-CENT: studying the physiological and anatomical effects of centrifugation and head down tilt.
  

  Bershad E, Venkatasubba Rao C, Marshall-Goebel K, Damani R, Cohen H, Clark J, et al.

• Physiological monitoring of fluid shifts during centrifugation.
  

  Marshall-Goebel K, Strangman G, Venkatasubba Rao C, Clark J, Frett T, Petrat G, et al.

• Zero G and ICP: invasive and noninvasive ICP monitoring and SANS biomarker identification.
  

  Williams M, Bershad E, Levine B, Clark J, Malm J, Eklund A, et al.

• The use of biofluids for biomarker discovery in SANS: RNAseq expression analysis on pilot ground biofluid samples.
  

  Zanello S, Bershad E, Hu X, Kitchen R, Yu S, Skog J

American Epilepsy Society (AES)
72^nd Annual Meeting in New Orleans, La. (Nov. 30 - Dec. 4, 2018)

• Tau loss modifies network excitability in brain tumor-related epilepsy.
  

  Hatcher A, Yu K, Noebels JL, Deneen B

• Functional involvement of periventricular nodular heterotopia.
  

  Houck KM, Haneef Z, Nayak A, Gavvala J, Quach MM, Van Ness PC, et al.

• An objective description of PTZ kindling in a standardized instrumented home cage environment.
  

  Jankovic M, Krishnan V

• Home cage monitoring reveals the presence of comorbid depression-related behavior in mice with deletions of Kcna1.
  

  Krishnan V, Jankovic M, Noebels JL

• Mice lacking 5-HT2C receptors display a novel adult-onset SUDEP phenotype and increased mortality in males.
  

  Massey C, Noebels JL

• Conditional deletion of PQ-type calcium channels in kainate receptor4 (Grik4)-expressing hippocampal neurons leads to adult onset absence epilepsy.
  

  Miao Q, Noebels JL

• Pharmacodynamic dependence of retigabine on Kcnq2 expression in PV+ interneurons.
  

  Park S, Dunbar C, Tarkunde Y, Akbar A, Marks R, Lee M, et al.

Society of Neuro-Oncology (SNO)
23^rd Annual Scientific Meeting and Education Day in New Orleans, La. (Nov. 15-18, 2018)

• Effect of health disparities on overall survival of patients with glioblastoma.
  

  Mandel J, Youssef M, Nam J, Patel A, Liu D, Wu J, et al.

Huntington Study Group (HSG)
Annual Meeting in Houston, Texas (Nov. 8-10, 2018)

• Real world experience with novel VMAT2 inhibitors.
  

  Niemann N, Jankovic J

• Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
  

  Savitt D, Jankovic J

Society for Neuroscience (SFN)
48^th Annual Meeting in San Diego, Calif. (Nov. 3-7, 2018)

• Interictal dentate gyrus hyperexcitation in a mouse model of Dravet syndrome.
  

  Aiba I, Noebels JL

• Dysregulation of mTORC2, but not mTORC1, underlies the neurophysiological and behavior abnormalities in Pten-deficient mouse model of ASD and epilepsy.
  

  Chen CJ, Sgritta M, Mays J, Noebels J, Costa-Mattioli M

• Tau loss modifies network excitability in brain tumor related epilepsy.
  

  Hatcher A, Yu K, Aiba I, Deneen B, Noebels JL

• β-spectrins maintain Na+ channels at axon initial segments and nodes of Ranvier.
  

  Liu CH, Stevens S, Seo R, Mohler P, Noebels J, Stankewich M, et al.

• Sex specific Alzheimer's disease heterogeneity identified through cross study integrative analysis of RNA-seq data from the AMP-AD consortium.
  

  Logsdon B, Perumal TM, Swarup V, Funk C, Allen M, Wang M, et al.

• T-type calcium channel bursting in thalamic association pathways precedes sensory pathways and can be activated by GABAergic input during early postnatal development.
  

  Miao Q, Noebels JL

• cindr, the Drosophila homolog of CD2AP, plays a conserved role in synapse function and protein turnover.
  

  Ojelade SA, Lee TV, Giagtzoglou N, Shulman J

• Deletion of KCNQ2/3 potassium channels from PV+ interneurons leads to homeostatic potentiation of excitatory transmission.
  

  Soh H, Park S, Springer K, Ryan K, Maheshwari A, Tzingounis A

• A druggable genome screen identifies modifiers of α-synuclein levels via a tiered cross-species validation approach.
  

  Vazquez-Velez G, Rousseaux MW, Al-Ramahi I, Jeong H-H, Bajic AS, Revelli J-P, et al.

• Missense epilepsy mutations in neuronal KCNQ/Kv7 channels occur at hotspots within highly conserved functional domains of Kv7.2 and Kv7.3.
  

  Zhang J, Chen C, Kim E, Procko E, Patel J, Choi R, et al.

American Neurological Association (ANA)
143^rd Annual Meeting in Atlanta, Ga. (Oct. 21-23, 2018)

• Disseminated mycobacterium avium-intracellulare presenting with multiple cranial neuropathies.
  

  Echiverri K, Pradeep S, Escott E, Sudhakar P

11^th World Stroke Congress
Montreal, Canada (Oct. 17-20, 2018)

• Constitution (Prakriti) as defined by traditional Indian medicine is a risk factor for stroke.
  

  Luthra A, Harini AJ, Rajesh KN, Aaron S, Purushotham A

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
65^th Annual Meeting in Washington, DC (Oct. 10-13, 2018)

• Validation of the Triple Timed Up-and-Go Test for clinical assessment in Lambert-Eaton myasthenia patients.
  

  Raja S, Sanders D, Juel V, Harati Y, Smith AG, Peltier A, et al.

Movement Disorder Society (MDS)
22^nd International Congress of Parkinson's Disease and Movement Disorders in Hong Kong, China (Oct. 5-9, 2018)

• Improvement in patient perceived quality of life with daxibotulinumtoxinA for injection in adults with cervical dystonia.
  

  Comella C, Brashear A, Jankovic J, Truong D, Patel A, Evatt M, et al.

• Predictors of alcohol responsiveness in dystonia.
  

  Junker J, Brandt V, Berman B, Vidailhet M, Roze E, Weissbach A, et al.

• Consensus for the measurement of the camptocormia angle.
  

  Margraf N, Wolke R, Granert O, Berardelli A, Berg D, Bloem B, et al.

• Integrated whole exome sequencing and chromosomal microarray in familial Parkinson's disease.
  

  Robak L, Du R, Yuan B, Gu S, Akdemir Z, Jankovic J, et al.

• Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson's disease?
  

  Sarwar A, Moore S

• Accuracy of the International Parkinson Disease and Movement Disorder Society progressive supranuclear palsy diagnostic criteria (IPD-MDS-PSP).
  

  Shoeibi A, Litvan I, Juncos J, Bordelon Y, Riley D, Reich S, et al.

• Genome-wide association study identifies common genetic variants associated with cervical dystonia.
  

  Sun Y, Hui Q, Perlmutter J, Ruehl S, Klein C, Jankovic J, et al.

• Erotophonophilia and severe impulse control disorder in a patient with Parkinson's disease.
  

  vander Linden C, Colle H, Colle D, Jankovic J

• Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults.
  

  von Coelln R, Dawe R, Shulman J, Yu L, Leurgans S, Hausdorff J, et al.

• Loss of VPS29 disrupts retromer function and synaptic transmission, leading to neurodegeneration in Drosophila.
  

  Ye H, Li-Kroeger D, Li Y, Bellen H, Shulman J

Neurocritical Care Society (NCS)
16^th Annual Meeting in Boca Raton, Fla. (Sept. 25-28, 2018)

• Rates of reintubation in neurocritical care.
  

  Ahmad A, Kazmi SO, Butt B, Parekh M, Venkatasubba Rao C, Bershad E, et al.

• Stroke without borders.
  [Symposium]
  

  Alexandrov A, Kirschen M, O'Phelan K, Venkatasubba Rao C

• Hyponatremia precedes vasospasm after subarachnoid hemorrhage.
  

  Escamilla-Ocana C, Kazmi O, Naveed A, Bershad E, Lazaridis C, Damani R, et al.

• Incidence of acute renal failure in patients with intracerebral hemorrhage.
  

  Gutierrez-Flores BL, Damani R, Bershad E, Calvillo E, Suarez JI, Venkatasubba Rao CP

• Full dose thrombolysis for a right middle cerebral artery stroke after an acute aortic dissection.
  

  Kazmi SO, Achi O, Damani R

• Neuro-ECMO: Extracorporeal membrane oxygenation and cerebral blood flow.
  

  Kazmi SO, Hafeez MU, Sivakumar S, Damani R, Saatee S, Chatterjee S, et al.

• Seizure induced Takotsubo cardiomyopathy.
  

  Ramzan A, Wang J, Kazmi O, Venkatasubba Rao C

• Cerebral air embolism associated with transcatheter aortic valve replacement.
  

  Surendranath A, Garg T, Kazmi SO, Bershad E

• Foster Kennedy syndrome secondary to cerebral fungal abscess in an immunocompetent patient.
  

  Tsetsou S, Reilly K, Yaeger K, Levy R, Pabich A, Lee M, et al.

• Renal injury in acute intracerebral hemorrhage.
  

  Venkatasubba Rao C, Guttierez B, Escamilla-Ocanas C, Damani R, Bershad E, Lazaridis C, et al.

• Wide variability of intracranial pressures measured in ventricular and parenchymal compartments warrant the use of separate terminology: A systematic review.
  

  Venkatasubba Rao CP, Ortega S, Ramsay J, Suarez JI, McNett MM, Aiyagari V, et al.

American Psychological Association (APA)
126^th Annual Convention in San Francisco, Calif. (Aug. 9-12, 2018)

• Moral injury in relational context: Future directions in treatment model and intervention strategy.
  

  Chen AY, Scholz M, McConnell J, Koster M, Malzahn C, Michaels M

2018 Alzheimer's Association International Conference (AAIC)
Chicago, Ill. (July 22-26, 2018)

• Update on the safety and tolerability of gantenerumab in the ongoing open-label extension (OLE) of the Marguerite Road Study in patients with mild Alzheimer's disease (AD) after approximately two years of study duration.
  

  Abi-Saab D, Andjelkovic M, Pross N, Delmar P, Voyle N, Klein G, et al.

• Update on the safety and tolerability of gantenerumab in the ongoing open-label extension of the Scarlet Road Study in patients with prodromal Alzheimer's disease after approximately two years of study duration.
  

  Andjelkovic M, Abi-Saab D, Delmar P, Pross N, Voyle N, Klein G, et al.

• Concord-AD: An international network of cohorts for better understanding of Alzheimer's disease.
  

  Burham, SC, Colom PM, Datigues JF, Doody R, Hansson O, et al.

• Twenty-four month amyloid PET results of the gantenerumab high dose open label extension studies.
  

  Klein G, Delmar P, Hofmann C, Abi-Saab D, Andjelkovic M, Ristic S, et al.

• Baseline characteristics from a phase 3 trial of crenezumab in prodromal to mild Alzheimer's disease (CREAD).
  

  Lin H, Ostrowitzki S, Sink KM, Millar L, Warren F, Smith J, et al.

• Cindr, the Drosophila homolog of CD2AP, affects synapse function and protein turnover.
  

  Ojelade SA, Lee TV, Giagtzoglou N, Shulman JM

• Twenty year trends in proportional mortality in a probable AD cohort.
  

  Pavlik VN, Darby E, Kass JS

• The effect of low doses of gantenerumab on amyloid and tau biomarkers in cerebrospinal fluid (CSF) in the Marguerite Road Study.
  

  Voyle N, Abi-Saab D, Klein G, Hofmann C, Delmar P, Pross N, et al.

2018 Congress of Neurological Surgeons (CNS)
Annual Meeting in Houston, Texas (June 22, 2018)

• Telestroke paradigms: What works and what doesn't.
  [Symposium]
  

  Bershad E

• IV tPA or not before thrombectomy for LVO?
  [Symposium]
  

  Damani R

• Challenges in stroke certification: The process and recertification.
  [Symposium]
  

  Rao C

Organization of Human Brain Mapping (OHBM)
2018 Annual Meeting in Singapore (June 17-21, 2018)

• The grey matter of G: The structural neural correlates of general intelligence.
  

  Yadav A, Lalwani P, Suri H, Jejurikar R, Purushotham A

American Society for Stereotactic and Functional Neurosurgery (ASSFN)
2018 Biennial Meeting in Denver, Colo. (June 2-5, 2018)

• Developing a comprehensive quality improvement registry for DBS in Parkinson's disease.
  

  McInerney J, Jimenez-Shahed J, Farace E, Saunders-Pullman R, Schwalb JM, Shih L, et al.

American Society of Clinical Oncology (ASCO)
54^th Annual Meeting in Chicago, Ill. (June 1-5, 2018)

• Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma.
  

  De Groot JF, Penas-Prado M, Mandel JJ, O'Brien BJ, Weathers S-PS, Zhou S, et al.

European Stroke Organisation (ESO)
4^th Conference in Gothenburg, Sweden (May 16-18, 2018)

• Does random LDL accurately guide statin-based management compared to fasting LDL in patients with acute ischemic stroke or TIA.
  

  Dadra D, Shehzad U, Singh D, Purushotham A

• NIHSS is a better predictor of outcomes in ICH compared to GCS and hematoma volume. Information theory approaches applied to databases from India and U.S..
  

  Hegde A, King Z, Ormseth C, Falcone G, Hwang D, Sansing L, et al.

• Epidemiology of rural/urban stroke disparities in the Greater Cincinnati/Northern Kentucky Stroke Study.
  

  Jasne A, Brokamp C, Alwell K, Moomaw C, Flaherty M, Adeoye O, et al.

Columbia University College of Physicians and Surgeons
1^st International Tremor Congress in New York City, N.Y. (May 11-12, 2018)

• Serum anti-gliadin antibodies in cerebellar ataxias: A systematic review and meta-analysis.
  [Previously Presented]
  

  Lin CY, Wang MJ, Tse W, Pinotti R, Green PH, Alaedini A, et al.

International Conference on Integrative Medicine and Health
2018 Annual Meeting in Baltimore, Md. (May 8-11, 2018)

• Stand-alone ayurvedic treatment in acute ischaemic stroke: A pilot study.
  

  Harini AJ, Luthra A, Madeka S, Shankar P, Mandava P, Pervaje R, et al.

University of Pittsburgh
Mitchell P. Fink Scholar Day in Pittsburgh, Penn. (April 24, 2018)

• Telemedicine assessment of brain death examinations.
  [Oral Presentation]
  

  Khandker N, Hirzallah MI, Darby JD, Shutter LA

American Academy of Neurology (AAN)
70^th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)

• Whole exome sequencing in essential tremor.
  

  Alfradique-Dunham I, Robak L, Kaw A, Fagbongbe OI, Akdemir ZC, Young E, et al.

• Spectral analysis of dynamic functional connectivity between resting-state networks reveals information beyond static connectivity.
  

  Chiang S, Vankov E, Yeh H, Guindani M, Vannucci M, Haneef Z, et al.

• TP73 is an amyotrophic lateral sclerosis candidate risk gene.
  

  Downie J, Gibson S, Tsetsou S, Keefe M, Bonkowsky J, Pulst S, et al.

• Outcomes of week-24 completers and subjects who had follow-up beyond week 24 after a single treatment of daxibotulinumtoxinA for injection (RT002): Results of a phase 2, open-label (level II), dose escalating study in isolated cervical dystonia.
  

  Jankovic J, Truong D, Patel A, Brashear A, Evatt M, Rubio R, et al.

• RAD-PD: Registry for the advancement of DBS in Parkinson's disease.
  

  Jimenez-Shahed J, Bressman S, Burack M, Farace E, McInerney J, Kirk J, et al.

• Higher dose gantenerumab leads to significant reduction in amyloid plaque burden - Results for the Marguerite and Scarlet Road open label extension studies.
  

  Klein G, Delmar P, Hofmann C, Adjelkovic M, Abi-Saab D, Milosavljevic-Ristic S, et al.

• Why aren't you giving feedback?
  

  Kung D

• Weekly feedback comment card on neurology clerkship.
  

  Kung D, Dunham R

• Serum anti-gliadin antibodies in cerebellar ataxias: A systematic review and meta-analysis.
  

  Lin CY, Wang MJ, Tse W, Pinotti R, Green PH, Alaedini A, et al.

• Wernicke encephalopathy masquerading as a right middle cerebral artery territory infarction.
  

  Lin CY, Yoo JY, Doshi A, Colman R

• Cervical dystonia and substance abuse.
  

  Mahajan A, Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C, et al.

• Effect of health disparities on overall survival of patients with glioblastoma.
  

  Mandel J, Youssef M, Nam JY, Wu J, Liu DD, Bondy M, et al.

• Unilateral versus bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.
  [Platform Presentation]
  

  Mitchell K, Peichel D, Wharen R, Okun M, Guthrie B, Uitti R, et al.

• Spinal dural arteriovenous fistula and concomitant intramedullary spinal lesion.
  

  Nascimento F, Kan P, Sharp L, Mandel J

• Phenomenology of leg stereotypy syndrome.
  

  Niemann N, Jankovic J

• Long-term outcomes of patients treated for idiopathic relapsing transverse myelitis.
  

  Orozco Leon V, Dunham SR, Hutton G

• Is benign hereditary chorea really benign? Brain-lung-thyroid syndrome caused by NKX2-1 mutations.
  

  Parnes M, Bashir H, Jankovic J

• Validation of a pre-diagnostic progression rate used to predict post-diagnostic change on common Alzheimer's disease outcome measures.
  

  Pavlik V, Chan W, Darby E

• Integrated whole exome sequencing and chromosomal microarray in familial Parkinson's disease.
  

  Robak L, Du R, Yuan B, Gu S, Akdemir ZC, Tejomurtula A, et al.

• Is excessive daytime sleepiness related to nocturnal sleep in Parkinson's disease?
  

  Sarwar A, Moore S, Hirshkowitz M

• Levodopa induced dyskinesias in neurodegeneration with brain iron accumulation due to a heterozygous mutation in C19orf12.
  

  Savitt D, Jankovic J

• The danger of flying with acute otitis media, which may result in Gradenigo's syndrome.
  

  Spiegel L, Pham L, Mandava P

• Impact of pre-existing dementia on intracerebral hemorrhage outcomes.
  [Platform Presentation]
  

  Yim E, Sekar P, Moomaw C, Osborne J, Martini S, Xiong L, et al.

• Vision impairment and papilledema as the initial manifestation of neurosyphilis in a young immunocompetent patient.
  

  Yuan D, Nascimento F, Woc-Colburn L, Foroozan R, Mandel J

San Juan Bautista School of Medicine
Symposium: Resiliency upon disaster in Caguas, Puerto Rico (April 7, 2018)

• Evidence based treatments for anxiety in Puerto Rico after Hurricane María.
  [Oral Presentation]
  

  Santiago-Mejías S, Martinez K

American Association of Neuroscience Nurses (AANN)
50^th Annual Meeting in San Diego, Calif. (March 17-20, 2018)

• Improving clinical outcomes in acutely ill neurology patients.
  

  Fadipe M, Bowman B

International Neuropsychological Society (INS)
46^th Annual Meeting in Washington, DC (Feb. 14-17, 2018)

• Detection of symptom over-reporting on the Neurobehavioral Symptom Inventory in OEF/OIF/OND veterans with mild TBI.
  

  Bodapati AS, Combs HL, Giammittorio AM, Pastorek NJ, Troyanskaya M, Romesser J, et al.

American Stroke Association
2018 International Stroke Conference in Los Angeles, Calif. (Jan. 24-26, 2018)

• Prevalence of undiagnosed risk factors in patients with first-ever ischemic stroke.
  

  Jasne A, Khoury J, Madsen T, Alwell K, Moomaw C, Flaherty M, et al.

• Endovascular therapy eligibility in the advent of DAWN and DEFUSE-3 results.
  

  Khatri P, Jovin T, Noqueira R, Albers GW, Jadhav A, Moomaw C, et al.

• A nurse dyad model for collaborative action planning and goal attainment to support patient self-management of stroke risk factors.
  

  Kimmel B, Burns J, George S, Roux K, Mbue N, Shegog R, et al.

• Potential impact of triage using non-contrast head CT and stroke severity on a regional stroke system of care: A population-based study.
  

  Kircher CE, Kleindorfer D, Moomaw C, Alwell K, Sucharew H, Woo D, et al.

• Acute ischemic stroke emergency department arrival times in the extended time window within a population.
  

  Kleindorfer DO, Moomaw CJ, Alwell K, Khatri P, Woo D, Flaherty ML, et al.

• Sex differences in severity of stroke risk factors in the greater Cincinnati/northern Kentucky stroke study.
  

  Madsen TE, Khoury JC, Jasne A, Alwell K, Moomaw CJ, Flaherty ML, et al.

• Temporal trends of sex differences in transient ischemic attack incidence within a population.
  

  Madsen TE, Khoury JC, Munir A, Alwell K, Moomaw CJ, Flaherty M, et al.

• Prior antiplatelet use and baseline stroke severity: A population-based study.
  

  Mistry EA, Sucharew H, Alwell K, Moomaw CJ, Flaherty M, Woo D, et al.

• Systematic review identified some early phase promising therapeutics for subarachnoid hemorrhage.
  [Oral Presentation]
  

  Shah N, Shah V, Venkatasubba Rao CP, Kent TA, Mandava P

National Aeronautics and Space Administration (NASA)
2018 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 22-25, 2018)

• SPACE-CENT: Studying the physiological and anatomical cerebral effects of centrifugation and head down tilt.
  

  Bershad E, Venkatasubba Rao C, Cohen H, Lazaridis C, Clark J, Sangi-Haghpeykar H, et al.

• Quantitative magnetic resonance of cerebral blood flow hemodynamics in acute head down tilt.
  

  Kramer LA, Hirzallah MI, Hasan KM, Younes K, Menon U, Macias B, et al.

• Assessment of artificial gravity as a countermeasure to cephalad fluid shifting.
  

  Marshall-Goebel K, Bershad E, Zhang Q

• Mechanical countermeasures to cephalad fluid shifts.
  [Oral Presentation]
  

  Marshall-Goebel K, Ivkovic V, Baggish A, Cohen A, Nahed B, Rosenthal E, et al.

• Zero G and ICP: Invasive and noninvasive ICP monitoring and VIIP biomarker identification.
  

  Williams M, Bershad E, Levine B, Clark J, Malm J, Eklund A, et al.

• SANS/VIIP biomarker identification: RNA-SEQ technology and expression analysis on ground biofluid samples.
  

  Zanello S, Bershad E, Calvillo E, Enderle D, Valentino M, Yu S, et al.

Vivekananda Yoga Anusandhana Samsthana (V-YASA)
22^nd International Conference on Frontiers in Yoga Research and Its Applications in Prashanti Kutiram, Bangalore, India (Jan. 5-8, 2018)

• Cognition — ayurveda and neuroimaging.
  [Oral Presentation]
  

  Purushotham A

American Epilepsy Society (AES)
71^st Annual Meeting in Washington, DC (Dec. 1-5, 2017)

• Responsive neuro-stimulation (RNS) versus vagus nerve stimulation (VNS) in focal epilepsy.
  

  Haneef Z, Englot DJ

• Tau loss modifies network excitability in glioma-associated epilepsy.
  

  Hatcher A, Yu K, Aiba I, Deneen B, Noebels J

• Evidence for brainstem network disruption in focal epilepsy and sudden unexplained death in epilepsy: A first validation study.
  

  Mueller SG, Nei M, Bateman L, Knowlton R, Laxer K, Friedman D, et al.

• Kv7.2 as a therapeutic target in Dravet Syndrome.
  

  Park S, Tarkunde Y, Akbar A, Marks R, Lee M, Soh H, et al.

• Autism with benzodiazepine-responsive electrical status epilepticus in sleep (ESES) caused by KCNQ3 gain-of-function variants.
  

  Sands TT, Miceli F, Lesca G, Beck A, Cimino M, Strong N, et al.

• Infantile spasms: ACTH dose response relationships.
  

  Swann JW, Le JT, Frost Jr JD

Society for Neuroscience (SFN)
47^th Annual Meeting in Washington, DC (Nov. 11-15, 2017)

• mTORC2 dysfunction underlies the neuronal physiological and behavioral abnormalities in Pten-deficient mouse model of autism.
  

  Chen C-J, Sgritta M, Lucero RD, Noebels JL, Costa-Mattioli M

• Systems biology resource for Alzheimer's disease target prioritization: The AMP-AD Knowledge Portal.
  

  Daily K, Logsdon B, Peters M, Al-Ouran R, Wan YW, Shulman JM, et al.

• Tau-mediated disruption of the spliceosome in Alzheimer's disease models.
  

  Hsieh Y-C, Guo C, Yalamanchili HK, Li Y, Lasagna-Reeves CA, Xu Y, et al.

• Development of T-type calcium channel bursting in thalamic association pathway precedes sensory pathways.
  

  Miao Q, Noebels JL

• Adrenergic signaling promotes T-type Ca2+ channel mediated oscillatory discharges in nucleus ambiguus neurons.
  

  Noebels JL, Aiba I

Society of Vascular and Interventional Neurology (SVIN)
10^th Annual Meeting in Boston, Mass. (Nov. 8-11, 2017)

• Outcomes of endovascular coiling versus surgical clipping of unruptured cerebral aneurysms in a large cohort.
  

  Komal F, Vahidy FS, Daileda TA, Chen PR, Liang CW, Sheth SA

American Society for Metabolic and Bariatric Surgery (ASMBS)
ObesityWeek 2017 in Washington, DC (Oct. 29 - Nov. 2, 2017)

• Executive function in adults with clinically significant weight loss via behavioral intervention.
  

  Gowey MA, Neumeier WH, Henry SK, Phillips J, Dutton GR

• Education quality accounts for racial differences in executive function testing in weight management.
  [Oral Presentation]
  

  Henry SK, Gowey MA, Neumeier WH, Phillips J, Dutton GR

• No difference in decision making assessment by individuals maintaining or regaining weight loss.
  

  Neumeier WH, Gowey MA, Henry SK, Phillips J, Dutton GR

National Academy of Neuropsychology (NAN)
37^th Annual Meeting in Boston, Mass. (Oct. 25-28, 2017)

• Comparison of performance-based and subjective reports of executive function in the context of weight management.
  

  Henry SK, Gowey MA, Neumeier WH, Dutton GR

American Congress of Rehabilitation Medicine (ACRM)
94^th Annual Conference in Atlanta, Ga. (Oct. 23-28, 2017)

• Self-efficacy, life satisfaction, mood, and functional outcomes for the PD-CoRE program.
  

  Kim SH, Sander A, Jimenez-Shahed J, York MK

American Neurological Association (ANA)
142^nd Annual Meeting in San Diego, Calif. (Oct. 15-17, 2017)

• Clinical utility of genetic testing in adults with epilepsy: 4-year experience of the Baylor Genetic Epilepsy Clinic.
  

  Marafie D, Rosenfeld J, Van Ness P, Zohrevand P, Haneef Z, Chen D, et al.

Neurocritical Care Society (NCS)
15^th Annual Meeting in Waikoloa, Hawaii (Oct. 10-13, 2017)

• Review of GAD65 auto-antibodies in patients with ketosis prone diabetes and epilepsy (RAPIDE Study).
  

  Desai K, Jacob J, Mulukutla S, Damani R, Hampe C, Balasubramanyam A

• Pulmonary embolism masquerading as ST elevations after spontaneous intracerebral hemorrhage.
  

  Gadoeh M, Chiang S, Teng S, Yuan D, Kazmi SO, Venkatasubba Rao C

• Causes of deterioration in neurological patients.
  

  Hirzallah MI, Edquilang G, Cooper S, Vu KY, Xavier A, Choi HA

• Trends in refractory status epilepticus for adults in the United States.
  

  Kazmi SO, Damani R, Faheem U, Kapadia A, Hartsell A, Hohmann S, et al.

• Rates of tract hemorrhages after external ventricular drain placement.
  

  Kazmi SO, Desai K, Gutierrez-Flores B, Venkatasubba Rao C

• Transcranial Doppler cerebral blood flow velocity characteristics in patients undergoing extracorporeal membrane oxygenation.
  

  Kazmi SO, Sivakumar S, Saatee S, Chatterjee S, Venkatasubba Rao C, Suarez JI, et al.

• Nonketotic hyperglycemia and unilateral neuro-imaging findings in the absence of a movement disorder.
  

  Lazaridis C, Pittard R, Yuan D

• Identification of promising therapeutics for subarachnoid hemorrhage.
  

  Mandava P, Shah N, Shah V, Rao CP, Kent TA

• A winter case of West Nile encephalitis with peculiar neuromuscular and neuroimaging findings.
  

  Rao C, Sohail M, Odaro O

Stanford University
Cannabinoid Signaling in Epilepsy: Pathways to Therapy Workshop in Stanford, Calif. (Oct. 9-10, 2017)

• STORM super-resolution imaging of cannabinoid signaling.
  [Oral Presentation]
  

  Dudok B

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
64^th Annual Meeting in Phoenix, Ariz. (Sept. 13-16, 2017)

• Eculizumab in refractory myasthenic crisis.
  

  Yeo C, Pleitez M

32^nd International Epilepsy Congress (IEC)
Barcelona, Spain (Sept. 2-6, 2017)

• Diurnal variation of potential ictal onsets detected by a responsive neurostimulation device.
  

  Van Ness P, Chen DK, Haneef Z, Yoshor D

• Classification of neonatal seizures: The results from a recent test of the ILAE commission on classification and terminology proposed neonatal seizure framework.
  

  Yozawitz E, Cilio MR, Lahorgue Nunes M, Vanhatalo S, Zuberi S, Plouin P, et al.

American Psychological Association (APA)
125^th Annual Convention in Washington, DC (Aug. 3-6, 2017)

• Facing the invisible wounds of war: A holistic review of current moral injury research.
  

  Koster ML, Cordial T, Scholz M, Malzahn C, McConnell JM

• Beyond combat veterans: Future directions in moral injury research with diverse populations.
  

  Scholz M, Cordial T, Malzahn C, Koster ML, McConnell JM

2017 Alzheimer's Association International Conference (AAIC)
London, United Kingdom (July 15-20, 2017)

• Predictors of atypical antipsychotic treatment in an AD clinical population.
  

  Pavlik VN, Bishop JS, Glosch C, Yu M, Darby E, Starks S, et al.

• Cohort effects in progression rate in a clinical registry of Alzheimer's patients accrued from 1995-2010.
  

  Pavlik VN, Chan W, Darby E, Kass JS

Movement Disorder Society (MDS)
21^st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Canada (June 4-8, 2017)

• Whole exome sequencing in essential tremor.
  

  Alfradique-Dunham I, Robak LA, Kaw A, Fagbongbe OI, Ternes K, Young E, et al.

• Predictive ability of clinical timed tests for postural instability and gait difficulty in Parkinson's disease.
  

  Bryant M, Hou J-G, Jamal F, Jackson G, Workman C, Protas E

• A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
  [Previously Presented]
  

  Comella C, Jankovic J, Truong D, Brashear A, Patel A, Evatt M, et al.

• Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD probe study.
  

  Dashtipour K, Mari Z, Jankovic J, Adler C, Schwartz M, Brin M

• Treatable rare movement disorders.
  

  Gatto E, Jinnah H, Espay A, Jankovic J, Bhatia K, Rodriguez M, et al.

• A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome.
  

  Gilbert D, Murphy T, Jankovic J, Budman C, Black K, Kurlan R, et al.

• Vitamin D and clinical phenotypes of Parkinson's disease in veterans.
  

  Jamal F, Jackson GR, Moore S, Sarwar AI

• Results from a phase 1b multiple ascending-dose study of prx002, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson's disease.
  

  Jankovic J, Goodman I, Safirstein B, Schenk D, Kinney G, Koller M, et al.

• Leg stereotypy disorder: Phenomenology and prevalence.
  

  Jankovic J, Lotia M, York MK, Strutt AM

• Emotion regulation and neuropsychological status in psychogenic subtypes.
  

  Scott B, Strutt A, Lundberg-Love P, Schmitt A, Jankovic J, Bowers D

• Hemidystonia associated with Alexander disease.
  

  Vijayakumar D, Lewis RA, Fuller GN, Dhar SU, Machol K, Robak L, et al.

Consortium of Multiple Sclerosis Centers (CMSC)
31^st Annual Meeting in New Orleans, La. (May 24-27, 2017)

• Patient-reported overactive bladder in neuromyelitis optica spectrum disorder.
  

  Orozco-Leon VI, Dunham SR, Hutton GJ

• Prevalence of self-reported sexual dysfunction in neuromyelitis optica spectrum disorder.
  

  Orozco-Leon VI, Dunham SR, Hutton GJ

European Stroke Organisation (ESO)
3^rd Conference in Prague, Czech Republic (May 16-18, 2017)

• Genetics, proteomics, metabolomics, and biomarkers unexpected conformational change of platelet glycoprotein IB (GPIB) receptor after rt-PA treatment of large vessel ischemic stroke.
  

  Da Q, Mandava P, Shah N, Cruz M, Thiagarajan P, Kent T

• Intracerebral hemorrhage effect of untreated hypertension on in-hospital outcomes among intracerebral hemorrhage patients.
  

  Divani A, Hevesi M, Bershad E

• SAH, aneurysms and vascular malformations identification of promising therapeutics for subarachnoid hemorrhage.
  

  Shah N, Shah V, Rao C, Mandava P, Kent T

Ponce Health Sciences University (PHSU)
13^th Annual Scientific Conference in Ponce, Puerto Rico (May 13, 2017)

• Evaluating physiological, cognitive, and psychological measures in obsessive-compulsive disorder (OCD).
  [Previously Presented]
  

  Santiago-Mejías S, Martinez K

Institute for Healthcare Advancement (IHA)
16^th Health Literacy Conference in Irvine, Calif. (May 3-5, 2017)

• Improving health literacy in veterans with epilepsy.
  

  Fadipe M, Bowman B

6^th World Intracranial Hemorrhage Conference (WICH)
Baltimore, Md. (May 1-3, 2017)

• Oxidative toxicity and DNA damage in experimental hemorrhage models: targeting with a novel carbon nano-antioxidant.
  [Oral Presentation]
  

  Kent TA, Dharmalingam P, Tour JM, Fabian RH, Derry PJ, Nilewski LG, et al.

• Testing treatments for intracranial hemorrhage compared to a pooled outcome model accounts for variability in baseline conditions and identifies potentially positive, neutral, and harmful interventions.
  [Oral Presentation]
  

  Mandava P, Murthy SB, Samson Y, Kent TA

• Resumption of anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis.
  

  Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, et al.

Baylor College of Medicine (BCM)
Annual Quality Improvement and Patient Safety Conference 2017 in Houston, Texas (April 26, 2017)

• A health intervention to improve medication adherence in patients with epilepsy.
  

  Tobias R, Hamby D, Gilder R, Fisher W

American Academy of Neurology (AAN)
69^th Annual Meeting in Boston, Mass. (April 22-28, 2017)

• Primary angiitis of the central nervous system.
  

  Alenzi B, Zhang H, Kass J

• Intrathecal NMDA receptor antibody reactivation due new ovarian teratoma in patient with previously resected ovarian teratoma for anti-NMDA receptor encephalitis.
  

  Bashir H, Kass J

• Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks in temporal lobe epilepsy.
  

  Chiang S, Vankov E, Yeh H, Guindani M, Vannucci M, Haneef Z, et al.

• A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
  

  Comella C, Brashear A, Jankovic J, Patel A, Truong D, Evatt M, et al.

• Mixed Curvularia and Klebsiella brain microabscesses in an immunocompromised patient.
  

  Das R, Pohlen M, Kass J

• Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD Probe study.
  

  Mari Z, Dashtipour K, Jankovic J, Adler CH, Schwartz M, Brin MF

• Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
  [Platform Presentation]
  

  Robak L, Jansen I, van Rooij J, Uitterlinden A, Kraaj R, Heutink P, et al.

• Presentation, diagnostic hurdles, and therapeutic measures in a case of isolated coccidioidomycosis meningitis in an immunocompetent individual.
  

  Samudralwar R, Kass J, Bellows S, Goldsmith C

• Leg discomfort and insomnia in Parkinson's disease.
  

  Sarwar A, Moore S, Hirshkowitz M

• Discovery and systematic functional validation of Parkinson's disease genes from exome sequencing.
  [Platform Presentation]
  

  Shulman J, Jansen I, Ye H, Heetveld S, Gibbs JR, Chouhan A, et al.

• Aphemia: A rare presentation of an acute infarct.
  

  Stachyra J, Davalos-Balderas A, Lee J, Kass J

• Assessment of capacity to consent in a Huntington disease clinical trial: Implications for future clinical trial design in neurodegenerative disease populations.
  

  Testa C, Edmondson M, Agarwal P, Blindauer K, Gray C, Jankovic J, et al.

• The predictability of smartphone video in distinguishing epileptic and nonepileptic seizures.
  

  Thanaviratananich S, Van Ness P, Haneef Z, Chen D

American Stroke Association
2017 International Stroke Conference in Houston, Texas (Feb. 22-24, 2017)

• Unexpected conformational change of platelet glycoprotein Ib (GPIb) receptor after rt-PA treatment of large vessel ischemic stroke.
  

  Da Q, Mandava P, Cruz M, Thiagarajan P, Kent TA

• Incorporating biological variability in experimental stroke to better mimic human stroke.
  

  Kent TA, Rea HC, Dalmeida W, Fabian RH, Ayata C, Mandava P

• A novel catalytic antioxidant carbon nanoparticle improves outcome in hyperglycemic stroke in rats at clinically relevant recanalization times.
  [Platform Presentation]
  

  Kent TA, Rea HC, Dalmeida W, Fabian RH, Tour JM, Nilewski LG, et al.

• Simulation training is a feasible implementation strategy for evidence based stroke swallowing screening.
  

  Stonecypher K, Garrett R, Kimmel B, Daniels S, Anderson J

Society of General Internal Medicine (SGIM)
2017 Southern Regional Meeting in New Orleans, La. (Feb. 10-12, 2017)

• Ataxia: The first sign of breast cancer.
  

  Rizk CB, Savitt DJ, Yu M, Kung D

International Neuropsychological Society (INS)
45^th Annual Meeting in New Orleans, La. (Feb. 1-7, 2017)

• Longitudinal cognitive asymmetry and decline in Alzheimer's disease patients.
  

  Alverson WA, Massman PJ, Doody RS

• Deep brain stimulation for Parkinson's disease: An investigation of post-surgical self-regulation and executive functioning.
  

  Combs HL, Garcia NE, Berry DTR, Segerstrom SC

• Performance on the Rey Auditory Verbal Learning Test (RAVLT) in neurologically intact Spanish-speaking older adults.
  

  Estevis E, Scott BM, Strutt AM

• Wisconsin Card Sorting Test subscales in Parkinson's disease and amyotrophic lateral sclerosis.
  

  Garcia NE, Combs HL, Roach A, Berry DTR, Segerstrom SC

• Assessment of language fluency and confrontation naming in monolingual Spanish speaking older adults.
  

  Strutt AM, Lafosse J, Mahoney M

International Neurotoxin Association (INA)
Toxins 2017 3^rd International Conference in Madrid, Spain (Jan. 18-21, 2017)

• A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia.
  

  Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, et al.

• Clinical relevance of treatment with onabotulinumtoxina in patients with cervical dystonia: Results from the CD Probe study.
  

  Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF Dashtipour K, et al.

• Potential new uses of botulinum toxin injections in movement disorders.
  

  Jankovic J

• Predictors of onabotulinumtoxinA response in patients with cervical dystonia.
  

  Jankovic J, Schwartz M, Manack Adams A

American Epilepsy Society (AES)
70^th Annual Meeting in Houston, Texas (Dec. 2-6, 2016)

• Center for SUDEP Research: Brainstem atrophy in SUDEP.
  

  Bateman L, Nei M, Goldman A, Mueller S

• Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks in temporal lobe epilepsy.
  

  Chiang S, Vankov E, Yeh H, Guindani M, Vannucci M, Haneef Z, et al.

• SUDEP rate in patients with medically intractable partial onset seizures treated with brain responsive neurostimulation.
  

  Devinsky O, Kapur R, Duckrow R, Fountain N, Gwinn R, Leiphart J, et al.

• The role of tau in modulating hyper excitability in an emerging model of tumor associated epilepsy.
  

  Hatcher A, Yu K, Lalonde J, Deneen B, Noebels J

• Functional characterization of three de novo KCNQ2 encephalopathy variants in the pore helix and responses to SF0034 and ICA-069673.
  

  Ji Z, Tran B, Li L, Xu M, Cooper E

• An informatics infrastructure for KCNQ2 encephalopathy research including a patient registry, database, curation platform, and website.
  

  Joshi N, Taglialatela M, Weckhuysen S, Nesbitt G, Cooper E

• Dynamics of gamma oscillations in a mouse model of absence epilepsy.
  

  Maheshwari A, Marks R, Davalos-Balderas A, Wang M, Noebels J

• Clinical utility of genetic testing in adults with epilepsy: Pilot experience of the Baylor genetic epilepsy clinic.
  

  Marafie D, Rosenfeld J, Van Ness P, Zohrevand P, Haneef Z, Chen D, et al.

• Asynchronous suppression of superficial cortex during absence seizures.
  [Platform Presentation]
  

  Meyer J, Maheshwari A, Noebels J, Smirnakis S

• A survey of neurophysiology fellows in the United States.
  

  Rutherford H, Chiang S, Antony A, Haneef Z

• A critical developmental window for 17β-estradiol antiepileptogenic effect in a mouse model of X-linked infantile spasms.
  

  Siehr M, Lucero R, Lalonde J, Noebels J

• Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
  

  Taglialatela M, Millichap J, Miceli F, De Maria M, Keator C, Joshi N, et al.

• Genotype-phenotype relationships In KCNQ2 related epilepsy and encephalopathy caused by variants in the pore region.
  

  Wang X, Li L, Xu M, Mays J, Joshi N, Cooper E

American Heart Association
2016 Scientific Sessions in New Orleans, La. (Nov. 12-16, 2016)

• Prior use of intravenous rt-PA improves outcome in endovascular stent retriever trials for acute large vessel ischemic stroke.
  

  Mandava P, Martini SR, Shah VA, Fabian RH, Kent TA

Society for Neuroscience (SFN)
46^th Annual Meeting in San Diego, Calif. (Nov. 12-16, 2016)

• Characterization of a polysynaptic microcircuit involved in sensory vagal afferent activation of dorsomotor vagal neurons in mouse.
  

  Aiba I, Noebels JL

• Effects of tau peptide aggregation inhibitor in human tau transgenic models.
  

  Frautschy SA, Hu S, Jones MR, Yang F, Chen P, Jackson GR, et al.

• The role of tau in modulating hyper-excitability in an emerging model of tumor associated epilepsy.
  

  Hatcher A, Yu K, Lalonde J, Deneen B, Noebels J

• αII-spectrin-dependent cytoskeletons are essential for axon function, domain assembly and integrity.
  

  Huang Y, Zhang C, Zollinger D, Lalonde J, Leterrier C, Noebels J, et al.

• Early development of thalamic low-threshold T-type calcium current in the VPM of C57BL/6 mice.
  

  Miao Q, Noebels JL

• A critical developmental window for 17β-estradiol antiepileptogenic effect in a mouse model of X-linked infantile spasms.
  

  Siehr M, Lucero R, Lalonde J, Noebels J

American Neurological Association (ANA)
141^st Annual Meeting in Baltimore, Md. (Oct. 16-18, 2016)

• Prevalence and character of severe epileptic encephalopathy in patients affected by MECP2 duplication syndrome.
  

  Marafie D, Schultz R, Glaze D, Suter B, Goldman A

• Dynamic participation patterns of superficial cortex during absence seizures.
  

  Meyer JF, Maheshwari A, Noebels JL, Smirnakis SM

• Hypothyroidism presenting with dysarthria and intermittent weakness of the extremities.
  

  Parker AS, Alobaidy AM, Kakker E, Tajuddin N, Nguyen SV, Pacheco VH, et al.

Neurocritical Care Society (NCS)
14^th Annual Meeting in National Harbor, Md. (Sept. 15-18, 2016)

• Bilateral recurrent artery of Heubner infarction after extensive resection of a large olfactory groove meningioma.
  

  Desai KA, Spiegel L, Reyes R, Vedantam A, Damani R, Bershad E

• CNS post-transplant lymphoproliferative disorder presenting as de novo status epilepticus: Case report.
  

  Kapadia AM, Kesari N, Sivakumar S, Venkatasubba Rao C

• Intravenous rt-PA use prior to endovascular thrombectomy increases probability of good outcome in acute ischemic stroke.
  

  Mandava P, Martini S, Shah V, Fabian R, Kent T

• Modeling outcome after intracerebral hemorrhage indicates no benefit and potential harm from aggressive blood pressure management.
  [Platform Presentation]
  

  Mandava P, Murthy S, Samson Y, Kent T

• Novel noninvasive detection of increased intracranial blood volume induced by head-down tilt using volumetric induction phase-shift spectroscopy (VIPS).
  

  Rao CP, Bershad E, Stevens B, Donoviel D, Pohlen M, Clarke C, et al.

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
63^rd Annual Meeting in New Orleans, La. (Sept. 14-17, 2016)

• Chronic endurance exercise training in a mouse model of myotonic dystrophy type 1.
  

  Sharp L, Cooper T

• Oculomotor and masticator muscle enhancement in a case of multiple cranial nerve palsies and internuclear ophthalmoplegia associated with herpes simplex virus infection.
  

  Yeo C, Simpson E, Pleitez M, Smith R

International OCD Foundation (IOCDF)
23^rd Annual OCD Conference in Chicago, Ill. (July 29-31, 2016)

• Evaluating physiological, cognitive, and psychological measures in obsessive-compulsive disorder (OCD).
  

  Santiago-Mejías S, Martinez K

2016 Alzheimer's Association International Conference (AAIC)
Toronto, Canada (July 22-28, 2016)

• Advancing therapeutics for neuroinflammation in Alzheimer's disease: Clinical development considerations.
  

  Margolin RA, Schneider LS, Cutter GR, Breitner JCS, Doody RS, Landreth G, et al.

Federation of American Societies for Experimental Biology (FASEB)
Science Research Conference (Neural Mechanisms in Cardiovascular Regulation: Novel Research and Disease Treatment Strategies) in Saxtons River, Vt. (July 17-22, 2016)

• Polysynaptic activation of dorsomotor vagal neurons by sensory afferent nerve.
  

  Aiba I, Noebels JL

16^th International Symposium on Intracranial Pressure (ICP) and Neuromonitoring
Boston, Mass. (June 28 - July 2, 2016)

• Evaluation of a non-invasive intracranial pressure meter (Vittamed) for spaceflight.
  

  Bershad E, Marshall-Goebel K, DeSantis S, Yang M, Sangi-Haghpeykar H, Calvillo E, et al.

• Cerebrovascular and intracranial effects of 12 degree head-down tilt and hypercapnia: A preliminary study using phase-contrast, volumetric and diffusion tensor MR imaging.
  

  Kramer L, Hasan K, Higashi S, Bershad E, Rittweger J, Gerlach D

• Cerebral blood pulsatility during head-down tilt and CO2 exposure.
  

  Strangman G, Zhang Q, Stevens B, Clark J, Bershad E

Movement Disorder Society (MDS)
20^th International Congress of Parkinson's Disease and Movement Disorders in Berlin, Germany (June 19-23, 2016)

• Understanding, predicting, and preventing falls in progressive supranuclear palsy.
  

  Bluett BR, Litvan I, Cheng S, Juncos J, Bordelon Y, Riley DE, et al.

• Objectives of the MDS rare movement disorders study group.
  

  Gatto EM, Albanese A, Bathia K, Cardoso F, Cesarini M, Chade A, et al.

• A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome.
  

  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy TK, Shprecher D, et al.

• Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia.
  

  Jankovic J, Marc S, Aubrey A

• Apraclonidine in blepharospasm.
  

  Jankovic J, Vijayakumar D, Wijemanne S

• Apraclonidine in the treatment of ptosis.
  

  Wijemanne S, Vijayakumar D, Jankovic J

National Institute of Mental Health and Neuro-Sciences (NIMHANS)
symposium on "History of psychiatry in India: Traditional systems and mental health" in Bangalore, India (June 15-16, 2016)

• Ayurvedic constitution type and disease susceptibility.
  [Oral Presentation]
  

  Purushotham A

Consortium of Multiple Sclerosis Centers (CMSC)
30^th Annual Meeting in National Harbor, Md. (June 1-4, 2016)

• Prevalence of dysphagia in multiple sclerosis and correlation with disability.
  [Platform Presentation]
  

  Mahmoud R, Hutton GJ, Altman KW, Carter F, Dunham SR

• Five-year outcomes of HALT-MS: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe relapsing-remitting multiple sclerosis.
  [Platform Presentation]
  

  Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Georges GE, et al.

2016 American Society of Neurophysiological Monitoring (ASNM)
Annual Meeting in Chicago, Ill. (May 12-15, 2016)

• Irreversible electroporation-induced sciatic neuropathy observed with intraoperative somatosensory evoked potential monitoring.
  

  Chu J, Nagata M, Chen X, Solomon S, Gonzalez-Aguirre A, Garcia-Aguilar J, et al.

American Academy of Neurology (AAN)
68^th Annual Meeting in Vancouver, BC, Canada (April 15-21, 2016)

• Sporadic Creutzfeldt-Jakob disease presenting as non-convulsive status epilepticus: A case report.
  

  Alobaidy A, Parker A, Bershad E

• Time-dependence of graph theory metrics in functional connectivity analysis.
  

  Chiang S, Cassese A, Guindani M, Vannucci M, Yeh H, Haneef Z, et al.

• Pre-surgical PET mapping predicts surgical outcome after anterior temporal lobectomy.
  

  Chiang S, Guindani M, Vannucci M, Yeh H, Haneef Z, Stern J

• A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome.
  

  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, et al.

• Comparison of three stroke severity scales with mortality within an intracerebral hemorrhage population: A population-based study.
  

  Katz B, Khoury J, Alwell K, Moomaw C, Kissela B, Flaherty M, et al.

• Stroke incidence rates in a biracial metropolitan population: The importance of county-level data.
  

  Kissela B, Khoury J, Alwell K, Moomaw C, Flaherty M, Woo D, et al.

• Impact of IDH-1 mutation status on outcome in clinical trials for recurrent glioblastoma.
  

  Mandel J, Cachia D, Liu DD, Aldape K, Fuller G, De Groot J

• Severe epileptic encephalopathy is a frequent neurological comorbidity of children affected by the MECP2 duplication syndrome.
  [Oral Presentation]
  

  Marafie D, Schultz R, Glaze D, Goldman A, Suter B

• Safety profile of unblinded internal pallidal deep brain stimulation for medically refractory Tourette syndrome.
  

  Niemann N, Strutt A, Viswanathan A, Jimenez Shahed J

• A case of neurosarcoidosis masquerading as subacute inflammatory demylelinating polyneuropathy.
  

  Rizk C, Savitt D, Jain S, Kass J

• Chronotypes, nocturnal melatonin level and excessive daytime sleepiness in Parkinson's disease (PD).
  

  Sarwar A, Moore S, Hirshkowitz M

• Reasons for prolonged length of stay in the epilepsy monitoring unit.
  

  Seals S, Dewar S, Haneef Z, Eliashiv D, Stern J, Moseley B

• Rare and fulminant presentation of adult Moyamoya disease: A case report.
  

  Shah V, Kass J

• PRISM II: Effectiveness of dextromethorphan 20 mg/quinidine 10 mg (Nuedexta®) for treatment of pseudobulbar affect secondary to dementia, stroke, or traumatic brain injury: Combined results of a multicenter open-label study.
  

  Siffert J, Hammond F, Alexander D, Cutler A, D'Amico S, Doody R, et al.

• Paradoxical worsening dystonia after deep brain stimulation in a patient with neurodegeneration with brain iron accumulation.
  

  Tarakad A, Jimenez Shahed J

• Long-term outcome of adults with medically intractable mesial temporal lobe seizures treated with responsive neurostimulation.
  [Oral Presentation]
  

  Van Ness P, Skarpaas TC, Morrell M, the RNS System Investigators

• Randomized, double-blind, placebo-controlled studies to evaluate treatment with aducanumab (BIIB037) in patients with early Alzheimer's disease: Phase 3 study design.
  [Oral Presentation]
  

  Viglietta V, O'Gorman J, Williams L, Tian Y, Sandrock A, Doody R, et al.

Association of University Radiologists (AUR)
64^th Annual Meeting in San Diego, Calif. (March 29 - April 1, 2016)

• Comparing two ¹²³I-Ioflupane SPECT processing methods for determination of basal ganglia volumes in patients with parkinsonian-like features.
  

  Echiverri K, Sinha P, Cheatham E, Quintero G, van Horne C, Oates ME

American Psychosomatic Society (APS)
74^th Annual Meeting in Denver, Colo. (March 9-12, 2016)

• A latent constellation of self-regulation and its association to chronic disease in older adults.
  

  Reed RG, Combs HL, Segerstrom SC

American Stroke Association
2016 International Stroke Conference in Los Angeles, Calif. (Feb. 17-19, 2016)

• Admission systemic inflammatory response syndrome and outcome following intracerebral hemorrhage in a multicenter study.
  

  Boehme AK, Comeau M, Langefeld C, Lord A, Moomaw C, Osborne J, et al.

• Predictors of in-hospital speech therapy referral in aphasic acute ischemic stroke patients within a population.
  

  Coleman ER, Sucharew H, Alwell K, Moomaw CJ, Kissela BM, Woo D, et al.

• Degree of functional independence after an ischemic stroke affects quality of life similarly in men and women.
  

  Demel SL, Khoury J, Moomaw CJ, Sucharew H, Alwell K, Kissela BM, et al.

• Bacterial endocarditis and acute stroke: A population-based study.
  

  Flaherty ML, Kleindorfer DO, Khoury JC, Alwell K, Moomaw CJ, Woo D, et al.

• Comparison of three stroke severity scales with mortality within an intracerebral hemorrhage population: A population-based study.
  

  Katz BS, Khoury JC, Alwell K, Moomaw CJ, Haverbusch M, Kissela BM, et al.

• A projection of endovascular therapy eligibility in the United States: A population-based analysis.
  

  Khatri P, Moomaw CJ, Alwell KS, Khoury JC, Heldner M, Fischer U, et al.

• Incidence and temporal trends in in-hospital stroke: A preliminary analysis from the Greater Cincinnati/Northern Kentucky Stroke Study.
  

  Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Flaherty ML, et al.

• A retrospective comparison of medical eligibility for acute ischemic stroke clinical trials compared with hospital enrollment rates: Greater Cincinnati/Northern Kentucky Population.
  

  Kleindorfer D, Moomaw CJ, Khoury J, Alwell K, Saver JL, Khatri P, et al.

• Stroke incidence in the Greater Cincinnati/Northern Kentucky Stroke Study is decreasing significantly in men but not women.
  [Oral Presentation]
  

  Madsen TE, Khoury JC, Alwell KA, Moomaw CJ, Flaherty ML, Woo D, et al.

• Factors influencing differential outcomes in stent retriever trials: Comparison to a new outcome model based on percent utilization of rt-PA.
  

  Mandava P, Martini SR, Shah VA, Fabian RH, Kent TA

• Analysis of outcomes from the endovascular treatment of posterior circulation strokes in the modern era of stent retriever thrombectomy.
  

  Mokin M, Sonig A, Sananthan S, Kan P, Duckworth E, Venkatasubba Rao C, et al.

• Selective serotonin reuptake inhibitors and risk of intracerebral hemorrhage.
  [Oral Presentation]
  

  Obeidat AZ, Sekar P, Moomaw CJ, Martini SR, Osborne J, Woo D, et al.

• The impact of specific neuroanatomical location in deep supratentorial intracerebral hemorrhage (ICH): Findings from the ethnic/racial variations of ICH study.
  

  Sheth KN, Moomaw CJ, Osborne J, Martini S, Katz B, Charidimou A, et al.

• Association of ischemic stroke location and demographic variables with percutaneous endoscopic gastrostomy placement.
  [Oral Presentation]
  

  Star M, Sucharew H, Ruland S, Moomaw CJ, Alwell K, Kissela BM, et al.

• Prevalence of positive troponins and association with abnormal echocardiograms in acute ischemic stroke.
  

  Wrigley P, Alwell K, Eckerle B, Moomaw CJ, De Los Rios La Rosa F, Flaherty M, et al.

• Impact of metformin on survival following ischemic stroke in patients with diabetes: The Greater Cincinnati Northern/Kentucky Stroke Study (GCNKSS).
  

  Yeramaneni S, Kleindorfer D, Sucharew H, Alwell K, Moomaw C, Flaherty M, et al.

• Dementia treatment was associated with reduced risk of intacerebral hemorrhage.
  

  Yim E, Sekar P, Moomaw CJ, Osbourne J, Martini SR, Xiong L, et al.

National Aeronautics and Space Administration (NASA)
Human Research Program Investigators' Workshop in Galveston, Texas (Feb. 10, 2016)

• SPACE-COT: Studying the physiological and anatomical cerebral effects of carbon dioxide and head down tilt: An international collaborative project with the German Aerospace Center (DLR).
  [Oral Presentation]
  

  Bershad E (Study PI), Venkatasubba Rao C, Suarez JI, Damani R, Calvillo E, Stevens B, et al.

• Vittamed intracranial pressure device evaluation study: Final results.
  [Oral Presentation]
  

  Bershad EM, Anand A, DeSantis SM, Yang M, Tang RA, Calvillo E, et al.

• Testing mechanical countermeasures for cephalad fluid shifts.
  

  Ivkovic V, Zhang Q, Baggish A, Cohen A, Nahed B, Dentinger A, et al.

• Psychogenic urinary retention associated with head down tilt bed rest: A rare medical complication.
  

  Limper U, Mulder E, Rittweger J, Bershad E

• Effects of head down tilt with or without 0.5% CO2 on intracranial and intraocular pressure: results from the SPACE-COT study.
  

  Marshall-Bowman K, Rittweger J, Suarez JI, Rao CV, Limper U, Mulder E, et al.

• Effects of head down tilt on internal jugular vein volume: Preliminary results from the SPACE-COT study.
  

  Stevens B, Venkatasubba Rao C, Suarez JI, Calvillo E, Arbeille P, Bershad EM on behalf of the SPACE-COT investigators

• Effects of head down tilt on intracranial blood volume: Preliminary results from the SPACE-COT study.
  

  Venkatasubba Rao C, Stevens B, Calvillo E, Suarez JI, Bershad EM on behalf of the SPACE-COT investigators

• Zero-G and ICP: Invasive and noninvasive ICP monitoring of astronauts on the ISS & multimodal modeling towards noninvasive assessment of ICP in weightlessness and biomarker identification of predisposition to VIIP syndrome.
  

  Williams MA, Bershad E, Levine BD, Clark J, Hamilton DR, Malm J, et al.

• Brain gene expression signatures from cerebrospinal fluid exosome RNA profiling.
  

  Zanello SB, Stevens B, Calvillo E, Tang R, Gutierrez Flores B, Skog J, et al.

International Neuropsychological Society (INS)
44^th Annual Meeting in Boston, Mass. (Feb. 3-6, 2016)

• Comparative patient satisfaction and efficacy of a Parkinson's Disease Enrichment Program (PEP).
  

  Choudhury TK, Crist K, Harris CG, Satterwhite TK, Treece B, York MK

• Deep brain stimulation (DBS) for treatment of therapy-refractory obsessive compulsive disorder (OCD): A case study highlighting neurocognitive and psychiatric changes.
  

  Choudhury TK, Davidson JE, Viswanathan A, Strutt AM

• Errors on the first 10 items of the Test of Memory Malingering predicts failure on later trials of the Test of Memory Malingering.
  

  Grabyan JM, Collins R, Alverson WA, Chen D

• Validating neurocognitive measures in an adolescent sports concussion sample: ImPACT computerized testing versus traditional neuropsychological measures.
  

  Koehl LM, Combs HL, Walls BD, Berry DT, Han D

• Performance validity in deep brain stimulation candidates.
  

  Rossetti M, Collins R, York MK

• Cognitive, somatic, and emotional changes in patients with mild traumatic brain injury (mTBI) and orthopedic injuries at baseline and three months post-injury.
  

  Samarina V, Merkley TL, Wilde EA, McCauley S, Barnes A, Hanten G, et al.

• Logopenic progressive aphasia in patient with meningioma: Neuropsychological evaluations over time.
  

  Stinson JM, Martin R, Chang JE, Collins R

Vivekananda Yoga Anusandhana Samsthana (V-YASA)
21^st International Conference on Frontiers in Yoga Research and Its Applications in Prashanti Kutiram, Bangalore, India (Jan. 3-5, 2016)

• Stand-alone ayurvedic treatment in acute ischemic stroke.
  [Oral Presentation]
  

  Harini JA, Luthra A, Madeka S, Shankar P, Mandava P, Pervaje R, et al.

University of Kentucky
Annual Conference of Clinical and Translational Science in Lexington, Ky.Annual Conference of Clinical and Translational Science in Lexington, Ky. (2016)

• Neurocognitive measures in an adolescent sports concussion sample.
  

  Koehl LM, Combs HL, Walls BD, Berry DTR, Han DY

American Epilepsy Society (AES)
69^th Annual Meeting in Philadelphia, Penn. (Dec. 4-8, 2015)

• Leaky ryanodine receptor-2 mutation lowers threshold for hypoxic spreading depolarization.
  

  Aiba I, Noebels JL

• Time-dependence of graph theory metrics in functional connectivity analysis.
  

  Chiang S, Cassese A, Yeh SJ, Haneef Z, Stern J

• An international, curated KCNQ2 registry, database and website.
  

  Joshi N, Cooper EC, Taglialatela M, Weckhuysen S

• KCNQ2 encephalopathy: Novel single amino acid deletion variants strongly suppress currents and are responsive to SF0034.
  

  Li L, Cooper EC

• Interictal relative gamma power as a biomarker for anti-epileptic drug response in absence epilepsy.
  

  Maheshwari A, Marks R, Yu K, Noebels J

• MECP2 duplication is associated with severe epileptic encephalopathy in the presence of permissive genetic background.
  

  Marafie D, Suter B, Pacheco VH, Glaze D, Drabek J, Goldman A

• KCNQ2 p.Arg198Gln, a gain-of-function variant presenting recurrently as West syndrome without preceding neonatal seizures.
  

  Millichap J, Miceli F, Tran B, Keator C, Joshi N, Virginia Soldovieri M, et al.

• Novel clinical features of KCNQ2 encephalopathy associated with the gain-of-function variant, R201C.
  

  Mulkey SB, Ben-Zeev B, Cooper EC, Cilio M

• A critical developmental window for 17β-estradiol anti-epileptogenic effect in a mouse model of x-linked infantile spasms.
  

  Siehr MS, Lucero RD, Lalonde JW, Noebels J

• Pharmacological rescue of KCNQ2 channels carrying early-onset epileptic encephalopathy mutations.
  

  Soldovieri M, Ambrosino P, De Maria M, Mosca I, Miceli F, Striano P, et al.

• Electrographic seizure detection and effectiveness of responsive neurostimulation in periventricular nodular heterotopias.
  

  Van Ness P, Arcot Desai S, Sun F, Kapur R, King-Stephens D, Bergey G, et al.

• Long-term outcome of adults with medically intractable mesial temporal lobe seizures treated with responsive neurostimulation.
  

  Van Ness P, Mizrahi E, King-Stephens D, Nair D, Bazil C, Goodman R, et al.

Gerontological Society of America (GSA)
68^th Annual Meeting in Orlando, Fla. (Nov. 18-22, 2015)

• Physician trust in older adults with diabetes.
  

  Henry S, Clay OJ, Crowe M

• The happy survivor: Effects of differential mortality on life satisfaction in older age.
  

  Segerstrom SC, Combs HL, Winning A, Boehm JK, Kubzansky LD

XXII World Congress of Neurology (WCN)
Santiago, Chile (Oct. 31 - Nov. 5, 2015)

• Unusual presentation of reversible vasoconstriction syndrome in post-partum woman.
  

  Jalali N, Chu J, Kass J

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
62^nd Annual Meeting in Honolulu, Hawaii (Oct. 28-31, 2015)

• Results from the DAPPER study: Inpatient double-blind, placebo-controlled withdrawal study of 3,4-diaminopyridine base (3,4-DAP) in subjects with Lambert-Eaton myasthenic syndrome.
  

  Sanders D, Juel V, Harati Y, Smith AG, Peltier A, Marburger T, et al.

• A rare heteroplasmic tRNALeu(CUN) mutation presenting with refractory seizures and myopathy.
  

  Shroff S, Nakawah M, Pleitez M, Rosenfield D, Simpson E

• Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
  [Previously Presented]
  

  Shroff S, Thonhoff J, Eatman J, Pleitez M, Rosenfield D

American Academy of Pediatrics (AAP)
2015 National Conference and Exhibition in Washington, DC (Oct. 23-27, 2015)

• Teaching mental health in middle schools: Two initiatives targeting students in two urban middle schools.
  

  Hernandez S, Billups D, Michael S, Peicher V, Rizk CB, Idicula S

American Society for Bioethics and Humanities (ASBH)
17^th Annual Meeting in Houston, Texas (Oct. 22-25, 2015)

• Ethics, professionalism and health policy program (EP3): Creating a longitudinal curriculum linked to ACGME milestones in training.
  

  Allen N, Antonio J, Fedson S, Malek J, Kass J, McCullough L, et al.

Society for Neuroscience (SFN)
45^th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2015)

• Cardiac arrhythmogenic leaky ryanodine receptor 2 mutation increases cortical excitability and lowers threshold for spreading depolarization in mouse brain.
  

  Aiba I, Noebels JL

• Excessive Ras-MAPK-dependent synaptic clustering drives enhanced motor learning in the MECP2-duplication mouse model of syndromic autism.
  

  Ash RT, Buffington SA, Fahey PG, Park J, Lu H, Costa-Mattioli M, et al.

• Characteristics of seizure termination in primary and secondarily generalized seizures.
  

  Borzello M, Maheshwari A, Chu C, Kramer M, Westover BM, Cash SS

• Validation of olfactory identification deficit as a biomarker of Alzheimer's disease.
  

  Lazar E, Woodward M, Amrutkar C, Hagemeier J, Shah H, Benedict R, et al.

• Population receptive field changes in hV5/MT+ of healthy subjects with simulated visual field scotomas.
  

  Papanikolaou A, Keliris GA, Lee S, Logothetis NK, Smirnakis SM

Society of Vascular and Interventional Neurology (SVIN)
8^th Annual Meeting in Bonita Springs, Fla. (Oct. 15-18, 2015)

• Successful thrombectomy in a 10 year-old boy with restrictive cardiomyopathy after cardioembolic infarct.
  

  Kulhari A, Saleem Y, Kandregula K, Ramos-Estebanez C

Society for Pediatric Pathology (SPP)
Fall Meeting in Toronto, Ontario, Canada (Oct. 1-4, 2015)

• Rare placental tumor: A report of two mesenchymomas.
  

  Shinnick JK, Lou LH, Ilse A, Rizk CB, Shahid R, Thomson L, et al.

American Neurological Association (ANA)
140^th Annual Meeting in Chicago, Ill. (Sept. 27-29, 2015)

• Safety of treadmill exercise testing in Parkinson disease.
  

  Jackson GR, Bryant M, Zaheer F, Protas E

• Results of a double-blind placebo-controlled study of 3,4-diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS).
  

  Sanders DB, Juel VC, Harati Y, Smith AG, Peltier A, Marburger T, et al.

7^th European Workshop on Cannabinoid Research
Sestri Levante, Italy (Sept. 17-19, 2015)

• Cell type-specific STORM super-resolution imaging of cannabinoid signaling in brain circuits.
  [Oral Presentation]
  

  Dudok B

University of Puerto Rico
Department of Students with Disabilities in Bayamón, Puerto Rico (September 2015)

• Managing stress and anxiety.
  [Oral Presentation]
  

  Santiago-Mejías S, Dávila D, Haddock RY, Roque L

31^st International Epilepsy Congress (IEC)
Istanbul, Turkey (Sept. 5-9, 2015)

• Neonatal estradiol prevents infantile spasms and seizures in arx-linked infantile spasms syndrome.
  [Platform Presentation]
  

  Noebels JL

• Utilization of fMRI in patients with epilepsy and right hemispheric dominance.
  [Platform Presentation]
  

  Van Ness PC

2015 Alzheimer's Association International Conference (AAIC)
Washington, DC (July 18-23, 2015)

• Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Comparison of patient-reported ratings to those of caregiver proxies in a 12-week open-label trial (PRISM II).
  

  Doody RS, Cutler AJ, D'Amico S, Shin P, Ledon F, Yonan C, et al.

• Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Examination of CNS-LS outcomes in a 12-week open-label trial (PRISM II).
  

  Doody RS, D'Amico S, Cutler AJ, Shin P, Ledon F, Yonan C, et al.

• Dextromethorphan/quinidine for treatment of pseudobulbar affect in patients with dementia: Treatment effects by concomitant antidepressant use in a 12-week open-label trial (PRISM II).
  [Platform Presentation]
  

  Doody RS, D'Amico S, Cutler AJ, Shin P, Ledon F, Yonan C, et al.

• TTP488 path to registration: Leveraging enrichment strategies.
  

  Sabbagh MN, Burstein A, Grimes I, Valcarce C, Doody RS, Sano M, et al.

• TTP488: From futile to fast track.
  

  Sabbagh MN, Burstein A, Grimes I, Valcarce C, Rose E, Doody RS, et al.

North American Primary Care Research Group (NAPCRG)
2015 Practice-Based Research Network Conference in Bethesda, Md. (June 29-30, 2015)

• Selection of resources from a vaccination standing order program toolkit during a randomized trial to improve vaccination rates in a PBRN.
  

  Brown A, Pavlik V, Zimmerman R, Danek L, Lacour-Chestnut F, Lateef M, et al.

• Content of patient instructions section of an EHR generated after visit summary affects patient satisfaction.
  

  Pavlik V, Nash SG, Laufman L

University of Kentucky
2015 Clinical & Translational Neuroscience Exposition in Lexington, Ky. (June 26, 2015)

• Headache and cutaneous allodynia in older adults without cognitive impairment.
  [Previously Presented]
  

  Echiverri K, Jicha GA, Smith JH

• Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
  [Previously Presented]
  

  Gan W, Echiverri K, Smith JH

American Headache Society
57^th Annual Scientific Meeting in Washington, DC (June 18-21, 2015)

• Headache and cutaneous allodynia in older adults without cognitive impairment.
  

  Echiverri K, Jicha GA, Smith JH

• Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
  

  Gan W, Echiverri K, Smith JH

Movement Disorder Society (MDS)
19^th International Congress of Parkinson's Disease and Movement Disorders in San Diego, Calif. (June 14-18, 2015)

• Comparative patient satisfaction and efficacy of a Parkinson's disease enrichment program (PEP).
  

  Choudhury TK, York MK, Harris C, Crist K, Treece B, Satterwhite T

• XCiDaBLE: Observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the USA.
  

  Fernandez HH, Jankovic J, Pagan F, Greeley D, Sethi K, Verma A

• Progressive supranuclear palsy and statin use.
  

  Fuentes A, Standaert D, Marras C, Riley D, Hall D, Kluger B, et al.

• DBS experience at a tertiary care referral center.
  

  Jimenez-Shahed J, Keller J, Hunter C, Jankovic J

• American multiple system atrophy natural history study.
  

  Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, et al.

• Cervical dystonia and work productivity: Results from the cervical dystonia patient registry for the observation of onabotulinumtoxinA efficacy.
  

  Molho ES, Stacy M, Gillard P, Charles D, Adler CH, Jankovic J, et al.

• Dystonia-spasticity in a patient with a novel SLC25A12 mutation.
  

  Parnes M, Robak L, Shulman JM, Stocco A, Jankovic J

• Gait and balance in Parkinson's disease (PD) following bilateral Subthalamic Nucleus (STN) and Globus Pallidus Interna (GPi) stimulation: 36 month follow-up of CSP#468 cohort.
  

  Sarwar AI, Carlson K, Luo P, Follett KA, Stern M, Weaver FM, et al.

• Psychogenic movement disorders: Are there neurocognitive differences between patients with non-epileptic seizures vs those with other hyperkinetic motor manifestations?
  

  Scott BM, Strutt AM, Lundberg-Love PK, Schmitt AL, Trifilio ER, Bowers D

• Clinical utility of apraclonidine in ptosis.
  

  Wijemanne S, Jankovic J

American Association of Neuropathologists, Inc. (AANP)
91^st Annual Meeting in Denver, Colo. (June 11-14, 2015)

• An unusual case of central nervous system Rosai-Dorfman disease.
  

  Chu J, Goodman JC, Jalali N, Kass J

International Myotonic Dystrophy Consortium (IDMC)
10^th Meeting in Paris, France (June 8-10, 2015)

• Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
  

  Shroff S, Thonhoff J, Eatman J, Pleitez M, Rosenfield D

American Society of Clinical Oncology (ASCO)
51^st Annual Meeting in Chicago, Ill. (May 29 - June 2, 2015)

• IDH1 mutation status and outcome in clinical trials for recurrent glioblastoma.
  

  Mandel JJ, Cachia D, Liu DD, Aldape KD, Fuller G, De Groot JF

University of Toronto
3^rd International Conference on Knowledge Gaps in Parkinson's disease and Other Movement Disorders in Toronto, Canada (May 8-10, 2015)

• Reticular myoclonus in type I myotonic dystrophy.
  

  Chu J, Luo L, Harati Y

American Stroke Association
Quality of Care and Outcomes Research Scientific Sessions in Baltimore, Md. (April 29 - May 1, 2015)

• The use of thrombolysis among acute ischemic stroke patients with limited English proficiency.
  

  Mejia N, Siddiqui KA, Erfe B, Schwamm LH

• Increased frequency of early dispensed but unused tPA shortens door to needle times in potentially eligible thrombolysis patients presenting to a tertiary stroke center.
  

  Siddiqui KA, Ali SF, Anderson CD, Rost N, Schwamm LH

• Patient characteristics and outcomes among early-arriving acute stroke patients for whom alteplase was dispensed but not administered.
  [Oral Presentation]
  

  Siddiqui KA, Syed FA, Anderson CD, Rost N, Schwamm LH

American Academy of Neurology (AAN)
67^th Annual Meeting in Washington, DC (April 18-25, 2015)

• Validation of olfactory deficit as a biomarker of Alzheimer's disease.
  

  Amrutkar C, Woodward M, Shah H, Benedict R, Rajakrishnan S, Doody R, et al.

• Seizure outcome after epilepsy surgery in patients with intractable non-lesional epilepsy.
  

  Barot N, Chen H, Modur P, Van Ness P, Agostini M, Hays R, et al.

• Reliability of the severity subscale of the revised Toronto Spasmodic Torticollis Rating Scale (TWSTRS-2).
  [Oral Presentation]
  

  Comella C, Perlmutter J, Jinnah H, Factor S, Goetz C, Adler C, et al.

• PRISM II: An open-label study to assess the safety, tolerability, and effectiveness of dextromethorphan 20 mg/quinidine 10 mg for treatment of pseudobulbar affect secondary to dementia, stroke, or traumatic brain injury: Results from the Alzheimer's disease/dementia cohort.
  

  Doody RS, D'Amico S, Cutler AJ, Shin P, Ledon F, Yonan C, et al.

• XCiDaBLE: An observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Final results from the blepharospasm cohort.
  

  Fernandez HH, Jankovic J, Holds J, Lin D, Burns J, Sethi K, et al.

• Decompressive hemicraniectomy for spontaneous supratentorial intracerebral hemorrhage: A descriptive analysis.
  

  Gildersleeve K, Hirzallah MI, Pandurengan P, Gonzales NR

• Autoimmune epilepsy: Clinical features, management and outcomes.
  

  Hays R, Dubey D, Samudra N, Agostini M, Ding K, Gupta P, et al.

• Use of best practice alerts in electronic medical records to improve care for women of childbearing age taking anti-seizure medications.
  

  Lin L, Castleman D, Glover C, Vieley J, Van Ness P

• The impact of cervical dystonia on work productivity: An analysis from the CD Patient Registry for the Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
  

  Molho E, Stacy M, Gillard P, Charles P, Adler C, Jankovic J, et al.

• Dystonia-spasticity in a patient with a novel SLC25A12 mutation.
  

  Parnes M, Robak L, Shulman J, Stocco A, Jankovic J

• "Review of systems" questionnaire as a predictive tool for psychogenic non-epileptic seizures.
  

  Robles L, Chiang S, Rutherford H, Haneef Z

• vCJD in the United States - Analysis of four cases.
  

  Saenz D, Marafie D, Maheshwari A, Hussein H

• Atypical presentation of inclusion body myositis.
  

  Shroff S, Pleitez M

• "Speechless" after a seizure: A rare case of postictal aphemia.
  

  Uppal G, Barot N, Van Ness P

• SUNCT responding to botulinum toxin.
  

  Wijemanne S, Jankovic J

• Hemichorea in a patient with diabetic ketoacidosis.
  

  Yassin A, Shroff S, Patel S, Parker A, Berman M, Jackson G

European Stroke Organisation (ESO)
1^st Conference in Glasgow, Scotland (April 17-19, 2015)

• Decompressive hemicraniectomy for supratentorial spontaneous intracerebral hemorrhage: A retrospective case-control study using propensity score matching.
  

  Gildersleeve K, Gonzales NR, Hirzallah MI, Esquenazi Y, Moomaw C, Sekar P, et al.

• Thrombolysis-associated parenchymal hemorrhage is not associated with CT perfusion variables.
  

  Tsetsou S, Amiguet M, Eskandari A, Wintermark M, Michel P

Anxiety and Depression Association of America (ADAA)
2015 Annual Conference in Miami, Fla. (April 9-12, 2015)

• Using research-domain criteria (R-Doc) to understand biological markers of anxiety.
  

  Gonzalez P, Bidot F, Santiago S, Merced K, Carrillo N, Rolon P, et al.

Experimental Biology (EB)
2015 Annual Meeting in Boston, Mass. (March 28 - April 1, 2015)

• Differential Ankyrin-G binding of voltage-gated sodium and KCNQ2/3 potassium channels is mediated by an overlapping N-terminal binding site.
  

  Xu M, Cooper E

American Psychosomatic Society (APS)
73^rd Annual Meeting in Savannah, Ga. (March 18-21, 2015)

• Higher heart rate variability predicts stronger performance on executive functioning tasks in older adults.
  

  Combs HL, Scott AB, Segerstrom SC

10^th University of Alabama at Birmingham (UAB)
Health Disparities Research Symposium in Birmingham, Ala. (March 17-18, 2015)

• Exploring racial differences in cognitive function.
  

  Henry S, Clay OJ, Crowe M

American Stroke Association
2015 International Stroke Conference in Nashville, Tenn. (Feb. 11-13, 2015)

• Baseline clinical and infarct characteristics as predictors of poor outcomes in patients not thrombolysed due to mild or resolving symptoms ("too good to treat").
  

  Ali SF, Siddiqui KA, Cohen AS, Ay H, Singhal AB, Schwamm LH

• Admission hemoglobin and sodium values are important factors associated with good outcome after acute ischemic stroke.
  

  Cohen AS, Siddiqui KA, Ali SF, Anderson CD, Silverman SB, Schwamm LH

• Sustained reliability in dysphagia screening by registered nurses.
  [Oral Presentation]
  

  Daniels SK, Pathak S, Morgan RO, Anderson JA

• Incidence of new or worsening renal insufficiency (RI) among stroke patients receiving IV contrast dye: A population-based study.
  

  Demel SL, Moomaw CJ, Khoury JS, Alwell KA, Kissela BM, Grossman AG, et al.

• Reasons why rt-PA was not given: Physician documentation vs. chart abstraction.
  

  Eckerle B, Khoury J, Alwell K, Moomaw C, Kissela B, Flaherty M, et al.

• Trends in anticoagulant-associated intracerebral hemorrhage and cardioembolic ischemic stroke.
  [Oral Presentation]
  

  Flaherty ML, Sekar P, Alwell K, Moomaw CJ, Ferioli S, Adeoye O, et al.

• Using simulation mannequins to train nurses in stroke dysphagia screening.
  

  Freeland T, Garrett R, Pathak S, Anderson JA, Daniels SK

• Temporal trends of emergency department arrival times after acute ischemic stroke: A population-based study.
  

  Katz BS, Khoury J, Alwell K, Moomaw CJ, Kissela BM, Flaherty ML, et al.

• Racial differences in ischemic stroke subtypes: The Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS).
  

  Kissela B, Khoury J, Alwell K, Moomaw CJ, Woo D, Flaherty ML, et al.

• Population-based eligibility for a stroke prevention trial evaluating novel anticoagulants and embolic strokes of uncertain etiology: Similar eligibility as for IV rt-PA.
  

  Kleindorfer D, Kasner S, Moomaw CJ, Alwell K, Adeoye O, Woo D, et al.

• Analysis of gender and time to arrival among ischemic stroke patients in the Greater Cincinnati/Northern Kentucky Stroke Study.
  

  Madsen TE, Sucharew H, Katz B, Alwell KA, Moomaw CJ, Kissela BM, et al.

• Multi-center experience with low dose intravenous abciximab in large vessel posterior circulation stroke.
  

  Mandava P, Rosso C, Samson Y, Kent TA

• Modeling outcome after intracerebral hemorrhage indicates no benefit from lowering blood pressure.
  [Oral Presentation]
  

  Mandava P, Samson Y, Kent TA

• Early improvement in NIHSS is common during inter-hospital transfer and is associated with lower in-hospital mortality.
  

  Siddiqui KA, Cohen AS, Ali SF, Schwamm LH

Texas Neurological Society
18^th Annual Winter Conference in Austin, Texas (Feb. 6-8, 2015)

• Pre-workout supplement triggered Call-Fleming Syndrome.
  

  Nguyen A, Hirzallah MI, Ondo W

International Neuropsychological Society (INS)
43^rd Annual Meeting in Denver, Colo. (Feb. 4-7, 2015)

• Chaining likelihood ratios to detect psychogenic non-epileptic events (PNEE).
  

  Booth JE, Wisdom NM, Robinson J, Chen D, Collins R

• The relation between the WMT and CVLT-2 in a sample of patients evaluated for dementia.
  

  Collins R, Miller B, Robinson J, Pacheco V

• Irritability and aggression as indicators of persistent post-concussive symptoms in adolescent athletes.
  

  Combs HL, Mason LH, Anderson AJ, Han D

• Higher heart rate variability predicts better performance on executive functioning measures in older adults.
  

  Combs HL, Russell ME, Segerstrom SC

• Neuropsychological improvement following a novel inpatient treatment for OEF/OIF veterans with PTSD and multiple comorbidities.
  

  McCauley S, Menefee D, Tran J, Wanner J, Hickey J, Leopoulos W, et al.

• Prospective memory in OEF/OIF veterans with PTSD with or without mild traumatic brain injury using virtual week.
  

  McCauley S, Tran J, Menefee D, Wanner J, Hickey J, Leopoulos W, et al.

• Persistent post-concussive symptoms and cortical thinning in mild traumatic brain injury.
  

  Merkley TL, Wilde EA, McCauley S, Barnes A, Li X, Bigler ED, et al.

• Added value of neuropsychological assessment to the Clinical Dementia Rating Scale in assessing mild cognitive impairment.
  

  Miller B, Robinson J, Pacheco V, Collins R

• Examination of the severe impairment profile in dementia evaluations.
  

  Robinson J, Collins R, Miller B, Pacheco V

• Comparison of psychogenic movement disorder patients with non-epileptic seizures vs other hyperkinetic motor manifestations: an integrated model of psychosocial and neuropsychological functioning.
  

  Scott BM, Strutt AM, Lundberg-Love P, Schmitt AL, Trifilio E, Bowers D

• Psychometric properties of the Patient Competency Rating Scale in a seizure disorder population.
  

  Stinson JM, Grabyan J, Robinson J, Proto D, Chen D, Collins R

• Improvement in psychiatric status following a novel inpatient treatment for OEF/OIF veterans with PTSD and multiple comorbidities.
  

  Wilde EA, Menefee D, Tran J, Wanner J, Leopoulos W, Hickey J, et al.

• An examination of cognitive deficits after controlling for respondent validity in veterans with chronic PTSD.
  

  Wisdom NM, Booth JE, Tang R, Miller B, Collins R, Pastorek NJ

• Volumetric and DTI analyses of sports concussion.
  

  Wu TC, Merkley TL, Wilde EA, Barnes A, Li X, Shin BC, et al.

• White matter integrity and its relationship to PTSD symptoms and sleep quality in OEF/OIF veterans.
  

  Zilberfayn I, Wilde EA, Tran J, Menefee D, Sanyal R, Hickey J, et al.

American Clinical Neurophysiology Society (ACNS)
2015 Annual Meeting in Houston, Texas (Feb. 3-8, 2015)

• Paroxysmal generalized electrographic delta activity with confusion during natalizumab infusion.
  

  Kadiwala H, Hays RS, Van Ness PC, Agostini M, Greenberg B, Ding K

International Neurotoxin Association (INA)
Toxins 2017 2^nd International Conference in Lisbon, Portugal (Jan. 14-17, 2015)

• Treatment patterns and patient disposition in the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE).
  

  Comella C, Charles D, Jankovic J, Stacy M, Schwartz M, Manack Adams A, et al.

• Long-term effects of botulinum toxin injections.
  

  Jankovic J

American Epilepsy Society (AES)
68^th Annual Meeting in Seattle, Wash. (Dec. 5-9, 2014)

• Hepatic safety of eslicarbazepine acetate: Summary of five Phase II and three Phase III adjunctive trials.
  

  Blum D, Van Ness P, Krauss G, Chung S, Elger C, Galimberti CA, et al.

• Characteristics of seizure termination in focal and generalized seizures.
  

  Borzello M, Maheshwari A, Chu C, Brandon Westover M, Kramer M, Cash S

• Computer-automated focus lateralization of temporal lobe epilepsy using fMRI.
  

  Chiang S, Levin H, Haneef Z

• Impact of psychogenic non-epileptic seizure (PNES) diagnosis on acute care resource utilization, role for psychiatric consultation, and follow-up within a Dallas county hospital system.
  

  Culver C, Konikkara J, Howe-Martin L, Van Ness P, Agostini M, Hays R, et al.

• Rhythmic ictal nonclonic extremity movements in temporal lobe epilepsy: A reappraisal.
  

  Ding K, Agostini M, Gupta P, Hays R, Van Ness P, Modur P

• Autoimmune epilepsy: Clinical features, management and outcomes.
  

  Dubey D, Hays R, Gupta P, Ding K, Agostini M, Van Ness P, et al.

• Brain graph theory topology changes associated with anti-epileptic drug use.
  

  Haneef Z, Levin H, Chiang S

• Responsive stimulation of eloquent cortex.
  

  Kapur R, Duckrow R, Heck C, Eisenschenk S, Gwinn R, Geller E, et al.

• Unique characteristics of patients with comorbid epileptic and psychogenic nonepileptic seizures.
  

  Konikkara J, Pacheco J, Van Ness P, Agostini M, Hays R, Howe-Martin L, et al.

• (1-3)insulin-like growth factor 1 suppresses seizures and hypsarrhythmia in an animal model of infantile spasms.
  [Platform Presentation]
  

  Lee C, Frost Jr. J, Le J, Hrachovy R, Swann J

• KCNQ2-deficiency: Clinical spectrum of epilepsy, encephalopathy, and response to ezogabine.
  

  Park K, Millichap J, Cooper E

• Responsive neurostimulation in patients with periventricular nodular heterotopia (PNH).
  

  Rutecki P, Herekar A, Van Ness P, Bergey G, Bazil C, King-Stephens D, et al.

• A KCNQ2/3 mutation causing severe epilepsy disrupts channel targeting to the axon initial segment.
  

  Tran B, Xu M, Cooper E

• Treatment resistance correlates with ECG abnormalities in a pilot clinical surveillance of epilepsy patients.
  

  Zohrevand P, Diaz M, Amador A, Goldman A

North American Primary Care Research Group (NAPCRG)
42^nd Annual Meeting in New York, N.Y. (Nov. 21-25, 2014)

• Provider survey of attitudes toward and uses of an electronic after visit summary.
  

  Almutairi A, Nash SG, Laufman LE, Pavlik V

• Patterns of glycemic control with exclusive oral hypoglycemic agent use in a community health care setting.
  

  Vaughan E, Aggarwal A, Pavlik V

Society for Neuroscience (SFN)
44^th Annual Meeting in Washington, DC (Nov. 15-19, 2014)

• Increased risk of hypoxic depolarization of the brainstem autonomic circuit in a mouse SUDEP model.
  

  Aiba I, Noebels JL

• Neural mechanisms of circuit homeostasis failure in MeCP2 disorders.
  

  Lu H, Ash RT, Wang W, Yu D, Arenkiel BR, Smirnakis SM, et al.

• Organization of human area V5/MT+ and sensitivity to motion coherence after lesions of the primary visual cortex.
  

  Papanikolaou A, Keliris GA, Lee S, Papageorgiou TD, Schiefer U, Logothetis NK, et al.

Gerontological Society of America (GSA)
2014 Resource Centers for Minority Aging Research (RCMAR) Cognitive Health Disparities Research & National Policy Workshop in Washington, DC (Nov. 5, 2014)

• Exploring racial differences in cognitive function among older adults with diabetes.
  

  Henry S, Clay OJ, Crowe M

American Neurological Association (ANA)
139^th Annual Meeting in Baltimore, Md. (Oct. 12-14, 2014)

• WIP safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with Alzheimer's disease/dementia: PRISM-II.
  

  Doody RS, D'Amico S, Cutler AJ, Shin P, Ledon F, Yonan C, et al.

• Antioxidant biomarkers predict annualized change in MMSE score in MCI and AD patients in the TARCC cohort.
  

  Majid T, Chan W, Darby E, Pavlik V, Doody R

Neurocritical Care Society (NCS)
12^th Annual Meeting in Seattle, Wash. (Sept. 11-14, 2014)

• Volumetric integral phase-shift spectroscopy (VIPS), in detecting early cerebral edema: Hemodialysis as a proof of principle model.
  [Platform Presentation]
  

  Damani R, Maldonado N, Bershad E, Calvillo E, Smirnakis S, Georgiadis A, et al.

• Human albumin (HA) usage in subarachnoid hemorrhage (SAH) patients at US academic medical centers: Analysis of the University Healthsystem Consortium (UHC) database.
  

  Suarez JI, Martin RH, Calvillo E, Hohmann SF, Bershad EM, Rao CPV, et al.

2014 Alzheimer's Association International Conference (AAIC)
Copenhagen, Denmark (July 12-17, 2014)

• Comparing recruitment among geographic regions in multinational Alzheimer's disease clinical trials.
  

  Grill JD, Raman R, Ernstrom K, Dowsett S, Chen Y-F, Liu-Seifert H, et al.

• Regional variation in Alzheimer's disease progression in a clinical trial setting.
  

  Henley DB, Dowsett SA, Chen Y-F, Liu-Seifert H, Grill JD, Doody R, et al.

North American Primary Care Research Group (NAPCRG)
2014 Practice-Based Research Network Conference in Bethesda, Md. (June 30 - July 1, 2014)

• Development of a codebook to describe the content of the patient instructions section of an EHR-generated after visit summary.
  

  Pavlik V, Campbell-Voytal K, Nash SG, Laufman L, Neale V

Movement Disorder Society (MDS)
18^th International Congress of Parkinson's Disease and Movement Disorders in Stockholm, Sweden (June 8-12, 2014)

• Treatment patterns and patient disposition in the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
  

  Charles D, Jankovic J, Adler CH, Comella C, Stacy M, Schwartz M, et al.

• Convergent validity of the revised motor and psychiatric TWSTRS modules of the Comprehensive Cervical Dystonia Rating Scale (CCDRS).
  

  Comella CL, Perlmutter JS, Jinnah HA, Factor S, Waliczek TA, Rosen AR, et al.

• Effectiveness and safety in the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
  

  Jankovic J, Adler CH, Charles D, Comella C, Stacy M, Schwartz M, et al.

• MER vs. MRI guidance in placement of DBS electrodes for Parkinson's disease.
  

  Jimenez-Shahed J, York M, Smith-Gloyd EM, Jankovic J, Viswanathan A

• Impact of post traumatic stress disorder (PTSD) on the clinical expression of REM sleep behavior disorder (RBD) in veterans with Parkinson's disease (PD).
  

  Sarwar AI, Moore S, Hirshkowitz M

• Methodology for a symptomatic impact study using a portable essential tremor (ET) monitor to direct therapeutic interventions.
  

  Vittal P, Pulliam CL, Goetz CG, Jankovic J, Ramirez-Castaneda JL, Heldman DA

• Parkinson's disease and ocular melanoma in veterans.
  

  Zaheer F, Moore S, Sarwar AI

• Reliability and validity of the revised TWSTRS psychiatric module (TWSTRS-PSYCH) of the Comprehensive Cervical Dystonia Rating Scale (CCDRS).
  

  Zurowski MJ, McDonald W, Comella CL, Perlmutter JS, Jinnah HA, Factor S, et al.

American Society of Clinical Oncology (ASCO)
50^th Annual Meeting in Chicago, Ill. (May 30 - June 3, 2014)

• Adverse effects of bevacizumab in brain tumor patients.
  

  Pawar T, Ladha H, Mandel J, Gilbert M, O'Brien B, Hamza M, et al.

• Venous thromboembolism (VTE) and glioblastoma.
  

  Yust-Katz S, Mandel J, Ying Y, Wu J, Courtney C, Ladha H, et al.

American Academy of Neurology (AAN)
66^th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)

• New risk score improves vasospasm prediction following subarachnoid hemorrhage using markers of vascular compliance.
  

  Anand A, Hussein H, Ezzeddine M, Kass J, Suarez J

• Optical coherence tomography visualization of optic nerve head structure detects acute changes in the intracranial pressure.
  

  Anand A, Pass A, Calvillo E, Tang R, Cajavilca C, Urfy M, et al.

• Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE): Treatment patterns and subject disposition.
  

  Charles P, Jankovic J, Comella C, Stacy M, Schwartz M, Manack A, et al.

• Graph theory based functional connectivity in lateralized temporal lobe epilepsy.
  [Platform Presentation]
  

  Chiang S, Stern J, Engel J, Levin H, Haneef Z

• Infantile cerebral arterial calcification.
  

  Chu J, Dicarlo S, Zeller R

• Cardiac valve strands in ischemic stroke: Strand effects and outcomes of medical or surgical intervention.
  

  Chu J, Fabian R

• Clinimetric testing of the modules for the Comprehensive Cervical Dystonia Rating Scale (CCDRS).
  [Platform Presentation]
  

  Comella C, Perlmutter J, Jinnah H, Adler C, Barbano R, Factor S, et al.

• Multiple autoimmune antibody limbic encephalitis: A case in a pregnant woman.
  

  Goyal M, Gildersleeve K, Tomko S, Kass J

• Oxidative metabolism during forearm exercise in McArdle disease.
  

  Haller R, Sharp L, Phillips L, Newby M, Wyrick P, Heinicke K

• Treatment outcomes in Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
  

  Jankovic J, Adler C, Charles P, Comella C, Stacy M, Schwartz M, et al.

• Epidemiological pilot analysis of epilepsy patients in a community clinic aims to inform effective care.
  

  Karas L, Goldsmith C, Ruppelt SC, Goldman A

• Improved progression free survival in 1p/19q co-deleted anaplastic oligodendroglioma treated with both chemotherapy and radiation therapy at diagnosis.
  [Platform Presentation]
  

  Mandel J, Webre CC, Shonka NA, Yung WK, De Groot J

• How long is long enough? The utility of prolonged inpatient video EEG monitoring.
  

  Moseley BD, Dewar S, Haneef Z, Stern J

• Thrombolytic outcomes for acute ischemic stroke in patients with primary brain tumors in the United States.
  

  Murthy S, Moradiya Y, Shah S, Shastri A, Bershad E, Suarez J

• Clinical outcomes of aneurysmal subarachnoid hemorrhage with cocaine use in the United States.
  [Platform Presentation]
  

  Murthy S, Shah S, Moradiya Y, Shastri A, Smirnakis S

• Alleviating maneuvers (sensory tricks) in cervical dystonia.
  

  Patel N, Hanfelt J, Marsh L, Jankovic J

• Reversible dementia with myoclonus due to concurrent HSV-2 and syphilis central nervous system infection in an immunocompetent man.
  

  Robles L, Anand A, Kass J

• Zung Self Rating Depression Scale in Parkinson's disease: A validity study in veterans.
  

  Sarwar A, Hirshkowitz M

• A distinctive delayed form of exertional rhabdomyolysis.
  [Platform Presentation]
  

  Sharp L, Haller R

• Not PFK deficiency.
  

  Sharp L, Romain N, Haller R

• Mentored peer review of standardized manuscripts for teaching neurology residents biostatistics, research methodology, and peer review.
  

  Strowd RE, Wong VSS, Aragón García R, Haut S, Kass J, Mays MA, et al.

• Dopamine transporter imaging in essential tremor with and without parkinsonian features.
  [Platform Presentation]
  

  Waln O, Wu Y, Perlman R, Van AK, Wendt J, Jankovic J

• Hereditary spastic paraplegia due to a novel mutation in SPG11 gene presenting as dopa responsive dystonia, parkinsonism and spasticity.
  

  Wijemanne S, Jankovic J

• Resource utilization in patients with suspected psychogenic non epileptic seizures and drug resistant epilepsy in the Harris County Health District between 2009 and 2012.
  

  Wolf B, Hayashi B, Sachs E, Van Hook C, Murphey D, Goldsmith C

Texas Scottish Rite Hospital for Children
36^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 13-14, 2014)

• A distinctive delayed form of exertional rhabdomyolysis.
  

  Sharp L, Haller RG

• Fixed weakness in McArdle disease.
  

  Sharp L, Haller RG

• Exercise intolerance with congenital anomalies.
  

  Sharp L, Haller RG, Heinicke K, Phillips L, Romain N, Park S, et al.

• Rare family with autosomal dominant oculopharyngeal muscular dystrophy showing anticipation.
  

  Smith S, Pleitez MY

International Neuropsychological Society (INS)
42^nd Annual Meeting in Seattle, Wash. (Feb. 12-15, 2014)

• Progression and stability of cognitive asymmetry in a large sample of Alzheimer's disease patients.
  

  Alverson WA, Massman PJ, Grabyan JM, Doody RS

• Perceived competency and quality of life deficits in individuals experiencing psychogenic non-epileptic events.
  

  Collins R, Robinson J, Plasencia M, Franks R, Chen D

• Effect of severity of concussion (mTBI) and PTSD on cognitive functioning in veterans with deployment-related mTBI.
  

  Combs HL, Berry D, Pape TL, Babcock-Parziale J, Smith BM, Schleenbaker RE, et al.

• Age and IQ moderate practice effects of verbal memory ability in older adults.
  

  Combs HL, Garcia NE, Segerstrom SC

• A longitudinal investigation of sleep quality following mild traumatic brain injury: Comparison with orthopedic and non-injured controls.
  

  Faber J, Adam S, Li X, McCauley S, Levin H

• Practice effects and longitudinal change in processing speed and executive functioning among older adults.
  

  Garcia NE, Combs HL, Segerstrom SC

• Patients with sports-related mTBI return to activities more rapidly than patients with motor vehicle crash-related mTBI.
  

  Rabinowitz AR, Li X, McCauley SR, Wilde EA, Hanten GR, Levin HS

• The relation of postconcussive symptom report and cognitive testing in an mTBI population: The effect of performance validity test results.
  

  Stinson JM, Pastorek NJ, Miller B, Linck J, Sim A, Romesser J

• Serial diffusion tensor imaging in subacute uncomplicated mild traumatic brain injury.
  

  Wilde EA, Bigler ED, Pedroza C, Barnes A, Wu TC, McCauley SR

• Discriminating between ADHD, ADHD with a comorbid psychological disorder and malingered ADHD in a college sample.
  

  Williamson KD, Combs HL, Harp JP, Mason LH, Edmundson M, Berry D

• Effects of PTSD, mild traumatic brain injury, and alcohol abuse on sleep quality in OEF/OIF veterans.
  

  Zilberfayn I, Wilde EA, Tran JK, Menefee DS, Sanyal R, Leopoulos WS, et al.

American Stroke Association
2014 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2014)

• ICD-9 code positive predictive value for stroke subtype in a population-based epidemiology study.
  

  Alwell K, Khoury JC, Kleindorfer DO, Moomaw CJ, Eilerman J, Woo D, et al.

• Use of emergency medical services by stroke patients.
  [Oral Presentation]
  

  Anderson AM, Sucharew H, Alwell K, Moomaw CJ, Adeoye O, Woo D, et al.

• Combination argatroban and TPA for acute ischemic stroke: A matched case-control analysis.
  

  Barreto AD, Mandava P, Guerrero W, Shen L, Grotta JC, Kent TA

• Prevalence of echocardiographic abnormalities in acute ischemic stroke.
  

  Eckerle B, Sucharew H, Alwell K, Moomaw CJ, Flaherty M, Martini S, et al.

• Impact of substance abuse on timely treatment with rt-PA: A population-based study.
  

  Goodall EB, Kimmel PL, Sucharew H, Alwell K, Moomaw CJ, de los Rios La Rosa F, et al.

• Prevalence of unsuspected renal insufficiency in stroke patients presenting to the emergency department: A population-based assessment.
  [Oral Presentation]
  

  Grossman AW, Khoury JC, Alwell K, Moomaw CJ, Khatri P, Woo D, et al.

• Predictors of platelet transfusion in patients with intracerebral hemorrhage.
  

  Guerrero WR, Gonzales NR, Sekar P, Castillo J, Moomaw CJ, Worrall BB, et al.

• Stroke in the young: Preliminary results for temporal trends in the age of stroke incidence in a large, bi-racial population.
  [Oral Presentation]
  

  Kissela BM, Alwell K, Khoury J, Moomaw C, Woo D, Adeoye O, et al.

• Temporal trends in stroke incidence over the past twenty years: Stroke incidence has stabilized, racial disparity is not improving.
  

  Kleindorfer D, Alwell K, Khoury J, Moomaw CJ, Woo D, Adeoye O, et al.

• Moderate alcohol use protects from intracerebral hemorrhage: Findings from the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
  

  Koch S, Brown MW, Moomaw CJ, Langefeld CD, Martini SR, Braimah J, et al.

• Migraine and risk of intracerebral hemorrhage in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
  

  Koch S, Elkind MS, Moomaw CJ, Brown MW, Martini SR, Osborne J, et al.

• Racial-ethnic blood pressure differences in acute intracerebral hemorrhage.
  [Oral Presentation]
  

  Koch S, Elkind MS, Testai FD, Brown MW, Martini SR, Sheth KN, et al.

• Does intraventricular hemorrhage lead to a normal pressure hydrocephalus-like syndrome?
  

  Kruger AJ, Flaherty M, Sekar P, Haverbusch M, Moomaw CJ, Martini S, et al.

• Stroke recurrence rates are not changing over time.
  [Oral Presentation]
  

  Lee I, Sucharew H, Alwell K, Moomaw CJ, Woo D, Ferioli S, et al.

• A pooled analysis indicates the promise and pitfalls of improving upon intravenous rt-PA for ischemic stroke.
  

  Mandava P, Shah SD, Sarma AK, Dalmeida D, Kent TA

• Improving quality of care and outcomes in the community through the inclusive collaboration between a certified comprehensive stroke center and regional hospitals.
  

  Mazabob JM, Styron S, Brown G, Jones-Brown M, Suarez J, Bershad E, et al.

• Clinical outcomes following thrombolysis for acute ischemic stroke in patients with systemic malignancy: A nationwide case-control study.
  

  Murthy S, Karanth S, Shah S, Shastri A, Rao C, Bershad E, et al.

• Clinical outcomes following thrombolysis for acute ischemic stroke in patients with primary brain tumors: A nationwide population study.
  

  Murthy SB, Shah S, Karanth S, Shastri A, Bershad E, Suarez JI

• Treatment of ischemic stroke with recombinant tissue plasminogen-activator in pregnancy: A population study.
  

  Shah S, Murthy S, Karanth S, Bershad EM, Venkatasubba Rao CP, Suarez J

• ICH & FUNC scores in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
  

  Sheth KN, Sung G, Langefeld CD, Moomaw CJ, Osborne J, Elkind MSV, et al.

• Prior use of statins may reduce hematoma growth in intracerebral hemorrhage patients.
  

  Siddiqui FM, Olson DM, Sekar P, Moomaw CJ, Rosand J, Kidwell C, et al.

• Utilization of vascular imaging in stroke: A population based study.
  

  Vagal A, Sucharew H, Alwell K, Khoury J, Khatri P, Woo D, et al.

• Is obesity a marker of good or bad functional outcome after ischemic stroke?
  

  Yeramaneni S, Kissela BM, Kleindorfer DO, Alwell K, Moomaw CJ, McCarthy M, et al.

American Epilepsy Society (AES)
67^th Annual Meeting in Washington, DC (Dec. 6-10, 2013)

• Longitudinal feasibility testing of the MINDSET vers 2.1: A clinic-based decision support system for epilepsy self-management.
  

  Begley C, Shegog R, Harding A, Newmark M, Goldsmith C, Hope O

• Predictors of postoperative seizure outcome: a longitudinal study of temporal and extratemporal resections.
  

  Chen H, Agostini M, Ding K, Gupta P, Hays R, Van Ness P, et al.

• Right hemispheric ictal asystole - Report of two cases.
  

  Chu J, Majmudar S, Chen D

• Discordance between functional magnetic resonance imaging (fMRI) and Wada test for language lateralization.
  

  Ding K, Yetkin Z, Van Ness P, Agostini M, Hays R, Gupta P, et al.

• Lateralization of temporal lobe epilepsy with long-term ambulatory intracranial monitoring using the RNS system: Experience in 82 patients.
  

  King-Stephens D, Mirro E, Weber P, Laxer K, Van Ness P, Salanova V, et al.

• STOP SUDEP Program: Application of visual automated fluorescence electrophoresis in the qualitative profiling of archived SUDEP samples.
  

  Klassen TL, Tomson T, Sveinsson O, von Dobeln U, Drabek J, Noebels J, et al.

• Practical implications of methodological differences in the Wada test protocols.
  

  Konikkara JJ, Frol AB, Agostini M, Ding K, Gupta P, Hays R, et al.

• Pore loop KCNQ2 mutations causing epileptic encephalopathy strongly suppress wild type KCNQ2 currents when co-expressed in mammalian cells.
  

  Li L, Tran B, Xu M, Millichap J, Porter B, Cooper E

• In vivo 2-photon confocal microscopy of cortical absence epilepsy.
  

  Meyer JF, Maheshwari A, Noebels J, Smirnakis S

• Long-term safety and efficacy of responsive brain stimulation in adults with medically intractable partial onset seizures.
  

  Morrell M, Sun F, King-Stephens D, Murro A, Barkley GL, Gwinn R, et al.

• How long is long enough? The utility of prolonged inpatient video EEG monitoring.
  

  Moseley B, Dewar S, Haneef Z, Stern J

• KCNQ2 targeting to the axon initial segment is disrupted in a mutant form causing severe epilepsy.
  

  Tran B, Xu M, Cooper E

• Ankyrin-G as a potential molecular mechanism linking epilepsy and comorbid mood disorder.
  

  Xu M, Cooper E

• Antiepileptic drugs and movement disorders: A frequently neglected story.
  

  Zaheer F, Jones K, Bensalem-Owen M, Slevin JT

Society of Neuro-Oncology (SNO)
18^th Annual Meeting in San Francisco, Calif. (Nov. 21-24, 2013)

• Survival outcomes of patients with recurrent anaplastic glioma treated with bevacizumab.
  

  Hamza M, O'Brien B, Mandel J, de Groot J

• Glioblastoma and leptomeningeal dissemination.
  

  Mandel J, Yust-Katz S, de Groot J, Yung A, Gilbert M

Society for Neuroscience (SFN)
43^rd Annual Meeting in San Diego, Calif. (Nov. 9-13, 2013)

• Bexarotene decreases hyperexcitability in two mouse models with epilepsy.
  

  Bomben VC, Holth JK, Cramer PE, Landreth GE, Noebels JL

• Paranodal ankyrins: Enigmatic glial anchors.
  

  Chang K-J, Zollinger DR, Susuki K, Ho TS, Cooper EC, Bennett V, et al.

• State dependence of noise correlations in monkey primary visual cortex.
  

  Ecker AS, Berens P, Cotton RJ, Subramaniyan M, Denfield GH, Smirnakis SM, et al.

• The roles of ankyrin-G in node of Ranvier formation in vivo.
  

  Ho T, Zollinger DR, Xu M, Cooper EC, Stankewich MC, Bennett V, et al.

• Estimation of average single-unit receptive field size by fMRI.
  

  Keliris GA, Shao Y, Papanikolaou A, Logothetis NK, Smirnakis SM

• Human area V5/MT+ organization changes following lesions of the primary visual cortex.
  

  Papanikolaou A, Keliris GA, Papageorgiou DT, Shao Y, Krapp E, Papageorgiou E, et al.

• Peripheral nerve graft implants into the substantia nigra of subjects with Parkinson's disease undergoing deep brain stimulation surgery: a safety study.
  

  Quintero JE, Asfahani WSZ, Zaheer F, Gurwell JA, Gerhardt GA, Slevin JT, et al.

• Population receptive field measurements in the visual cortex of macaque monkeys with and without retinal lesions.
  

  Shao Y, Keliris GA, Schmid MC, Papanikolaou A, Logothetis NK, Smirnakis SM

• Genetic ablation of betaII-spectrin in the central nervous system results in axon degeneration, epilepsy and postnatal lethality.
  

  Zhang C, Huang Y-M, Zhu P, Reed JG, Costa-Mattioli M, Noebels JL, et al.

American Neurological Association (ANA)
138^th Annual Meeting in New Orleans, La. (Oct. 13-15, 2013)

• Sudden unexplained death in epilepsy: Can genomics help?
  [Plenary Talk]
  

  Goldman A

• A new class of antioxidant carbon nanoparticles: Superoxide to oxygen generators.
  

  Kent TA, Fabian RH, Marcano D, Samuel ELG, Berka V, Tsai A-L, et al.

• Comparison of outcomes with pipeline and SILK flow diverters for the treatment of intracranial aneurysms: A systematic review of literature.
  

  Murthy SB, Shah S, Venkatasubba Rao CP, Bershad E, Suarez JI

• Efficacy and safety of IPX066, a carbidopa-levodopa, extended-release formulation, in early Parkinson's disease.
  

  Pahwa R, Ellenbogen A, Kell S, O'Conell M, Hauser R, Fahn S, et al.

• A pooled analysis identifies the potential to improve upon intravenous rt-PA.
  [Oral Presentation]
  

  Shah S, Mandava P, Sarma AK, Kent TA

Neurocritical Care Society (NCS)
11^th Annual Meeting in Philadelphia, Penn. (Oct. 1-4, 2013)

• Generation of a pooled outcome model for traumatic brain injury to use for prediction of potential trial success.
  

  Mandava P, Murthy SB, Dalmeida W, Hannawi Y, Wu EY, Kent TA

• Takotsubo cardiomyopathy increases mortality in traumatic brain injury patients: analysis of the nationwide inpatient sample.
  

  Murthy SB, Shah S, Karanth S, Venkatasubba Rao C, Bershad EM, Suarez JI

• Clinical outcomes of venous thromboembolism in subarachnoid hemorrhage patients: a U.S. population study.
  

  Murthy SB, Shah S, Shastri A, Karanth S, Venkatasubba Rao C, Bershad E, et al.

• Profound olfactory impairment in idiopathic intracranial hypertension.
  

  Urfy MZ, Chen D, Calvillo E, Suarez JI, Rao CPV, Tang RA, et al.

• Distortion product otoacoustic emissions for non-invasive intracranial pressure assessment.
  

  Urfy MZ, Voss S, Rao CPV, Suarez JI, Calvillo E, Pechacek A, et al.

XXI World Congress of Neurology (WCN)
Vienna, Austria (Sept. 21-26, 2013)

• A case of autoimmune encephalitis caused by antibodies to GABA-B receptor.
  

  Nunez-Wallace KR, Van Hook C, Kass JS

Alzheimer's Association, Houston and Southeast Texas Chapter
7^th Annual Research Symposium on Alzheimer's Disease (Sept. 12, 2013)

• Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy.
  

  Bomben V, Holth J, Reed J, Cramer P, Landreth G, Noebels J

Northwestern University
Evanston, Ill. (August 2013)

• Race and resting-state fMRI.
  [Oral Presentation]
  

  Santiago S, Chiao J

2013 Alzheimer's Association International Conference (AAIC)
Boston, Mass. (July 13-18, 2013)

• A study to assess the safety, tolerability, and effectiveness of Nuedexta (dextromethorphan 20 mg/quinidine 10 mg) in the treatment of pseudobulbar affect (PBA) [PRISM II].
  

  Doody R, Cutler A, D'Amico S, Zorowitz R, Alexander D, Hammond F, et al.

• Ordered subset analysis CNV association with Alzheimer's disease AAO phenotypes.
  

  Szigeti K, Trummer B, Lal D, Yan L, Song L, Doody R

American Academy of Clinical Neuropsychology (AACN)
11^th Annual Meeting in Chicago, Ill. (June 19-22, 2013)

• The effects of posttraumatic stress disorder, mild traumatic brain injury, and combined PTSD/mTBI on returning veterans.
  

  Combs HL, Berry DT, High WM

Movement Disorder Society (MDS)
17^th International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia (June 16-20, 2013)

• The long-term safety and efficacy of thalamic deep brain stimulation in essential tremor.
  

  Baizabal-Carvallo JF, Kagnoff M, Jimenez-Shahed J, Fekete R, Jankovic J

• Minimal clinically important changes in UPDRS scores in early PD in rotigotine clinical trials.
  

  Hauser R, Surmann E, Rubin Z, Jankovic J

• Continuous home monitoring of essential tremor using motion sensors.
  

  Heldman D, Pulliam C, Eichenseer S, Goetz C, Waln O, Hunter C, et al.

• Cervical Dystonia Patient Registry for Observation of onaBotulinumtoxinA Efficacy (CD PROBE): Baseline demographic and clinical characteristics.
  

  Jankovic J, Charles D, Adler C, Comella C, Stacy M, Schwartz M, et al.

• Long-term outcomes from the VA/NIH Cooperative Study on deep brain stimulation for Parkinson's disease.
  

  Marks Jr W, Luo P, Lanier E, Patel U, Carlson K, Rothlind J, et al.

• Sensory tricks (corrective maneuvers) in cervical dystonia.
  

  Patel N, Hanfelt J, Marsh L, Jankovic J, for the Dystonia Coalition

• Sleep disordered breathing and excessive sleepiness in Parkinson's disease.
  

  Sarwar AI, Sarwar O, Hirshkowitz M

• Safinamide significantly improves responder rates in fluctuating Parkinson's disease (PD) patients as add-on to levodopa (SETTLE).
  

  Schapira AHV, Fox SH, Hauser RA, Jankovic J, Jost W, Kulisevsky J, et al.

• Long-term safety of neurotrophic factor gene therapy using AAV2-neurturin (CERE-120) in Parkinson's disease.
  

  Taylor R, Baumann T, Marks Jr W, Ostrem J, Verhagen L, Stacy M, et al.

European Neurological Society (ENS)
23^rd Annual Meeting in Barcelona, Spain (June 8-11, 2013)

• Tosedostat and posterior reversible encephalopathy syndrome (PRES).
  [Oral Presentation]
  

  Mandel J, Tremont-Lukats I, Tummala S

• Severe neurological disability in cancer patients acutely infected with the West Nile virus (WNV).
  

  Mandel J, Woodman K, Tummala S, Tremont-Lukats I

American Society of Clinical Oncology (ASCO)
49^th Annual Meeting in Chicago, Ill. (May 31 - June 4, 2013)

• Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
  

  Hamza MA, Mandel J, Conrad CA, Gilbert MR, Yung WKA, Puduvalli VK, et al.

Consortium of Multiple Sclerosis Centers (CMSC)
27^th Annual Meeting in Orlando, Fla. (May 29 - June 1, 2013)

• Neuromyelitis optica presenting as multiple sclerosis worsening on natalizumab.
  

  Dragan E, Hutton G

• Treatment of idiopathic relapsing transverse myelitis.
  

  Dragan E, Hutton G

• Case series of cardiac complications during fingolimod first dose observation period.
  

  Dragan E, Hutton G, Birnbaum Y

• Efficacy of fingolimod in ethnic minorities.
  

  Dragan E, Saldana-King T, Hutton G

• Two-year follow-up results of the HALT MS clinical trial (ITN033AI).
  

  Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Georges GE, et al.

Society for Industrial and Applied Mathematics (SIAM)
13^th International Conference on Data Mining in Austin, Texas (May 2-4, 2013)

• Classification and diagnosis of myopathy from EMG signals.
  [Platform Presentation]
  

  Bue B, Merényi E, Killian J

Texas A&M College of Medicine
Clinical Neurology to First Year Medical Students in Bryan, Texas (April 2013)

• Neurological exam pearls: MSI lecture and workshop.
  [Oral Presentation]
  

  Kapadia A, Clark J

Society for Neuroscience - Bluegrass Chapter (BGSFN)
29^th Annual Spring Neuroscience Research Meeting in Lexington, Ky. (April 8, 2013)

• Combined thalamic and subthalamic nucleus stimulations in Parkinson disease.
  

  Stafford W, Zaheer F, Gurwell J, van Horne CG

• Effect of combined subthalamic and nigral stimulation on gait and postural stability in Parkinson's disease.
  

  Zaheer F, van Horne CG

American Academy of Neurology (AAN)
65^th Annual Meeting in San Diego, Calif. (March 16-23, 2013)

• FDG-PET reveals reduced metabolic activity in the basal ganglia of a patient with anti-NMDA receptor encephalitis.
  

  Abers MS, Zafar S, Kass J

• Examining anti-dementia drug persistence in Alzheimer's disease (AD) patients.
  

  Biernot J, Darby E, Chan W, Pavlik V, Doody R

• BK virus-related progressive multifocal leukoencephalopathy.
  

  Chu J, Dhungana S, Johnson P, Woc-Colburn L, Kass J

• A case of limb shaking transient ischemic attacks associated with middle cerebral artery stenosis and functional aortic stenosis.
  

  Daye J, Zafar S, Basra S, Greenberg S, Kass J

• Movement disorders in golfers.
  

  Dhungana S, Jankovic J

• Treatment of idiopathic relapsing transverse myelitis.
  

  Dragan E, Hutton G

• XCiDaBLE: An observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Interim results from the first 145 subjects with cervical dystonia.
  

  Fernandez H, Pagan F, Danisi F, Greeley D, Jankovic J, Verma A, et al.

• Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome patients with high t-helper cell count: Report of two cases.
  [Previously Presented]
  

  Hannawi Y, Majmudar S, Shah J, Johnson PW, Goodman C, Kass J

• Cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE): Baseline demographic and clinical characteristics.
  

  Jankovic J, Charles P, Adler C, Comella C, Stacy M, Schwartz M, et al.

• Treatment of intracranial aneurysms with pipeline embolization device: A systematic review of literature.
  

  Murthy S, Shah S, Venkatasubba Rao C, Bershad E, Suarez J

• Identifying the correlates of pseudobulbar affect in patients with parkinsonian disorders and ALS.
  

  Patel N, York M, Phan C, Jimenez Shahed J

• Continuous home monitoring of essential tremor using motion sensors.
  

  Pulliam CL, Eichenseer S, Goetz C, Waln O, Hunter C, Jankovic J, et al.

• Long-term efficacy, safety, and side effect profile of botulinum toxin injections in dystonia - a 20-year follow-up.
  

  Ramirez Castaneda J, Jankovic J

• Parkinson's disease and narcolepsy.
  

  Sarwar A, Hirshkowitz M

• Safinamide add on to L-dopa: A randomized, placebo-controlled, 24-week global trial in patients with Parkinson's disease (PD) and motor fluctuations (SETTLE).
  

  Schapira A, Fox S, Hauser R, Jankovic J, Jost W, Kulisevsky J, et al.

• Glycogen breakdown is preserved during exercise in severe muscle phosphorylase b kinase deficiency.
  [Previously Presented]
  

  Sharp L, Heinicke K, Ren J, Newby M, Wyrick P, Rice G, et al.

• Exploring the impact of Parkinson disease (PD) susceptibility genes in elders without PD.
  [Platform Presentation]
  

  Shulman J, Yu L, Buchman A, Evans D, Schneider J, Bennett D, et al.

• Transthoracic echocardiography for lacunar strokes: Do we need it in all patients?
  

  Suchdev K, Damani R, Varade P, Abhishek F, Norris G

• Safety and efficacy of 5 mg and 10 mg dalfampridine extended release tablets in patients with multiple sclerosis: First results from a double-blind, placebo-controlled trial.
  

  Thrower B, Yapundich R, Applebee A, Hutton G, Klingler M, Henney H, et al.

• Zolpidem improves tardive dyskinesia with and without akathisia.
  

  Waln O, Jankovic J

• Clinical and imaging data in essential tremor with parkinsonian features.
  

  Waln O, Wendt J, Van AK, Jankovic J

• The long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
  

  Wijemanne S, Jankovic J

• Clinical characteristics and predictors of outcome in patients with Moyamoya Disease in the United States: Experience from two clinical centers.
  

  Zafar S, Gildersleeve K, Venkatasubba Rao C, Newmark M, Duckworth E, Suarez J, et al.

• Knowledge and attitudes about epilepsy in a low socioeconomic population.
  

  Zafar S, Tobias R, Gill S, Friedman D, Kass J, Goldsmith C

University of Puerto Rico
San Juan, Puerto Rico (February 2013)

• Neuroscience research opportunities to increase diversity program orientation.
  [Oral Presentation]
  

  Santiago S, Negron C, Berrios I, Cintron R, Cepeda K, Qui ñones, et al.

Texas Scottish Rite Hospital for Children
35^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 14-15, 2013)

• Glycogen breakdown is preserved during exercise.
  

  Sharp L, Heinicke K, Ren J, Newby M, Wyrick P, Rice G, et al.

• Not PFK deficiency.
  [Oral Presentation]
  

  Sharp L, Romain N, Haller RG

American Heart Association/American Stroke Association
2013 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2013)

• Secondary stroke prevention program: Effect on stroke specific quality of life.
  

  Damush T, Anderson J, Yu Z, Ofner S, Myers L, Schmid A, et al.

• Implementation of a secondary stroke prevention program: Effect on medication adherence.
  

  Damush T, Myers L, Anderson J, Yu Z, Ofner S, Schmid A, et al.

• Novel carbon-based particle antioxidants in reversible hyperglycemic MCA occlusion.
  

  Fabian RH, Marcano D, Samuel EL, Tour J, Kent TA

• Outcomes after tPA in African American women with explicit consideration of baseline factors.
  

  Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al.

• Extending the time window with low dose IV abciximab in acute non-lacunar stroke.
  

  Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al.

• Comparison of clinical characteristics of neurogenic stunned myocardium in patients with subarachnoid hemorrhage and acute ischemic stroke.
  

  Murthy SB, Shah S, Hannawi Y, Georgiadis A, Smirnakis S, Bershad E, et al.

• High utilization of CAS procedures among the elderly in the post CREST era.
  

  Rayes M, Bhattacharya P, Damani R, Chaturvedi S

• Increased carotid stenting for nonspecific symptoms in the post-CREST era.
  

  Rayes M, Bhattacharya P, Damani R, Chaturvedi S

International Neuropsychological Society (INS)
41^st Annual Meeting in Montreal, Waikoloa, Hawaii (Feb. 6-9, 2013)

• Executive functioning across the lifespan: An examination of the D-KEFS.
  

  Averill L, Wisdom N, Mignogna J, Robinson J, Collins RL

• Neural correlates of a novel Spanish word recognition fMRI memory task.
  

  Fernandez V, Allen M, York MK, Wilde EA, Karmonik C, Strutt AM

• A simple method for enhancing prediction of longitudinal decline in instrumental activities of daily living in Alzheimer's patients.
  

  Grabyan JM, Massman PJ, Alverson W, Doody RS

• Improving predictive validity of the Clinical Dementia Rating Scale for functional outcomes.
  

  Lowe DA, Balsis S, Miller T, Benge JF, Doody RS.

• How to select between the Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA) when accounting for the base rate of the sample and the level of severity being screened for.
  

  Mcculloch K, Collins RL

• Sensitivity and specificity of the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) in screening for mild and severe cognitive impairment related to dementia.
  

  Mcculloch K, Collins RL

• Predicting caregiver burden from patient functional ability and mood.
  

  Mcculloch K, Stinson JM, Collins RL.

• Exploring the impact of anxiety on learning in the California Verbal Learning Test-2nd edition.
  

  Stinson JM, Mcculloch K, Collins RL.

• Treatment effects in resting state fMRI in veterans with comorbid alcohol abuse, post-traumatic stress disorder, and mild traumatic brain injury.
  

  Wilde EA, Anderson J, Tran JK, Menefee DS, Bigler ED, Sanyal R, et al.

• Learning stories vs. word lists: The role of executive functioning.
  

  Wisdom N, Booth J, Mcculloch K, Stinson J, Averill L, Collins RL

• Use of the Health History Checklist (HHC) to detect patients experiencing psychogenic nonepileptic events (PNEE) on a long-term monitoring unit.
  

  Wisdom N, Collins RL, Sestito N, Robinson J, Proto D, Franks R, et al.

• Normal aging and verbal memory: A comparison of tests.
  

  Wisdom N, Mignogna J, Averill L, Miller B, Proto D, Collins RL

• Frontostriatal changes detected by DTI tractography in Parkinson's disease dementia.
  

  Wu TC, Wilde EA, Karmonik C, Yallampalli R, Strutt AM, Jankovic J, et al.

• Diffusion tensor imaging findings in mild traumatic brain injury and orthopedic injury.
  

  Wu TC, Wilde EA, McCauley SR, Barnes A, Hanten G, Chu ZD, et al.

American Stroke Association
2013 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2013)

• Racial differences in perceived risk, self-efficacy, and fear of stroke.
  

  Anderson AM, Khoury J, Frankel M, Kissela BM, Rademacher E, Flaherty ML, et al.

• Public perceived risk of stroke, myocardial infarction, and cancer.
  

  Anderson AM, Khoury J, Frankel M, Kissela BM, Rademacher E, Flaherty ML, et al.

• Location of intracerebral hemorrhage in a tri-ethnic cohort: the ERICH study.
  

  Birnbaum L, Leonard A, Andino J, Moomaw CJ, Langfeld C, Brown WM, et al.

• Novel carbon-based particle antioxidants in reversible hyperglycemic MCA occlusion.
  

  Fabian RF, Marcano D, Samuel EL, Tour J, Kent TA

• Risk of intracerebral hemorrhage with combined antiplatelet and anticoagulant use.
  [Oral Presentation]
  

  Flaherty ML, Ding L, Woo JG, Martin L, Haverbusch M, Moomaw CJ, et al.

• Classification of periventricular white matter disease (WMD) in clinical radiology reports vs. direct film review in ischemic stroke patients.
  

  Hancher J, Eilerman J, Alwell K, Sucharew H, Moomaw CJ, Woo D, et al.

• Outcomes after tPA in African American women with explicit consideration of baseline factors.
  

  Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al.

• Extending the time window with low dose IV abciximab in acute non-lacunar stroke.
  

  Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al.

• Comparison of clinical characteristics of neurogenic stunned myocardium in patients with subarachnoid hemorrhage and acute ischemic stroke.
  

  Murthy SB, Shah S, Hannawi Y, Georgiadis A, Smirnakis S, Bershad E, et al.

• Withdrawal of care in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
  [Oral Presentation]
  

  Sheth KN, Martini SR, Tirschwell DL, Becker KJ, Worrall BB, James ML, et al.

• Apolipoprotein E and use of statins in intracerebral hemorrhage.
  [Oral Presentation]
  

  Woo D, Deka R, Woo JG, Martini S, Flaherty M, Haverbusch M, et al.

Keystone Symposium
New Frontiers in Neurodegenerative Disease Research Meeting in Santa Fe, N.M. (Feb. 5, 2013)

• Casein kinase Iε phosphorylation of TDP-43 causes oligomerization and enhances toxicity in vivo.
  

  Jackson GR, Choksi DK, Roy B, Chatterjee S, Sengupta E, Kayed R

University of Puerto Rico
21^st Annual Puerto Rico Neuroscience Conference in Old San Juan, Puerto Rico (Dec. 1, 2012)

• Genetic variation of the serotonin transporter (5-HTTLPR) in human fear conditioning and extinction.
  

  Santiago S, Amador F, Martinez K

American Epilepsy Society (AES)
66^th Annual Meeting in San Diego, Calif. (Nov. 30 - Dec. 4, 2012)

• Clustering of mutations in a North American series supports a dominant-negative mechanism of KCNQ2 encephalopathy.
  

  Cooper EC, Carmant L, Flamini R, Kendall FD, Levisohn PM, Millichap JJ, et al.

• Regional atrophy in temporal lobe epilepsy: Correlations with cognitive impairment.
  

  Ding K, Gong Y, Frol A, Gupta P, Van Ness P, Agostini M, et al.

• SUDEP Tissue Donation Program (STOP): Collaborative network in support of SUDEP registry, tissue repository and human translational research.
  

  Goldman AM

• Universal DNA extraction protocol for the utilization of alternative tissue sources in downstream epilepsy genetic analysis.
  

  Goldman AM, Klassen TL, von Rueden EL, Drabek JM, Noebels JL

• SUDEP research consortium: A new collaborative network to discover predictive genes, mechanisms and biomarkers of SUDEP.
  [Investigators' Workshop]
  

  Goldman AM, Richerson G, Parent JM, Bateman L, Nordli DR, Noebels JL

• Loss of tau protein reduces hyperexcitability in mouse and drosophila genetic models of epilepsy.
  

  Holth J, Reed JG, Inoue T, Pautler R, Botas J, Noebels JL

• Myotonia in brain: 'Skeletal' chloride channel ClC-1 linked to idiopathic generalized epilepsy with focal myotonia.
  

  Klassen TL, Chen TT, Reed JG, Kole MJ, Goldman AM, Marini C, et al.

• Channotyping epilepsy: Profiling personal variation in ion channel genes.
  

  Klassen TL, Goldman A, Davis C, Chen T, Gibbs R, Noebels J

• An abbreviated support group therapy for psychogenic nonepileptic events: A neurologist-initiated program in an epilepsy center.
  

  Maheshwari A, Trolley G, Franks R, Chen DK

• Treatment of KCNQ2 encephalopathy with ezogabine.
  

  Millichap JJ, Levisohn PM, Tsuchida TN, Cooper EC

• 17?-estradiol decreases seizure and interictal spike frequency in a genetic mouse model of X-linked infantile spasms.
  

  Olivetti PR, Noebels JL

• Electrocorticographic events preceding sudden unexplained death in epilepsy (SUDEP).
  

  Van Ness PC, Fountain NB, Duckrow RB, Gwinn RP, Liephart JW, Morrell MJ, et al.

National Academy of Neuropsychology (NAN)
32^nd Annual Meeting in Nashville, Tenn. (Nov. 7-10, 2012)

• Mexican American normative references on tasks of memory and language: The Texas Mexican American normative studies.
  

  Edwards M, Balldin V, Hall J, Strutt A, Pavlik V, Marquez de la Plata C, et al.

• Normative data for Mexican American on tasks of executive and physiometric functions: The Texas Mexican American normative studies.
  

  Hall J, Edwards M, Balldin V, Strutt A, Pavlik V, Marquez de la Plata C, et al.

• Normative performance on the RBANS in a multi-ethnic bilingual cohort: The Texas Mexican American normative studies.
  

  Hobson Balldin V, Menon C, Younes S, Hall J, Strutt A, Pavlik V, et al.

• Adaptation and norming of the Boston Naming Test for Spanish-speaking older adults in the USA.
  

  Resendiz C, Scott B, Farias G, York M, Lozano V, Mahoney M, et al.

Baylor College of Medicine (BCM)
Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012)

• Internal carotid artery dissection with visual accompaniments.
  

  Chu J, Ubogu E

• Movement disorders in golfers - Four case reports and a brief review of literature.
  

  Dhungana S, Jankovic J

• GABA_B receptor limbic encephalitis: Case report and a brief literature review.
  

  Dhungana S, Nunez-Wallace KR, Van Hook C, Tarakad A, Kass JS

• Eye movement abnormalities in thalamic midbrain junction infarcts: Report of two cases.
  [Previously Presented]
  

  Hannawi Y, Johnson PW, Shirani P, Phan CL, Kass JS

• Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome patients with high t-helper cell count: Report of two cases.
  

  Hannawi Y, Majmudar S, Shah J, Johnson PW, Goodman C, Kass J

• Multiple sclerosis patient treated with natalizumab develops immune thrombocytopenic purpura.
  

  Stosic M, De Jesus P, McCarthy J, Hutton GJ, Rivera VM

Houston Neuropsychological Society
2012 Annual Symposium in Houston, Texas (October 2012)

• Factor structure of the Zarit Burden Interview and relation to dementia severity and patient neuropsychological performance.
  

  Stinson JM, Collins RL, Maestas K, Pacheco V, LeMaire A

Society for Neuroscience (SFN)
42^nd Annual Meeting in New Orleans, La. (Oct. 13-17, 2012)

• Neuronal Elavl proteins regulate RNA splicing and abundance to control brain glutaminase expression and neuronal excitability.
  

  Ince Dunn G, Okana HJ, Okana H, Jensen K, Park W-Y, Mele A, et al.

• Visualization of the population receptive field structures in human visual cortex.
  

  Lee S, Keliris GA, Papanikolaou A, Smirnakis SM, Logothetis NK

• Impact of single cell firing on in vivo cortical activity.
  

  Meyer JF, Golshani P, Smirnakis SM

• Pattern motion and direction selectivity in mouse V1.
  

  Palagina GS, Torsky S, Smirnakis SM

• Population activity in the motor cortex of the MeCP2 duplication mouse.
  

  Suter B, Meyer JFH, Ash RT, Zoghbi HY, Smirnakis SM

World Stroke Organization (WSO)
8^th World Stroke Congress in Brasilia, Brazil (Oct. 10-13, 2012)

• Risk factors for in-hospital pneumonia in intracerebral hemorrhage.
  

  Divani A, Thomson RM, Luo X, Saurez JI, Bershad EM

• Eye movement abnormalities in thalamic midbrain junction infarcts: Report of two cases.
  

  Hannawi Y, Johnson PW, Shirani P, Phan CL, Kass JS

American Neurological Association (ANA)
137^th Annual Meeting in Boston, Mass. (Oct. 7-9, 2012)

• Clinical assessment of the effect of tetrabenazine on motor function in moderate Huntington disease.
  

  Fekete R, Davidson A, Jankovic J

• A prospective, observational trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results on the health impact of CD on patients using the cervical dystonia impact profile (CDIP).
  

  Jankovic J, Thomas M, Vasquez A, Sethi KD, Verma A, Pappert EJ, et al.

• A prospective, observational trial evaluating Xeomin [IncobotulinumtoxinA] for cervical dystonia or blepharospasm in the US - Preliminary baseline results for patients with blepharospasm.
  

  LeDoux MS, Jankovic J, Sethi KD, Verma A, Pappert EJ, Fernandez HH

• Mutations in the novel protein PRRT2 cause infantile convulsions with paroxysmal kinesigenic dyskinesia.
  

  Lee H-Y, Huang Y, Bruneau N, Roll P, Roberson EDO, Hermann M, et al.

• Protective association between ACE inhibitors and lobar intracerebral hemorrhage.
  

  Martini SR, Flaherty ML, Brown WM, Moomaw CJ, Comeau ME, Haverbusch M, et al.

• Widely used clinical predictors do not account for outcome variability in mild traumatic brain injury.
  

  Moretti P, McCauley S, Wilde E, Levin H

• Genetic susceptibility for amyloid pathology in Alzheimer's disease.
  

  Shulman JM, Chen K, Keenan BT, Chibnik LB, Thiyyagura P, McCabe C, et al.

• Integrating human and fly genetics to understand Alzheimer's disease susceptibility.
  

  Shulman JM, Imboywa S, Diamond AE, Chipendo P, De Jager PL, Feany MB

• Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
  [Platform Presentation]
  

  Szigeti K, Lal D, Li Y, Doody RS, Yan L

• Incidence of Lewy body negative parkinsonism in a community based sample.
  

  Zaheer F, Slevin JT, Abner EL , Nelson PT, Jicha GA

• Inclusion of axial rigidity may improve diagnostic accuracy for dementia with Lewy bodies.
  

  Zaheer F, Slevin JT, Abner EL , Nelson PT, Jicha GA

Neurocritical Care Society (NCS)
10^th Annual Meeting in Denver, Colo. (Oct. 4-7, 2012)

• Prior statin use reduces rate of delayed cerebral ischemia after subarachnoid hemorrhage.
  

  Abhishek F, Damani R, Mohamed W, Suchdev K, Varade P, Atkinson B, et al.

• Angiogram-negative subarachnoid hemorrhage (aN-SAH): Not as benign as you would think.
  

  Damani R, Abhishek F, Mohamed W, Suchdev K, Varade P, Norris G, et al.

• Post surgical cerebral venous sinus thrombosis: A rare surgical complication and challenging management case.
  

  Hannawi Y, Shah S, Bershad EM, Suarez JI, Shaltoni HM, Yoshor D, et al.

• Low dose IV Abciximab for acute ischemic stroke patients ineligible for IV rt-PA.
  [Platform Presentation]
  

  Mandava P, Shah S, Murthy SB, Kent TA

• Comparing perfusion computed tomography to digital subtraction angiography in detecting delayed cerebral ischemia.
  

  Mohamed W, Varade P, Damani R, Abhishek F, Suchdev K, Norris G, et al.

• The utility of DynaCT in evaluation of subarachnoid hemorrhage: A case report.
  

  Shah S, Hannawi Y, Urfy MZ, Venkatasubba Rao CP

University of Puerto Rico
San Juan, Puerto Rico (August 2012)

• Using genetic polymorphisms to predict fear and the development of anxiety disorders.
  [Oral Presentation]
  

  Santiago S, Amador F, Martinez K

American Psychological Association (APA)
120^th Annual Convention in Orlando, Fla. (Aug. 2-5, 2012)

• Assessing quality of life in pain populations: Utility of a single-item measure.
  

  Stinson JM, Szafranski D, Sloan PA, York KM

Alzheimer's Association International Conference (AAIC)
Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012)

• Premorbid IQ and intrinsic progression rate explain substantial variance in observed progression of Alzheimer's disease (AD) on multiple measures.
  

  Doody R, Chan W, Pavlik V, Rountree S, Massman P

• Factors influencing time to nursing home placement in persons with probable Alzheimer's disease.
  

  McGee JS, Nguyen A, Darby E, Chan W, Pavlik V, Doody R

• Factors that influence long term care placement in an Alzheimer disease cohort.
  

  Rountree S, Chan W, Pavlik V, Doody R

• Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease.
  

  Szigeti K, Li Y, Shaw C, Sheffer I, Sule N, Powell S, et al.

• Dimebon in Alzheimer's disease: Summary and contract of three efficacy trials.
  

  Winblad B, Doody R, Cummings J, Tariot P, Sano M, Aisen P, et al.

AREADNE Foundation, Inc.
Conference in Santorini, Greece (June 21-24, 2012)

• Population receptive field mapping in human subjects after lesions of the visual pathway.
  

  Papanikolaou A, Keliris GA, Papageorgiou DT, Shao Y, Krapp E, Schiefer U, et al.

• Population receptive field measurements in the visual cortex of macaque monkeys.
  

  Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Nagy D, Jaegle H, et al.

Movement Disorder Society (MDS)
16^th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland (June 17-21, 2012)

• Flu-like and systemic symptoms following treatment with botulinum toxins.
  

  Baizabal Carvallo JF, Suresh K, Hunter C, Jankovic J

• AAV2-Neurturin (CERE-120) and Parkinson's disease: The safety and feasibility of combined substantia nigral and putaminal stereotactic targeting via a phase 1/2b clinical trial in advanced Parkinson's disease.
  

  Baumann T, Lang AE, Lozano AM, Olanow CW, Boulis N, Turner D, et al.

• Cervical dystonia subtypes baseline results from the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE).
  

  Charles PD, Stacy M, Jankovic J, Schwartz M, Brin M, Papapetropoulos S (on behalf of the CD PROBE Study Group)

• Clinical assessment of the effect of tetrabenazine on motor function in moderate Huntington's disease.
  

  Fekete R, Davidson A, Jankovic J

• XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results on the health impact of CD on patients using the cervical dystonia impact profile.
  

  Jankovic J, Thomas M, Vasquez A, Sethi K, Verma A, Pappert EJ, et al.

• XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm in the United States - Preliminary baseline results for patients with blepharospasm.
  

  LeDoux MS, Jankovic J, Sethi K, Verma A, Pappert EJ, Fernandez HH

• Analysis of CYP2D6 genotype and response to tetrabenazine.
  

  Mehanna R, Hunter C, Davidson A, Ondo W, Jimenez-Shahed J, Jankovic J

• Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome.
  

  Ondo WG, Jankovic J, Jimenez-Shahed J

• Neuroprotection by neuropeptide orexin A in a cellular model of Parkinson's disease.
  

  Pan T, Wu Y, Zhu JX, Jankovic J

• Entropy measurements in pallidal neurons in dystonia and Parkinson disease.
  

  Sanghera MK, Darbin O, Alam M, Friehs J, Friehs G, Jankovic J, et al.

• Pathological sleepiness and age in Parkinson's disease.
  

  Sarwar AI, Hirshkowitz M

• Concomitant use of antidepressants and neuroleptics with tetrabenazine during treatment of Huntington's disease.
  

  Shen V, Clarence-Smith K, Hunter C, Jankovic J

• Long-term safety and efficacy of tetrabenazine in the treatment of chorea associated with Huntington's disease.
  

  Shen V, Clarence-Smith K, Hunter C, Jankovic J

• Tetrabenazine for moderate vs. severe/disabling chorea associated with Huntington's disease.
  

  Shen V, Clarence-Smith K, Hunter C, Jankovic J

• Parkinson's Study Group Neurosurgical Working Group (PSG-NSWG) deep brain stimulation (DBS) non-motor symptoms (NMS) survey: Real world pre-operative practice patterns.
  [Previously Presented]
  

  York MK, Marsh L, Jimenez-Shahed J, Okun M, Moro E, Hunter C, et al.

• Anti-parkinsonian effects of Nurr1 activator in UPS impairment induced animal model of Parkinson's disease.
  

  Zhang Z, Xie W, Hintermann S, Jankovic J, Le W

American Society of Hypertension (ASH)
27^th Annual Scientific Meeting and Exposition in New York, N.Y. (May 19-22, 2012)

• Pooled analysis of three cluster randomized hypertension control trials in African-Americans.
  

  Pavlik V, Chan W, Hyman D, Feldman P, Tobin J, Ogedegbe G, et al.

Vision Sciences Society (VSS)
12^th Annual Meeting in Naples, Fla. (May 11-16, 2012)

• Population receptive field measurements in macaque visual cortex.
  [Platform Presentation]
  

  Smirnakis SM, Keliris GA, Shao Y, Papanikolaou A, Logothetis NK

Parkinson Study Group (PSG)
26^th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012)

• Genetic analyses of Parkinson's disease endophenotypes.
  [Platform Presentation]
  

  Shulman JM

• Parkinson's Study Group Neurosurgical Working Group (PSG-NSWG) deep brain stimulation (DBS) non-motor symptoms (NMS) survey: Real world pre-operative practice patterns.
  

  York MK, Marsh L, Jimenez-Shahed J, Okun M, Moro E, Hunter C, et al.

American Academy of Neurology (AAN)
64^th Annual Meeting in New Orleans, La. (April 21-28, 2012)

• Left ventricular hypertrophy is more common in blacks than whites with intracerebral hemorrhage.
  

  Albright K, Burak J, Boehme A, Siegler J, Denny MC, Alexandrov A, et al.

• Flu-like and systemic symptoms following treatment with botulinum toxins.
  

  Baizabal Carvallo J, Jankovic J

• Complication rates among women receiving contemporary carotid revascularization procedures.
  

  Bhattacharya P, Damani R, Rayes M, Chaturvedi S

• Severity of cervical dystonia: Baseline characteristics from the Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CDPROBE).
  

  Charles P, Jankovic J, Adler C, Brin M, Stacy M, Schwartz M, et al.

• Stroke associated with severe cerebral vasospasm after petroclival meningioma resection.
  

  Chmayssani M, Murthy S, Ghosh S, Bershad E, Suarez J

• Concomitant use of antidepressants and neuroleptics with tetrabenazine during treatment of Huntington's disease (HD).
  

  Clarence-Smith K, Shen V, Hunter C, Jankovic J

• Ion channel modifications in epilepsy.
  

  Cooper E

• Rare case of recurrent meningitis due to neurocysticercosis.
  

  Dhamne M, Murthy S, Kass J

• IncobotulinumtoxinA (Xeomin®) is well tolerated for the treatment of blepharospasm when injected according to patient needs.
  

  Evidente VG, Brodsky M, Gollomp S, Marx M, Hanschmann A, Jankovic J

• Hyperacute stenting for acute ischemic stroke is associated with a high rate of symptomatic intracranial hemorrhage.
  

  Fong A, Bershad E, Morsi H, Shaltoni H, Mawad M, Georgiadis A, et al.

• Functional connectivity MRI asymmetries in lateralized temporal lobe epilepsy.
  

  Haneef Z, Lenartowicz A, Yeh H, Engel J, Stern J

• Post surgical cerebral venous sinus thrombosis: A rare surgical complication and challenging management case.
  

  Hannawi Y, Bershad E, Suarez J, Shaltoni H, Yoshor D, Venkatasubba Rao C

• Long-term neuropsychological follow-up in pallidal stimulation for medically-refractory Tourette syndrome.
  

  Jimenez Shahed J, Scott B, Strutt A

• Outcomes of endovascular intervention in post cardiac catheterization ischemic strokes.
  

  Kansara A, Damani R, Xavier A, Chaturvedi S

• Analysis of the behavioral features conferred by the intermediate allele for Huntington disease in the prospective Huntington at risk observational study (PHAROS).
  

  Killoran A, Biglan K, Jankovic J, Eberly S, Kayson E, Oakes D, et al.

• XCiDaBLE: A phase 4, observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Preliminary baseline disease severity and quality of life data.
  

  LeDoux M, Lin D, Jankovic J, Pappert E, Verma A, Sethi K, et al.

• Sporadic CJD (VV2 Type) presenting with central vestibular abnormalities.
  

  Mandel J, Oas J

• Early predictors of progression in idiopathic sensory neuropathy.
  

  Mandel J, Quick A, Lawson V

• Dystonic respiratory dysregulation and other breathing disorders associated with dystonia.
  

  Mehanna R, Jankovic J

• Comparing clinical features of young-onset, middle-onset and late-onset Parkinson's disease.
  

  Mehanna R, Moore S, Hou J-G, Lai E, Sarwar A

• Clinical and radiologic spectrum of corpus callosum infarctions: A case series.
  

  Murthy S, Chmayssani M, Shah S, Goldsmith C, Kass J

• Excessive sleepiness and depression in Parkinson's disease.
  

  Sarwar A, Hirshkowitz M

• Genome-wide association study of Gilles de la Tourette Syndrome.
  

  Scharf J, Yu D, Mathews C, Neale B, Stewart E, Fagerness J, et al.

• The Clinical Skills Examination Training Program (CSET): An interactive training exercise for evaluators.
  

  Shanker V, Kass J, Potrebic S, Abramowitz M, London Z

• Long-term safety and efficacy of tetrabenazine in the treatment of chorea associated with Huntington's disease.
  

  Shen V, Clarence-Smith K, Hunter C, Jankovic J

• Tetrabenazine for moderate vs. severe/disabling chorea associated with Huntington's disease (HD).
  

  Shen V, Clarence-Smith K, Hunter C, Jankovic J

• Anti-epileptic drug use and outcome in the ethnic and racial variations in intracerebral hemorrhage (ERICH) study.
  [Oral Presentation]
  

  Sheth KN, Martini SR, Koch S, Elkind M, Sung G, Kittner S, et al.

• Diagnostic reliability of DaTscan in movement disorders.
  

  Waln O, Jimenez Shahed J, Juliet Wendt, York M, Baizabal Carvallo J, Mehanna R, et al.

• West Nile virus infection associated with central nervous system vasculitis and strokes.
  

  Zafar S, Dash D, Chachere M, Cowart J, Kass J

University of Pittsburgh
Undergraduate Honors Research Fair in Pittsburgh, Penn. (April 2012)

• The protection of dopamine neurons in dissociated midbrain cultures with neurotrophic factor combinations from MPP+ toxicity.
  [Previously Presented]
  

  Wyrostek SL, Jaumotte JD, Zigmond MJ

Texas Scottish Rite Hospital for Children
34^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 23-24, 2012)

• Progressive weakness in a patient with static encephalopathy and colpocephaly.
  

  Phillips L, Sharp L, Herndon E, Pascual J, Trivedi J

International Neuropsychological Society (INS)
40^th Annual Meeting in Montreal, Quebec, Canada (Feb. 15-18, 2012)

• Use of the Health Attitude Survey (HAS) to detect patients experiencing Psychogenic Non-Epileptic Events (PNEE) on a long-term monitoring unit.
  

  Collins RL, Wisdom NM, Sestito N, Chen DK

• Plasma cortisol does not predict rate of cognitive decline in Alzheimer's patients.
  

  Grabyan JM, Massman PJ, Porter B, Doody RS

• Patterns of reliable digit span performance in patients with Alzheimer's disease.
  

  Kiewel NA, Bradshaw M, Strutt AM, Hane LK

• Neuropsychological correlates of early impaired self-awareness following traumatic brain injury.
  

  McCauley SR, Sherer M, Hart T

• The relation of regional diffusion tensor imaging with incentivized event-based prospective memory in children following traumatic brain injury.
  

  McCauley SR, Wilde EA, Merkley TL, Bigler ED, Vasquez AC, Chu Z, et al.

• Amnestic MCI, sleep disturbance, and cognitive functioning.
  

  McGee JS, Darby EJ, Biernot J, Doody RS

• Determination of suspect effort: Primarily Spanish-speaking TBI patients and the test of memory malingering.
  

  Scott BM, Peery S, Tieu PG, Lozano VJ, Strutt AM

• Correlation between persistent memory impairment following mild, blast-related TBI and PTSD symptoms in OEF/OIF service members and veterans.
  

  Troyanskaya M, Pastorek NJ, Scheibel RS, Petersen NJ, Wilde EA, McCauley SR, et al.

• Establishing common data elements for adult and pediatric traumatic brain injury research.
  

  Wilde EA, McCauley SR

American Clinical Neurophysiology Society (ACNS)
2012 Annual Meeting in San Antonio, Texas (Feb. 7-12, 2012)

• Can EEG sampling be used as an effective tool for detecting clinically significant seizures?
  

  Pacheco V, Cherian V, Izadyar S, Hrachovy R

American Stroke Association
2012 International Stroke Conference in New Orleans, La. (Feb. 1-3, 2012)

• Has patient selection for carotid endarterectomy and stenting changed over time? Carotid revascularization in the post CREST era.
  

  Bhattacharya P, Damani R, Rayes M, Chaturvedi S

• Carotid revascularization in elderly asymptomatic patients: Are the results optimal?
  

  Damani R, Rayes M, Bhattacharya P, Chaturvedi S

• Acute hyperglycemia induces functional cerebrovascular uncoupling associated with worsened outcome and impaired reperfusion.
  

  Fabian RH, Dalmeida W, Kent TA

• Antioxidant carbon-based nanomaterials: In-vitro protection and in-vivo effects on the neurovascular unit.
  [Platform Presentation]
  

  Kent TA, Bitner BR, Berlin JM, Robertson CR, Marcano DC, Fabian RH, et al.

• Error rate estimates for the modified Rankin Score "Shift Analysis" using information theory modeling.
  

  Krumpelman CS, Mandava P, Kent TA

• A new more sensitive method to assess balance among stroke trial populations.
  

  Mandava P, Brooks ME, Krumpelman CS, Kent TA

• A systematic analysis of endovascular and intravenous therapy for ischemic stroke based on time window using a novel outcome model.
  

  Mandava P, Shah S, Sarma AK, Murthy SB, Kent TA

• Differential effect of high cholesterol by intracerebral hemorrhage location.
  [Moderated Poster]
  

  Martini SR, Brown WM, Comeau ME, Flaherty M, Haverbusch M, Moomaw C, et al.

• Protocol for rapid acquisition and interpretation of head CT in acute stroke patients eligible for thrombolysis.
  

  Mazabob JM, Brown G, Livesay S, Nguyen T, Hu B-B, Suarez J, et al.

• Auto-generated summary maps for CT-perfusion improve interobserver reliability.
  

  Tai WA, Purushotham A, Straka M, Sugg RM, Akhtar N, Rymer MM, et al.

• Rate of inappropriate statin use after intracerebral hemorrhage.
  

  Woo D, Comeau M, Flaherty ML, Brown M, Haverbusch M, Moomaw C, et al.

2011 International Society for Zinc Biology (ISZB)
Meeting in Melbourne, Australia (Jan. 15-19, 2012)

• Intracellular dialysis can be exploited to distinguish sources of intracellular Zn²⁺ accumulation in hippocampal neurons.
  

  Aiba I, Shuttleworth CW

Biochemical Society
Conference: The biology and pathology of tau and its role in tauopathies II in Cambridge, U.K. (Jan. 8-9, 2012)

• Dissection of tauopathy mechanisms using unbiased genetic screening in the Drosophila retina.
  [Invited Plenary Speaker]
  

  Jackson GR

Texas A&M College of Medicine
Seminar Week in Bryan, Texas (December 2011)

• Alzheimer's disease.
  [Oral Presentation]
  

  Kapadia A

American Epilepsy Society (AES)
65^th Annual Meeting in Baltimore, Md. (Dec. 2-6, 2011)

• Does memory test performance have localizing significance in pediatric epilepsy?
  

  Chapieski L, Agadi S, Evankovich K, Collins R, Riviello J, Schultz R, et al.

• Intact vs. impaired ictal sensorium: Does it affect outcome of psychogenic nonepileptic events following disclosure of diagnosis.
  

  Izadyar S, Franks R, Chen DK, Hrachovy RA

• Dendritic AMPA receptor deficit on cortical interneurons in the stargazer mouse model of absence epilepsy.
  

  Maheshwari A, Reed JG, Noebels JL

Society for Neuroscience (SFN)
41^st Annual Meeting in Washington, DC (Nov. 12-16, 2011)

• NMDA receptor activation prolongs the duration of ionic dyshomeostasis following spreading depolarization in murine brain slices.
  

  Aiba I, Shuttleworth CW

• Blue cheese/Alfy affects autophagy activation and tau toxicity in a Drosophila model of tauopathy.
  

  Bakhoum MF, Jackson GR

• Propagation of spreading depolarizations is limited by the synaptic release and extracellular actions of Zn²⁺.
  

  Carter RE, Aiba I, Carlson AP, Sheline CT, Shuttleworth CW

• Flupirtine reverses hyperexcitability in Kv1.1 potassium channel deficient myelinated vagal axons.
  

  Glasscock E, Qian J, Kole MJ, Noebels JL

• Tau loss regulates excitability in mouse and Drosophila genetic models of epilepsy.
  

  Holth J, Reed JG, Inoue T, Pautler R, Botas J, Noebels J

• RNA binding protein hnRNP K/bancal and its intronic microRNA miR-7 exert opposite effects on tau toxicity through regulation of Insulin Receptor Substrate/chico and GSK-3beta activity.
  

  Jackson GR, Ambegaokar S

• Protection of cultured dopamine neurons from MPP+ requires presence of several neurotrophic factors.
  

  Jaumotte JD, Wyrostek SL, Zigmond MJ

• ADAM11 is responsible for trafficking of Kv1 subunits to cerebellar basket cell terminals.
  

  Kole MJ, Waase MP, Klassen TL, Chen TT, Breslow JL, Noebels JL

• Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia.
  

  Mark MD, Maejima T, Kuckelsberg D, Woo JW, Hyde RA, Shah V, et al.

• Early 17-beta-estradiol treatment decreases seizure and interictal spike frequency in the ARX(GCG)10+7 genetic mouse model of X-linked infantile spasms.
  

  Olivetti PR, Noebels JL

• Population receptive field mapping in human subjects with lesions of the visual cortex.
  

  Papanikolaou A, Keliris GA, Shao Y, Krapp E, Papageorgiou E, Schiefer U, et al.

• Transformation of visual sensory information from cortical layer 4 to layer 2/3: The second stage of visual cortical processing.
  

  Polack P-O, Chow D, Sharim J, Friedman J, Gruver R, Smirnakis S, et al.

• Horizontal and vertical eye movements in Huntington's disease patients and age matched controls.
  

  Red S, Ing J, Jeter CB, Hood AJ, Patel SS, Jankovic J, et al.

• Population receptive field measurements in visual cortex of macaque monkeys.
  

  Shao Y, Keliris GA, Papanikolaou A, Augath M, Logothetis NK, Smirnakis SM

• Suppression of the protein kinase PKR promotes network hypersynchrony and enhanced cognition.
  

  Zhu P, Huang W, Kalikulov D, Yoo J, Placzek A, Stoica L, et al.

Honor Society of Nursing, Sigma Theta Tau International (STTI)
41^st Biennial Convention in Grapevine, Texas (Oct. 29 - Nov. 2, 2011)

• Evaluation of video teleconferencing technology to provide chronic disease self-management access for rural veterans.
  

  Anderson J, Willson P

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
World Stroke Day in Pondicherry, India (Oct. 29, 2011)

• Tissue, time and thrombolysis.
  [Keynote Address]
  

  Purushotham A

University of Pittsburgh
Science 2011: Next Gen Conference in Pittsburgh, Penn. (Oct. 6-7, 2011)

• The protection of dopamine neurons in dissociated midbrain cultures with neurotrophic factor combinations from MPP+ toxicity.
  

  Wyrostek SL, Jaumotte JD, Zigmond MJ

American Neurological Association (ANA)
136^th Annual Meeting in San Diego, Calif. (Sept. 25-27, 2011)

• Comparison of subthalamic (STN) and pallidal (GPI) deep brain stimulation (DBS) on gait and balance in patients with Parkinson's disease (PD).
  

  Hou JG, Thant M, Sarwar A, Fincher L, Bryant MS, Atassi F, et al.

• Association of PSP with chemical occupational exposure factors.
  

  Litvan I, Cunningham CR, Lees P, Jackson L, Juncos J, Riley D, et al.

• Neurological outcome scale for traumatic brain injury: Predictive validity and sensitivity to change.
  

  Moretti P, McCauley SR, Wilde EA, Scott JN, Clifton GL

• Visuospatial construction measures and their utility in identifying dementia of the Alzheimer's type.
  

  Scott BM, Duncan G, Carlson H, Nance M, York MK, Larery A, et al.

• Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
  [Platform Presentation]
  

  Shulman JM, Chipendo PI, Chibnik LB, Keenan BT, Tran D, Huentelman MA, et al.

Neurocritical Care Society (NCS)
9^th Annual Meeting in Montreal, Quebec, Canada (Sept. 21-24, 2011)

• Clinical utility of continuous electroencephalogram (CEEG) monitoring in hypothermia after cardiac arrest.
  

  Livesay S, Bershad E, Suarez J, Hrachovy R, Manian P, Herlihy JP, et al.

Michael J. Fox Parkinson's Research Foundation
Genetic Epidemiology of Parkinson's Disease Consortium Meeting in Evanston, Ill. (Sept. 18-21, 2011)

• What can endophenotypes teach us about Parkinson's disease?
  [Oral Presentation]
  

  Shulman JM

European Federation of Neurological Societies (EFNS)
15^th Congress in Budapest, Hungary (Sept. 10-13, 2011)

• A systematic analysis of intravenous and endovascular therapy for ischemic stroke using a novel predictive outcome model.
  

  Mandava P, Sarma AK, Shah S, Kent TA

• Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients.
  

  Mayer RR, Maharaj AS, Schiffman JS, Debnam JM, Kass JS, Weinberg JS

• Sustained efficacy of long-term incobotulinumtoxin-a (Xeomin®; botulinum neurotoxin type-a, free from accessory proteins) treatment for cervical dystonia, blepharospasm and upper limb post-stroke spasticity.
  

  Truong DD, Brodsky MA, LeWitt PA, Gollomp SM, Kanovsky P, Pulte I, et al.

American Psychological Association (APA)
119^th Annual Convention in Washington, DC (Aug. 4-7, 2011)

• Predicting women's feminist perspectives: The effects of internalization of masculine role norms and attitudes toward men.
  

  Stinson JM, McDermott RC, Trevathan-Minus M, Petho-Robertson K, Schwartz J

2011 International Conference on Alzheimer's Disease (ICAD)
Paris, France (July 16-21, 2011)

• Serum granulocyte colony stimulating factor and Alzheimer's disease.
  

  Barber R, O'Bryant S, Reisch J, Doody R, Fairchild T, Adams P, et al.

• The impact of depression on cognition varies by APOE4 status.
  

  Dentino A, Hall J, Barber R, Doody R, Royall D, O'Bryant S

• Biomarkers associated with cardiovascular risk in the Texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and homocysteine.
  

  Doody R, Chan W, Ballantyne C, Pavlik V, Barber R, O'Bryant S, et al.

• Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort.
  

  Doody R, Chan W, Barber R, Ballantyne C, Pavlik V, O'Bryant S, et al.

• A candidate causal variant in the CR1 locus.
  

  Keenan B, Shulman J, Chibnik L, Corneveaux J, Allen A, Myers A, et al.

• Plasma sphingomyelin is associated with cognitive progression in Alzheimer's disease.
  

  Mielke M, Haughey N, Bandaru VVR, Weinberg D, Zaidi N, Pavlik V, et al.

• Refinement and expansion of the Texas Alzheimer's research consortium serum-based diagnostic algorithm for Alzheimer's disease.
  

  O'Bryant S, Xiao G, Barber R, Hall J, Doody R, Reisch J, et al.

• A serum protein-based algorithm for the detection of Alzheimer's disease.
  

  O'Bryant S, Xiao G, Robert B, Hall J, Doody R, Reisch J, et al.

• Racial/ethnic group differences in the association of APOE ε4 genotype and visuospatial test performance in a non-demented sample.
  

  Pavlik V, Massman P, Rustveld L, Doody R

• Alzheimer's disease susceptibility loci: Evidence for natural selection and altered gene expression.
  

  Raj T, Shulman J, Chibnik L, Keenan B, Stranger B, Evans D, et al.

• Factors that influence survival in Alzheimer's patients.
  

  Rountree S, Chan W, Pavlik V, Darby E, Doody R

• The cognitive correlates of functional status: a new approach to dementia.
  

  Royall DR, Doody R, Barber R, Palmer R, O'Bryant S, Reisch J, et al.

• Genetic factors associated with the rate of cognitive decline in Alzheimer's disease.
  

  Sherva R, Tripodis Y, Shulman J, Chibnik L, Crane P, Bennett D, et al.

• A genome-wide association scan for episodic memory decline in aging.
  

  Shulman J, Chibnik L, Keenan B, Destefano A, Leurgans S, Wilson R, et al.

• Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
  [Platform Presentation]
  

  Shulman J, Chipendo P, Chibnik L, Keenan B, Tran D, Aubin C, et al.

• Genome-wide association scan replication for biomarker endophenotypes of Alzheimer's disease.
  

  Wilhelmsen K, Chasse S, Griffin N, Diaz-Arrastia R, Barber R, Royall D, et al.

• Developing and validating of diagnostic algorithm for Alzheimer's disease.
  

  Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, et al.

Gordon Research Conferences (GRC)
Excitatory Synapses & Brain Function Meeting in Easton, Mass. (June 26 - July 1, 2011)

• NMDA-R activation contributes to metabolic burden following spreading depolarization in murine hippocampal slices.
  

  Aiba I, Shuttleworth CW

Movement Disorder Society (MDS)
15^th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada (June 5-9, 2011)

• Deep brain stimulation: Hardware related complications in patients with movement disorders.
  

  Baizabal Carvallo JF, Mostile G, Almaguer M, Davidson A, Simpson R, Jankovic J

• The long-term impact of early versus delayed treatment with rotigotine transdermal system in patients with early-stage, idiopathic Parkinson's disease.
  

  Boroojerdi B, Watts RL, Jankovic J, Surmann E, Ghys L

• IncobotulinumtoxinA (NT-201) injections are safe and effective in adult subjects with blepharospasm across dosing intervals in a repeated dose-study.
  

  Brodsky M, Jankovic J, Evidente VGH, Fernandez HH, Grafe SK

• The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.
  

  Brown CH, Ha AD, York MK, Jankovic J

• Correlation of patient impression with the cervical dystonia impact questionnaire.
  

  Charles PD, Jankovic J, Stacy M, Adler CH, Comella C, Brin M, et al.

• Convergence spasm in conversion disorders: Prevalence in psychogenic and other movement disorders compared to controls.
  

  Fekete R, Baizabal-Carvallo JF, Ha AD, Jankovic J

• Constant current DBS: A randomized controlled clinical trial in Parkinson's disease: 12 month results.
  

  Gallo BV, Okun MS, Mandybur G, Arle J, Elias J, Ford B, et al.

• Essential tremor quantification during activities of daily living.
  

  Heldman DA, Filipkowski D, Jankovic J, Vaillancourt D, Prodoehl J, Elble RJ, et al.

• Identification of a novel downstream target of Nurr1 transcription factor for midbrain dopamine neuron development.
  

  Hen X, Li L, Zhang X, Jankovic J, Le W

• Cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE): Study design of a prospective observational registry.
  

  Jankovic J, Stacy M, Charles PD, Adler CH, Comella C, Brin M, et al.

• A mechanistic study of proteasome inhibition-induced iron misregulation in dopaminergic neuron degeneration.
  

  Li X, Xie W, Jankovic J, Le W

• Amplitude fluctuations in essential tremor. A prospective study.
  

  Mostile G, Fekete R, Giuffrida JP, Yaltho T, Davidson A, Nicoletti A, et al.

• A randomized controlled trial of constant current DBS active stimulation versus off stimulation in Parkinson's disease.
  

  Okun MS, Gallo BV, Mandybur G, Arle J, Elias J, Ford B, et al.

• Efficacy and safety of IPX066, a new carbidopa-levodopa (CD-LD) extended-release formulation, in LD-naive early Parkinson's disease (APEX-PD trial).
  

  Pahwa R, Ellenbogen A, Jankovic J, Hauser R, Fahn S, Clinical Team at Impax Pharmaceuticals

• Patients' perspective of tetrabenazine two years after FDA approval.
  

  Palao AM, Hunter CB, Jankovic J

• Alpha-synuclein: Possible link between Parkinson's disease and melanoma.
  

  Pan T, Zhu J, Li X, Jankovic J

• Situational sleep tendency in "sleepy" veterans with Parkinson's disease.
  

  Sarwar AI, Varghese R, Lai EC

• Brain glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG33 repeat length in the Huntington's disease gene.
  

  Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J

• Postural instability and gait difficulty scores from the MDS-UPDRS.
  

  Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Tilley BC

• Assessing dissociative pathology in psychogenic movement disorders: Clinical utility of the Dissociative Experiences Scale-II.
  

  Strutt AM, Scott BM, Ferrara J, York MK, Jankovic J

• Safety data in a randomized controlled trial of constant current deep brain stimulation versus lead placement alone for treatment of motor fluctuations in Parkinson's disease.
  

  Tagliati M, Gallo BV, Mandybur G, Arle J, Elias J, Ford B, et al.

• Peripheral trauma and movement disorders: A systematic review of reported cases.
  

  van Rooijen DE, Geraedts EJ, Marinus J, Jankovic J, van Hilten JJ

International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
Brain 2011, 25^th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Barcelona, Spain (May 25-28, 2011)

• Antioxidant carbon nanotubes: In-vitro characterization and in-vivo effects on cerebrovascular regulation.
  

  Kent TA, Bitner BR, Berlin JB, Marcado D, Robertson CR, Fabian RH, et al.

European Stroke Conference (ESC)
20^th Annual Meeting in Hamburg, Germany (May 24-27, 2011)

• How gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.
  [Previously Presented]
  

  Mandava P, Sarma A, Anderson J, Wehner B, Kent T

• Hyperglycemia is an independent risk factor for poor outcome after rtPA only in the large artery stroke subtype.
  

  Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA

• Novel analysis methodology indicates extended window low-dose IV abciximab improves outcome.
  

  Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA

International Neuromodulation Society (INS)
10^th World Congress in London, United Kingdom (May 21-26, 2011)

• The sacral spine and coccygeal space.
  

  Alo KM, Hirzallah MI, Richter EO

American College of Physicians (ACP)
Michigan Chapter Scientific Meeting in Ann Arbor, Mich. (May 20, 2011)

• A case report of cryptosporidium diagnosed by small bowel biopsy in an AIDS patient.
  

  Hiploylee J, Damani R, Khokhar S

American Heart Association
2011 Quality of Care and Outcomes Research Meeting (QCOR) in Washington, DC (May 12-14, 2011)

• Mind the time: a quality improvement project to increase the percent of ischemic stroke patients receiving intravenous t-PA within 60 minutes after emergency department arrival.
  

  Mazabob J, Livesay S, Meade A, Brown G, Suarez JI, Bershad EM, et al.

Plasticise
2^nd Annual Meeting in Stresa, Italy (May 4-6, 2011)

• Population receptive field mapping in human subjects with visual cortical lesions.
  

  Papanikolaou A, Keliris GA, Shao Y, Krapp E, Papageorgiou E, Schiefer U, et al.

• Population receptive field measurements in a macaque monkey with macular degeneration.
  

  Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Jaegle H, Seeliger MW, et al.

University of Edinburgh
Edinburgh, Scotland (April 26, 2011)

• Ablation and protection of dopaminergic neurons in zebrafish embryos.
  

  Hirzallah MI, Davies NO, Becker T, Becker CG

The Southern Group on Educational Affairs
Meeting in Houston, Texas (April 14-16, 2011)

• Teaching communication skills to learners: A faculty development workshop.
  

  Mian A, Friedland J, Loboprahbu S, Blakely-Harris T, Kass J, Singhal G, et al.

American Academy of Neurology (AAN)
63^rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)

• Distal limb discoloration in patients with multiple sclerosis - Case series of 41 patients.
  

  Avila M, Prieto P, Avila-Ornelas J, Stosic M, Amin A, Hutton GJ, et al.

• Deep brain stimulation system revision, and hardware related complications in 512 patients with movement disorders.
  

  Baizabal Carvallo JF, Mostile G, Simpson R, Almaguer M, Davidson A, Jankovic J

• Cervical dystonia patient registry for observation of BOTOX® efficacy (CD PROBE): Interim results of pain-related outcomes.
  

  Charles P, Adler CH, Stacy M, Comella C, Jankovic J, Boo LM, et al.

• Double trouble: Neuroleptic malignant syndrome (NMS) clouding initial presentation of anti-NMDA-receptor encephalitis (ANRE).
  

  Chmayssani M, Bandi V, Frost D, Kass J, Friedman D, Kalkonde Y

• Efficacy and safety of donepezil 23 mg/day in patients with moderate-to-severe Alzheimer's disease with concomitant memantine use.
  

  Doody RS, Ramos H, Faison W, Zou H

• Efficacy and safety of repeated incobotulinumtoxin A injections in subjects with cervical dystonia previously treated with botulinum toxin.
  

  Evidente VG, Truong D, Fernandez H, Comella C, Brodsky M, Jankovic J, et al.

• Efficacy and safety of repeated incobotulinumtoxin A injections in subjects with cervical dystonia previously naive to botulinum toxin treatment.
  

  Fernandez H, Comella C, Brodsky M, Evidente VG, Jankovic J, Truong D, et al.

• Intermediate CAG repeats: Analysis of the cooperative Huntington's observational research trial.
  

  Ha AD, Davidson A, Jankovic J

• Essential tremor quantification during activities of daily living.
  

  Heldman D, Filipkowski D, Jankovic J, Vaillancourt D, Prodoehl J, Elble R, et al.

• Levodopa is necessary to improve gait and balance in Parkinson's patients after deep brain stimulator implantation.
  

  Hou JG, Thant M, Bryant MS, Fincher L, Sarwar A, Lai E

• Cervical dystonia patient registry for observation of BOTOX® efficacy (CD PROBE): Interim results of physician-reported outcomes.
  

  Jankovic J, Charles P, Adler CH, Stacy M, Comella C, Boo LM, et al.

• Carotid endarterectomy in normal and high surgical risk patients: A study of regional variation.
  

  Kansara A, Damani R, Wazim M, Chaturvedi S

• Widely used clinical predictors do not account for outcome variability in mild traumatic brain injury.
  

  Moretti P, McCauley S, Wilde E, Levin H

• Coding and decoding pathogenic ion channels in epilepsy.
  

  Noebels J

• Double-blind, placebo-controlled fixed-dose trial of IPX066, a novel carbidopa-levodopa (CD-LD) extended-release formulation, in early Parkinson's disease (APEX-PD).
  

  Pahwa R, Hauser R, Jankovic J, Nausieda P, Ellenbough A, Hsu A, et al.

• AMPK-mediated neuroprotection on cellular models of Parkinson's disease.
  

  Pan T, Li X, Zhu J, Le W, Jankovic J

• Differences in the association of peripheral insulin and cognitive function in non-diabetic ad cases and normal controls.
  

  Pavlik V, Massman P, Ballantyne C, Barber R, Doody RS

• Epidemiology of patients transported by ambulance with seizures in Andhra Pradesh, India: A prospective analysis.
  [Oral Presentation]
  

  Purushotham A, Strehlow MC, Pirrotta E, Sistla S, Boyapati NVS, Gimkala A, et al.

• Decreased CBV is not a good measure of infarct core in acute ischemic stroke.
  [Oral Presentation]
  

  Purushotham A, Sugg RM, Straka M, Akhtar N, Rymer MM, Tung CE, et al.

• Incidence of multiple sclerosis in patients presenting with neurogenic bladder.
  

  Qiu C, Avila M, Hutton G

• Chronotypes in Parkinson's disease: What are they? And what can they predict?
  

  Sarwar AI, Varghese R, Hirshkowitz M, Lai EC, Johnson S, Hou JG

• A genome-wide association scan for episodic memory decline in aging.
  [Platform Presentation]
  

  Shulman JM, Chibnik LB, Leurgans SE, Wilson RS, Tran D, Keenan BT, et al.

• Functional fine mapping of the CR1 locus identifies a causal variant for Alzheimer's disease susceptibility.
  [Platform Presentation]
  

  Shulman JM, Keenan BT, Chibnik LB, Raj T, Tran D, Aubin C, et al.

• Cervical dystonia patient registry for observation of BOTOX® efficacy (CD PROBE): Interim results of patient-reported outcomes.
  

  Stacy M, Charles P, Adler CH, Comella C, Jankovic J, Boo LM, et al.

• Postural instability and gait difficulty scores from the MDS-UPDRS.
  

  Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Tilley BC

• Psychosocial profiles of psychogenic movement disorder patients with non-epileptic seizures and other abnormal motor manifestations.
  

  Strutt AM, Scott BM, Ferrara JM, York MK, Jankovic J

• Variations in the use of preoperative medications for carotid endarterectomy patients.
  

  Wazim M, Kansara A, Damani R, Reyes M, Chaturvedi S

• Diffusion tensor tractography of the internal capsule in depressed and anxious Parkinson's disease patients.
  

  York M, Yallampalli R, Gallander K, Strutt A, Chu Z, Karmonik C, et al.

AD/PD
10^th International Congress on Alzheimer's and Parkinson's Diseases in Barcelona, Spain (March 9-13, 2011)

• Diffusion tensor tractography of the internal capsule differentiates stages of cognitive impairment in Parkinson's disease.
  

  York M, Yallampalli R, Gallander K, Strutt A, Chu Z, Karmonik C, et al.

Keystone Symposium
Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011)

• Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
  [Platform Presentation]
  

  Shulman JM

Texas Scottish Rite Hospital for Children
33^rd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 17-18, 2011)

• CMT and tremor — is it really CMT?
  

  Patton E, Phan CL, Harati Y

• Unusual case of myasthenia gravis and high white blood cell count.
  

  Patton E, Phan CL, Harati Y

• A 65 year old female with subacute onset of limb weakness.
  

  Phan CL, Lai E, Harati Y

• A case of the dancer who can no longer dance.
  

  Phan CL, Patton E, Harati Y

• Legs weakness, isolated quadriceps atrophy and elevated CPK.
  

  Phan CL, Patton E, Harati Y

American Stroke Association
2011 International Stroke Conference in Los Angeles, Calif. (Feb. 8-11, 2011)

• The acute diffusion lesion reliably represents infarct core: Clinically relevant reversibility is rare.
  

  Campbell B, Purushotham A, Christensen S, Desmond P, Nagakane Y, Parsons M, et al.

• Implementation of the American Stroke Association Sharegiver Program (Peer Support).
  

  Damush TM, Anderson J, Nicholas G, Kimmel B, Kent T, Williams LS

• Hyperglycemia worsens outcome after rt-PA in the large artery stroke subtype.
  

  Mandava P, Munoz M, Dalmeida W, Sarma K, Brooks MA, Anderson J, et al.

• Gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.
  

  Mandava P, Munoz M, Sarma K, Brooks MA, Dalmeida W, Anderson J, et al.

• A multidisciplinary quality improvement project to address delays in CT imaging and thrombolytic treatment in acute stroke patients.
  

  Mazabob JM, Brown G, Stewart P, Livesay S, Freeborg S, Suarez JI, et al.

• MRI based TIA triage study.
  

  Wolford C, Mlynash M, Schwartz N, Purushotham A, Lansberg M, Kemp S, et al.

International Neuropsychological Society (INS)
39^th Annual Meeting in Boston, Mass. (Feb. 2-5, 2011)

• Longitudinal voxel-based analysis in traumatic brain injury: A comparison of diffusion tensor imaging metrics over an 18-month post-injury interval.
  

  Ayoub KW, Wilde EA, Chu Z, Bigler ED, Hunter JV, Wu TC, et al.

• Performance on the structured inventory of malingered symptoms in known epilepsy and psychogenic non-epileptic seizure groups.
  

  Benge JF, Collins RL, Lemaire A, Chen D, Franks R, Izadyar S

• The relation of perforant pathway and temporal lobe structures to memory function in patients with severe traumatic brain injury.
  

  Christidi F, Bigler ED, McCauley SR, Schnelle KP, Merkley TL, Mors MB, et al.

• Differential recall of nouns and verbs in patients with probable Alzheimer's disease (AD).
  

  Havins W, Harika L, Massman PJ, Doody RS

• Cognitive reserve as a moderator for the relationship between depression and cognitive functioning in Alzheimer's disease.
  

  Havins WN, Agbayani KA, Massman PJ, Doody RS

• Explaining discrepant math performance in children with epilepsy: Relative contribution of cognitive and attentional factors.
  

  Johnson C, Collins RL, Chapieski ML

• Centrum semiovale and corpus callosum integrity in relation to information processing speed of patients with severe traumatic brain injury.
  

  Kourtidou P, Wu TC, Traipe E, Hunter JV, Bigler ED, Chu Z, et al.

• Cortisol levels in Alzheimer's patients are related to premorbid functioning and rate of progression.
  

  Massman PJ, Burrows C, Hall J, Doody RS

• Monetary incentive effects on event-based prospective memory one year after traumatic brain injury in children.
  

  McCauley SR, Pedroza C, Chapman SB, Cook L, Vasquez AC, Levin HS

• Neuropsychological correlates of early impaired self-awareness following traumatic brain Injury.
  

  McCauley SR, Sherer M, Hart T, Roberge M

• Diffusion tensor imaging of incentive effects in prospective memory three months after pediatric traumatic brain injury.
  

  McCauley SR, Wilde EA, Bigler ED, Chu Z, Yallampalli R, Oni MB, et al.

• Cortical thinning in adolescence.
  

  Merkley TL, Wilde EA, Bigler ED, Schnelle KP, McCauley SR, Hanten G, et al.

• Age related changes in variability in on WAIS-IV subtests.
  

  Mignogna J, Wisdom N, Collins RL

• A comparison of Rey-15 scoring systems and alternative indices of suspect effort with primarily Spanish speaking older adults.
  

  Strutt AM, Scott BM, Shrestha S, York MK

• The relation between diffusion tensor imaging and volumetrics in the midbrain and brainstem and neurological functioning in severe traumatic brain injury.
  

  Wilde EA, Wu TC, Merkley TL, McCauley SR, Bigler ED, Hasley S, et al.

Texas Brain and Spine Institute (TBSI)
Research Symposium in Bryan, Texas (January 2011)

• Klüver-Bucy secondary to normal pressure hydrocephalus.
  

  Kapadia A, Simpson E, Roman G

National Neurotrauma Society (NNS)
Annual National Neurotrauma Symposium in Hollywood, Fla. (2011)

• Skill training, exercise and constraint-like therapy together promote major functional reorganization of remaining motor cortex after controlled cortical impact injury in rats.
  

  Combs HL, Adkins DL, Kozlowski DA, Jones TA

Aga Khan University
Annual Research Assembly in Karachi, Pakistan (2011)

• A mechanistic study on the medicinal use of mint in diarrhea.
  

  Siddiqui KA, Mahmood H, Khawja A

• Pharmacological basis for the medicinal use Mentha Arvensis in airway disorders.
  

  Siddiqui KA, Mahmood H, Khawja A

Rush University
ROS/MAP Investigator Meeting in Chicago, Ill. (2011)

• Genomics of cognitive decline and neuropathology.
  [Oral Presentation]
  

  Shulman JM

The University of Texas, Institute of Neuroscience
Annual Symposium in Austin, Texas. (2011)

• Motor learning, forced exercise rehabilitation, and functional neuroplasticity following controlled cortical impact.
  

  Combs HL, Adkins DL, Jones TA

2010 American Society for Cell Biology (ASCB)
Annual Meeting in Philadelphia, Penn. (Dec. 11-15, 2010)

• An unbiased genetic screen for modifiers of tauopathy using both loss and gain of function approaches.
  

  Jackson GR, Ambegaokar S

American Epilepsy Society (AES)
64^th Annual Meeting in San Antonio, Texas (Dec. 3-7, 2010)

• Simultaneous EEG and fMRI of sleep spindles and K-complexes.
  

  Caporro M, Haneef Z, Yeh H, Buttinelli C, Lenartowicz A, Stern J

• High resolution copy number variation of ion channel genes in epilepsy.
  

  Goldman A, Klassen T, Gu W, Zhang F, Bomben V, Chen T, et al.

• Hippocampal networks in temporal lobe epilepsy: A seed-based fMRI study.
  

  Haneef Z, Yeh H, Lenartowicz A, Mumford J, Stern J

• Induction of psychogenic non-epileptic events: Success rates vary with ictal semiology and neuropsychological profile.
  

  Izadyar S, Chen D, Collins R, Benge J, LeMaire A, Hrachovy R

• Lateralization of temporal lobe epilepsy with long-term ambulatory intracranial monitoring using the RNS system: Experience at four centers.
  

  King-Stephens D, Mirro E, Van Ness P, Salanova V, Spencer D

• Effect of temporal lobe epilepsy on the default mode network.
  

  Stern J, Yeh H, Haneef Z, Lenartowicz A, Mumford J

• How helpful are repeat epilepsy monitoring unit admissions after an initial nondiagnostic evaluation?
  

  Taneja A, Gupta P, Van Ness P

Society for Neuroscience (SFN)
40^th Annual Meeting in San Diego, Calif. (Nov. 13-17, 2010)

• Metabolic dependence of zinc effects on spreading depression in murine brain slices.
  

  Aiba I, Shuttleworth CW

• Modulation of tau oligomers by passive vaccination.
  

  Castillo DL, Lasagna-Reeves C, Guerrero-Munoz MJ, Estes DM, Barrett A, Dineley K, et al.

• MeCP2 deficiency in GABAergic neurons recapitulates Rett syndrome phenotypes.
  

  Chao H-T, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, et al.

• Characterization of tau oligomers in Alzheimer's disease.
  

  Kayed R, Lasagna-Reeves C, Guerrero-Munoz M, Sengupta U, Troncoso J, Jackson GR

• Assessing the spatio-temporal dynamics of visual receptive fields by fMRI.
  

  Keliris GA, Shao Y, Papanikolaou A, Peng X, Logothetis K, Smirnakis SM

• Effects of transcranial cortical stimulation and motor rehabilitative training on functional recovery following unilateral cortical infarcts in rats.
  

  O'Bryant A, Combs H, Nordquist S, Jones TA

• Population receptive field mapping in human subjects with visual cortical lesions.
  

  Papanikolaou A, Keliris GA, Peng X, Shao Y, Krapp E, Papageorgiou E, et al.

• Synergistic effects of tau and alpha-synuclein in dopaminergic neurons.
  

  Roy B, Ambegaokar SS, Jackson GR

• Tau oligomers in Parkinson disease and dementia with Lewy bodies and their connection with alpha-synuclein oligomers.
  

  Sengupta U, Lasagna-Reeves C, Guerrero-Munoz M, Castillo-Carranza D, Jackson GR, Troncoso J, et al.

• Population receptive field mapping in a macaque monkey with macular degeneration.
  

  Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Nagy D, Jägle H, et al.

Mission Connect/TIRR Foundation
Scientific Meeting in Houston, Texas (Nov. 12, 2010)

• Rehabilitation of prospective memory in children after traumatic brain injury.
  

  McCauley SR

American Society of Human Genetics (ASHG)
60^th Annual Meeting in Washington, DC (Nov. 2-6, 2010)

• Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
  [Platform Presentation]
  

  Shulman JM, Chipendo1 P, Aubin C, Kramer P, Schneider JA, Bennett DA, et al.

29^th International Congress of Clinical Neurophysiology (ICCN)
Kobe, Japan (Oct. 28 - Nov. 1, 2010)

• Sectional anatomy of the pelvic floor.
  

  Kass JS, Taber KH, Harrell JS, Zhang H, Chiou-Tan FY

Baylor College of Medicine (BCM)
Annual Academy of Distinguished Educators Showcase of Educational Scholarship in Houston, Texas (October 2010)

• Teaching communication skills to learners.
  

  Mian AI, Friedland JA, Loboprabhu SM, Das GS, Harris TB, Kass J, et al.

Neurocritical Care Society (NCS)
8^th Annual Meeting in San Francisco, Calif. (Sept. 15-18, 2010)

• Neurocritical care morbidity and mortality (M&M): A multidisciplinary systems-based approach for improving patient care.
  

  Livesay S, Suarez J, Bershad E, Smirnakis S, Newmark M, Ansari S, et al.

• The neurocritical care telestroke network: Extending high quality care to the underserved community for reasonable cost.
  

  Livesay S, Suarez J, Bershad E, Smirnakis S, Newmark M, Ansari S, et al.

• Single brain death examination does not improve organ transplantation.
  

  Varelas P, Rao CV, Rehman M, Patel A, Rai V, Barber A, et al.

American Psychological Association (APA)
118^th Annual Convention in San Diego, Calif. (Aug. 12-15, 2010)

• Development of the Women's Traditional Attitudes of Men Scale (WTAMS).
  

  McDermott RC, Schwartz-Moravec M, Stinson JM, Brown AS, Petho-Robertson K

• Gender role journey.
  

  McDermott RC, Schwartz-Moravec M, Stinson JM, Brown AS, Petho-Robertson K

Honor Society of Nursing, Sigma Theta Tau International (STTI)
21^st International Nursing Research Congress in Orlando, Fla. (July 12-16, 2010)

• Chronic disease: Framework, education and practice.
  

  Anderson J, Willson P

• Chronic disease: A telehealth Transition Assistance Program (TAP) for veteran caregivers.
  

  Willson P, Anderson J

2010 International Conference on Alzheimer's Disease (ICAD)
Honolulu, Hawaii (July 10-15, 2010)

• An inflammatory endophenotype of Alzheimer's disease.
  

  Barber R, Xiao G, O'Bryant S, Saunders J, Reisch J, Doody R, et al.

• Presence of cardiovascular disease is associated with slower cognitive decline in Alzheimer's disease in the absence of cerebrovascular pathology.
  

  Chan M, Pavlik VN, Chan W, Darby E, Khaleeq A, Doody RS

• A serum protein-based diagnostic algorithm for Alzheimer's disease.
  

  Diaz-Arrastia R, Xiao G, Reisch J, Barber R, Doody R, Fairchild T, et al.

• Results from CONNECTION: A global, Phase 3 double-blind, placebo-controlled confirmatory trial of dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease.
  

  Doody RS, Tariot P, Cummings J, Winblad B, Selby B, Langenberg A, et al.

• Association of genetic variation in the electron transport chain and Alzheimer's disease.
  

  Huebinger RM, Wilhelmsen K, Diaz-Arrastia R, Chasse S, O'Bryant SE, Doody R, et al.

• Genome-wide association scan for biomarker endophenotypes of Alzheimer's disease.
  

  Wilhelmsen KC, Chasse SA, Gizer IR, Cameron NG, Ellis JW, Diaz-Arrastia R, et al.

European Neurological Society (ENS)
20^th Annual Meeting in Berlin, Germany (June 19-23, 2010)

• Associations between annualized relapse rate and long-term exposure to subcutaneous interferon beta-1a in the Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study.
  

  Uitdehaag B, Constantinescu C, Cornelisse P, Jeffery D, Kappos L, Li D, et al.

Movement Disorder Society (MDS)
14^th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010)

• Longitudinal analysis of intermediate CAGn repeat length expansion in the prospective Huntington's disease at-risk observational study (PHAROS).
  

  Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, et al.

• Alpha-synuclein oligomers in Parkinson's disease and Lewy body dementia.
  

  Castillo-Carranza DL, Lasagna-Reeves CA, Guerrero-Munoz MJ, Roy B, Jackson GR, Kayed R

• CD-PROBE (cervical dystonia patient registry for observation of BOTOX® efficacy) — preliminary safety data.
  

  Charles D, Adler C, Comella C, Jankovic J, Stacy M, Kurth M, et al.

• Validation of a cervical dystonia questionnaire (CDQ).
  

  Davidson AL, Hunter C, Jankovic J

• Prospective 5-year natural history study of probable multiple system atrophy (MSA) in 175 North American subjects.
  

  Gilman S, Low P, May S, Tanner C, Stern M, Sandroni P, et al.

• Safety and efficacy of repeated NT 201 (botulinum neurotoxin type A free from complexing proteins) injections of patients with blepharospasm.
  

  Grafe S, Hanschmann A, Jankovic J, Comella C

• Validation of a motor screen for undiagnosed parkinsonism: The Baylor Functional Assessment Screen (BFAS).
  

  Hunter CB, York MK, Jankovic J

• CD-PROBE (cervical dystonia patient registry for observation of BOTOX® efficacy) — CD impact on quality of life (QOL) and patient reported outcomes (PRO).
  

  Kurth M, Adler C, Comella C, Charles D, Jankovic J, Stacy M, et al.

• The formation of pore-like amyloid aggregates in movement disorders.
  

  Lasagna-Reeves CA, Jackson GR, Troncoso J, Kayed R

• Role of tau oligomers in Parkinson's disease and dementia with Lewy bodies.
  

  Lasagna-Reeves CA, Roy B, Bakhoum M, Guerrero-Munoz MJ, Castillo-Carranza DL, Troncoso J, et al.

• Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease.
  

  Li C, Xie W, Jankovic J, Le W

• Use of an interactive voice response system by patients with blepharospasm receiving repeated injections of NT 201 (botulinum neurotoxin type A free from complexing proteins).
  

  Marx M, Grafe S, Jankovic J, Comella C

• Assessing patients' access to tetrabenazine (Xenazine) after FDA approval.
  

  Palao AM, Mostile G, Hunter CB, Jankovic J

• Curcumin accelerates the clearance of mutant alpha-synuclein and injured mitochondria via autophagy induction.
  

  Pan T, Wu Y, Le W, Jankovic J

• Handedness and Parkinson's disease.
  

  Sarwar AI, Lai EC

• SETTLE study design: A 24-week, double-blind, placebo-controlled study of the efficacy and safety of safinamide as add-on therapy to levodopa in patients with Parkinson's diseases.
  

  Schapira AHV, Fox S, Hauser R, Jankovic J, Kulisevsky J, Pahwa R, et al.

• Neuropsychological assessment of monolingual Spanish speaking Parkinson's disease patients in the United States pre and post STN-DBS.
  

  Strutt AM, Scott BM, Yaltho T, Simpson R, Jankovic J, York MK

• Open-label extension trial assessing the effects of long-term treatment with rotigotine in subjects with early-stage, idiopathic Parkinson's disease: Results from up to 7 years.
  

  Watts RL, Boroojerdi B, Jankovic J, on behalf of the SP702 Study Group

• Retrospective study of the therapeutic effect of deep brain stimulation in multiple system atrophy.
  

  Wu Y, Almaguer MA, Atassi F, Lai EC, Jankovic J, Ondo WG

• Orthostatic tremor: A review of 40 cases.
  

  Yaltho TC, Jankovic J, Ondo WG

Organization of Human Brain Mapping (OHBM)
16^th International Conference in Barcelona, Spain (June 6-10, 2010)

• Classification accuracy and spatial networks of motion coherence and direction using real-time fMRI.
  

  Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

Consortium of Multiple Sclerosis Centers (CMSC)
24^th Annual Meeting in San Antonio, Texas (June 2-5, 2010)

• The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.
  

  Avila J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, et al.

• Recurrent and multiphasic disseminated encephalomyelitis, case series.
  

  Avila M, Hutton G, Rivera VM

• Distal lower limb discoloration in patients with multiple sclerosis.
  

  Avila M, Prieto P, Robles L, Avila J, Stosic M, Hutton G, et al.

• Sleep disorders in multiple sclerosis.
  

  Avila M, Prieto P, Robles L, Stosic M, Avila J, Hutton G, et al.

• Use of natalizumab in Hispanic patients with relapsing remitting multiple sclerosis.
  

  Robles L, Hutton GJ, Rivera VM

• Computer-assisted cognitive rehabilitation for multiple sclerosis — Updated findings.
  

  Thorne BJ, Perez FI, Rivera VM, Hutton GJ

European Stroke Conference (ESC)
19^th Annual Meeting in Barcelona, Spain (May 25-28, 2010)

• Rebalancing the NINDS rt-PA trial.
  

  Mandava P, Kent TA

Rutgers/UMDNJ-Robert Wood Johnson Medical School
Research Session in Piscataway, N.J. (April 2010)

• Effects of miRNA-22 on embryonic rat cortical neurogenesis.
  [Oral Presentation]
  

  Chu J

American Academy of Neurology (AAN)
62^nd Annual Meeting in Toronto, Canada (April 10-17, 2010)

• Unilateral opercular lesion and eating-induced epileptic spasms.
  

  Chaluvadi S, Kung D, Friedman D, Newmark M

• Clinical experience with generic levetiracetam in a tertiary care epilepsy clinic.
  

  Chaluvadi S, Tran L, Goldsmith C, Friedman D

• Relation of the Alzheimer's disease susceptibility allele at the CR1 locus to cognitive decline and Alzheimer's disease neuropathology in older persons.
  [Platform Presentation]
  

  De Jager P, Chibnik L, Aggarwal N, Shulman J, Schneider J, Evans D, et al.

• Uncinate fasciculus integrity and impaired problem solving and memory in complex partial seizures.
  

  Dulay M, Karmonik C, Verma A, Raghubar K, Strutt A, York M, et al.

• Upper face chorea in Huntington disease.
  

  Fekete R, Jankovic J

• Effect of tetrabenazine (TBZ) on motor function in patients with Huntington disease (HD).
  

  Ferrara J, Mostile G, Hunter C, Adam O, Jankovic J

• Multiple sclerosis and other CNS demyelination after treatment with tumor necrosis factor alpha blockers.
  

  Hutton G, Avila M, Prieto PG, Avila J, Rivera V

• Comparison of detection rates of non-convulsive status epilepticus and non-convulsive seizure in critically ill patients using routine EEG and continuous EEG in a busy county and a private hospital.
  

  Izadyar S, Friedman D, Pacheco V, Hrachovy R

• Intravenous immunoglobulin (IVIG) in treatment of central pontine and extrapontine myelinolysis.
  

  Izadyar S, Sultan S, Kass J, Goldsmith C

• CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX® Efficacy) — A multicenter, observational study of onabotulinumtoxin A injections in cervical dystonia (CD) patients — Interim patient reported outcome data.
  

  Jankovic J, Adler C, Charles D, Comella C, Stacy M, Kurth M, et al.

• CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX® Efficacy) — A multicenter, observational study of repeated onabotulinumtoxin A injections in cervical dystonia (CD) patients — Preliminary baseline data.
  

  Jankovic J, Adler C, Charles D, Comella C, Stacy M, Kurth M, et al.

• A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.
  

  Jawaid A, Murthy S, Wilson A, Qureshi S, Amro M, Wheaton M, et al.

• Clinical correlates of eye movements in Huntington disease.
  

  Jeter C, Hood A, Palao A, Patel S, Jankovic J, Sereno A

• Ubiquitin proteasome system impairment mouse model of Parkinson's disease.
  

  Li X, Li C, Xie W, Jankovic J, Le W

• Prevalence of seizures in HIV patients measured in the outpatient setting.
  

  Nord K, Tomko S, Forst D, Robles L, Friedman D, Kass J

• HIF-1α-mediated neuroprotection on MPP+-induced apoptosis in SH-SY5Y cells.
  

  Pan T, Wu Y, Xie W, Le W, Jankovic J

• The natural progression of clinical symptoms in Parkinson's disease may not be faster in the earlier stages: Results from the ADAGIO delayed-start study.
  

  Rascol O, for the ADAGIO investigators

• Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
  [Platform Presentation]
  

  Shulman JM, Aubin C, Tran D, Kramer P, Feany MB, Bennett D, et al.

• Open-label extension trial assessing the effects of long-term treatment with rotigotine in subjects with early-stage, idiopathic Parkinson's disease: Results from up to seven years.
  

  Watts R, Boroojerdi B, Jankovic J, on behalf of the SP702 Study Group

• Asian over representation among patients with hemifacial spasm compared to cranial dystonia.
  

  Wu Y, Davidson A, Huang M, Pan T, Jankovic J

• Alzheimer's disease risk alleles in PCDH11X and SORL1 are associated with the rate of cognitive decline in subjects with multiple sclerosis.
  [Platform Presentation]
  

  Xia Z, Chibnik LB, Shulman JM, Aubin C, Tran D, Glanz BI, et al.

• A novel set shifting fMRI task identifies differences in brain activation in Parkinson's disease and healthy controls.
  

  York M, Karmonik C, Burton P, Richards D, Kakkar E, Grossman R, et al.

Southwestern Psychological Association (SWPA)
2010 Annual Convention in Dallas, Texas (April 8-10, 2010)

• Active exploration of and commitment to gender roles: A new scale.
  

  Nguyen NT, Petho-Robertson K, Brown AS, Schwartz-Moravec M, Stinson JM

University of Jordan
Scientific Day at Faculty of Medicine in Amman, Jordan (April 6, 2010)

• Attitudes and perceptions of medical students at the University of Jordan towards medical research.
  

  Hirzallah MI, Ehlayel AM, Amireh SO, Ghanem MT, Al-Samhouri AS, Quneibi SS, et al.

Howard Hughes Medical Institure (HHMI)
Structural Plasticity in the Mammalian System Symposium at Janelia Farm in Chevy Chase, Md. (March 2010)

• Visual cortex plasticity in adulthood: Why consensus remains elusive.
  [Platform Presentation]
  

  Smirnakis SM

American Society for Neurochemistry (ASN)
41^st Annual Meeting in Santa Fe, N.M. (March 6-10, 2010)

• Different roles of extracellular and intracellular Zn²⁺ in spreading depression-like events in hippocampal slice.
  

  Aiba I, Dietz RM, Sheline CT, Shuttleworth CW

Texas Scottish Rite Hospital for Children
32^nd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 25-26, 2010)

• Unusual case of a brachial plexus disorder.
  

  Patton Jr E, Phan CL, Harati Y

• A 32-year-old male with predominantly distal weakness, atrophy and myotonia.
  

  Phan CL, Patton E, Harati Y

• A case of myopathy associated with monoclonal gammopathy.
  

  Phan CL, Patton E, Tran L, Harati Y

American Stroke Association
2010 International Stroke Conference in San Antonio, Texas (Feb. 23-26, 2010)

• No differential effect of tPA based on final stroke etiologic subtype: A reanalysis of the NINDS tPA trial.
  [Moderated Poster]
  

  Martini SR, Yeatts SD, Belagage SR, Khatri P

• Apparent diffusion coefficient correlates with Tmax in acute ischemic stroke.
  

  Purushotham A, Lansberg MG, Mlynash M, Olivot J-M, Bammer R, Kemp SM, et al.

• Tissue salvageability in the penumbra decreases linearly with increasing Tmax.
  [Oral Presentation]
  

  Purushotham A, Lansberg MG, Mlynash M, Olivot J-M, Bammer R, Kemp SM, et al.

Baylor College of Medicine (BCM)
20^th Annual Rush and Helen Record Neuroscience Forum in Galveston, Texas (Feb. 19-21, 2010)

• A genetic mouse model of epilepsy with interneuronopathy and autistic-like features.
  

  Olivetti P, Noebels J

• Classification accuracy and spatial networks of motion coherence using real-time fMRI.
  

  Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

International Neuropsychological Society (INS)
38^th Annual Meeting in Acapulco, Mexico (Feb. 3, 2010)

• The Dementia Severity Rating Scale: Factor structure and neuropsychological correlates.
  

  LeMaire A, Maestas K, Collins R

• Veterans with dementia and their caregivers: Neuropsychological correlates of caregiver burden.
  

  Maestas K, LeMaire A, Collins R

• Assessment of the efficacy of immediate release methylphenidate, sustained release methylphenidate, and modafinil for patients with primary brain tumor.
  

  Patwardhan S, Myszka K, Collins R, Etzel C, Meyers C, Wefel J

• Change in quality of life as a function of duration of stimulant treatment in primary brain tumor patients.
  

  Patwardhan S, Teo I, Fitzgerald KM, Collins R, Meyers CA, Wefel J

NINDS and ALS Association
Workshop: Advances in Disease Modeling for ALS and FTD in San Diego, Calif. (2010)

• Wing phenotypes produced by misexpression of an ALS-associated TDP-43 mutation include supernumerary veins: A possible clue to signaling pathways.
  

  Ambegaokar SS, Yusuff T, Choksi DK, Kayed R, Jackson GR

Rice University and the Texas Medical Center
Bioscience Research Collaborative in Houston, Texas (2010)

• Real-time fMRI can decode visual mental imagery during a motion coherence task.
  

  Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

Rush University
CHAP Investigator Meeting in Chicago, Ill. (2010)

• Genome-wide association scans for cognitive decline.
  [Oral Presentation]
  

  Shulman JM

World Federation of Neurology (WFN)
XVIII World Congress on Parkinson's Disease and Related Disorders in Miami Beach, Fla. (Dec. 13-16, 2009)

• Rasagiline provides symptomatic benefit in early Parkinson's disease (PD).
  

  Jankovic J, ADAGIO Investigators

• Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD).
  

  Marks Jr W, Bartus R, Siffert J, Starr P, Ostrem J, Stacy M, et al.

• Treatment of dysautonomia associated with Parkinson's disease.
  

  Mostile G, Jankovic J

• Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?
  

  Sarwar A, Lai EC

American Epilepsy Society (AES)
63^rd Annual Meeting in Boston, Mass. (Dec. 4-8, 2009)

• Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.
  

  Bertaso F, Zhang X, Yoo J, Schmedt C, Clancy S, Noebels JL, et al.

• Simultaneous EEG and fMRI of vertex sharp transients.
  

  Caporro M, Haneef Z, Yeh S, Buttinelli C, Stern J

• Everyday verbal memory and pediatric epilepsy.
  

  Chapieski M, Evankovich K, Hiscock M, Collins R

• High frequency EEG activity associated with ictal events in the TTX model of infantile spasms.
  

  Frost JD, Lee CL, Hrachovy RA, Swann JW

• Long QT mouse model links the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.
  

  Goldman A, Glasscock E, Yoo J, Chen T, Klassen T, Noebels J

• Impact of evidence-based recommendations on referral pattern for epilepsy surgery.
  

  Haneef Z, Stern J, Engel Jr. J

• Epilepsy and neurocysticercosis in Houston, Texas.
  

  Kung D, Serpa-Alvarez J, Kass J, Friedman D

• A burst suppression pattern at termination of secondarily generalized seizures.
  

  Maheshwari A, Cash SS

Neurocritical Care Society (NCS)
7^th Annual Meeting in New Orleans, La. (Nov. 11-14, 2009)

• Single brain death examination with confirmatory cerebral blood flow testing as an alternative to the standard dual brain death examination.
  

  Rao CV, Rehman M, Barber A, Sommerfield S, Patel A, Rai V, et al.

Baylor College of Medicine (BCM)
Current Neurology 2009 in Houston, Texas (Oct. 31 - Nov. 1, 2009)

• Influence of levodopa and psychotropic medication on emotional and physical symptoms of depression before and following STN-DBS for the treatment of Parkinson's disease.
  

  Gallander KM, Strutt AM, Simpson R, Jankovic J, York MK

• Alternating fluency performance following bilateral STN DBS for the treatment of Parkinson's disease.
  

  Marshall DF, Williams AE, Strutt AM, Jankovic J, York MK

Society for Neuroscience (SFN)
39^th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2009)

• MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.
  

  Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, et al.

• MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.
  

  Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, et al.

• Internally mediated developmental desynchronization of neocortical network activity.
  

  Golshani P, Goncalves JT, Khoshkhoo S, Mostany R, Smirnakis S, Portera-Cailliau C

• Functional correlation of brain loci during cognitive tasks in multiple sclerosis.
  

  Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, et al.

• Non-convulsive seizure phenotypes and dementia in mice and humans.
  

  Noebels JL

• AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD): Efficacy and safety results from a controlled Phase 2 clinical trial.
  

  Siffert J, Marks Jr WJ, Starr PA, Stacey MA, Boulis NM, Vitek JL, et al.

• Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.
  

  Zhang X, Bertaso F, Yoo J, Schmedt C, Clancy S, Noebels JL, et al.

Baylor College of Medicine (BCM)
Annual Academy of Distinguished Educators Showcase of Educational Scholarship in Houston, Texas (October 2009)

• Program evaluation of medical student professionalism curriculum at Baylor College of Medicine.
  

  Kass JS, Johnson K

Society of Teachers of Family Medicine (STFM)
Northeast Region Conference in Rye Brook, N.Y. (October 2009)

• "Poetry of life" on medicine and patient relationships.
  [Oral Presentation]
  

  Chu J

North American Brain Injury Society (NABIS)
7^th Annual Conference on Brain Injury in Austin, Texas (Oct. 14-17, 2009)

• Event-based prospective memory performance during subacute recovery following moderate to severe TBI in children: Effects of monetary incentives.
  

  McCauley SR, Chapman S, Vasquez AC, Pedroza C, Levin HS

• Patterns of cortical thinning in relation to event-based prospective memory performance of children with traumatic brain injury.
  

  McCauley SR, Merkley TL, Wilde EA, Schnelle KP, Bigler ED, Vasquez AC, et al.

• Neural correlates of event-based prospective memory in children 3 months after moderate to severe traumatic brain injury: A volumetric study.
  

  McCauley SR, Wilde EA, Merkley TL, Schnelle KP, Bigler ED, Vasquez AC, et al.

• Changes in the cingulate in acute mild TBI detectable with diffusion tensor imaging and their relation to memory function.
  

  Trevor Wu, Wilde EA, Yallampalli R, Bigler ED, McCauley SR, Troyanskaya M, et al.

American Neurological Association (ANA)
134^th Annual Meeting in Baltimore, Md. (Oct. 11-14, 2009)

• Deep brain stimulation in multiple sclerosis-related Holmes' tremor.
  

  Bernitsas E, Hutton GJ, Rivera VM

Optical Society of America (OSA)
Annual Vision Meeting in Seattle, Wash. (Sept. 24, 2009)

• Neural repair at the systems level: Lessons from the visual system.
  [Platform Presentation]
  

  Smirnakis SM

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
25^th Congress in Dusseldorf, Germany (Sept. 9-12, 2009)

• Effects of natalizumab on relapses and MRI outcomes in Hispanic patients with relapsing multiple sclerosis.
  

  Herbert J, Rivera V, Ford C, Pace A, Hyde R

• Final results from the Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis study.
  

  Rivera V, Weinstock-Guttman B, Beagan J, Al-Sabbagh A, Bennett R, Dangond F

>>View platform presentation

International Federation for Medical and Biological Engineering (IFMBE)
World Congress on Medical Physics and Biomedical Engineering in Munich, Germany (Sept. 7-12, 2009)

• Automated 24 well neuro-screening system with life support.
  

  Ilchmann F, Becker B, Grundl D, Meyer J, Wolf B

• Multiparametric NeuroLab with integrated MEA and life support.
  

  Ilchmann F, Meyer J, Schmidhuber M, Zottmann M, Becker B, Wolf B

US Department of Defense
Military Health Research Forum 2009 in Kansas City, Mo. (Aug. 31 - Sept. 3, 2009)

• Assessment of acute mild traumatic brain injury by quantitative EEG analysis — Mission Connect: Mild Traumatic Brain Injury Translational Research Consortium — The Integrated Clinical Protocol: Neurophysiology Core.
  

  Mizrahi EM, Frost JD, Jr., Friedman DE, Hrachovy RA, Slater JD

American Psychological Association (APA)
117^th Annual Convention in Toronto, Canada (Aug. 6-9, 2009)

• Cultural stressors, coping mechanisms, and subjective well-being in urban adolescents.
  

  Vera EM, Doud K, Bena K, Langrehr K, Dick L, Hewitt A, et al.

VA Mental Health
3^rd Annual Conference in Washington, DC (July 21-23, 2009)

• Clinical depression, anxiety, and PTSD as risk factors for morbidity following coronary artery bypass grafting surgery.
  

  Dao T, Nguyen Q, Chu D, Anderson T, Springer J, Collins R, et al.

Honor Society of Nursing, Sigma Theta Tau International (STTI)
20^th International Nursing Research Congress in Vancouver, Canada (July 13-17, 2009)

• The Self-management TO Prevent (STOP) Stroke Tool: A final alpha testing.
  

  Anderson J, Willson P

2009 International Conference on Alzheimer's Disease (ICAD)
Vienna, Austria (July 11-16, 2009)

• Spanish translation and normative data for the Dementia Rating Scale, second edition.
  

  Strutt AM, Ayanegui IG, York MK

28^th International Epilepsy Congress (IEC)
Budapest, Hungary (June 29 - July 2, 2009)

• Human KvLQT1 mutations in mice link the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.
  

  Goldman A, Glasscock E, Yoo J, Chen T, Klassen T, Noebels J

• Impact of maternal anxiety and age of child on restrictions in childhood activities.
  

  Schutlz RJ, Chapieski ML, Evankovich KD, Wilfong AA, Collins RL

• Summary of the U.S. National Institute of Neurological Disorders and Stroke (NINDS) Workshop on SUDEP.
  

  So EL, Hirsch JL, Donner JE, Noebels JL, Jacobs PM, Buchhalter RJ

Movement Disorder Society (MDS)
13^th International Congress of Parkinson's Disease and Movement Disorders in Paris, France (June 7-11, 2009)

• Long-term deep brain stimulation for essential tremor: 12- year clinicopathologic follow up and literature review.
  

  DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ

• Double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor.
  

  Ferrara FM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J

• Impact of STN-DBS on health-related quality of life in patients with Parkinson's disease.
  

  Ferrara JM, Diamond A, Davidson A , Almaguer M, Jankovic J

• Tourette syndrome in adults.
  

  Gelineau-Kattner RN, Jankovic J, Davidson AL

• Efficacy and safety of NT 201 (botulinum neurotoxin type A free from complexing proteins) in treatment-naive cervical dystonia patients.
  

  Grafe S, Comella C, Jankovic J, Truong D, Hanschmann A

• Efficacy and safety of NT 201, botulinum neurotoxin type A free from complexing proteins) in pre-treated cervical dystonia patients.
  

  Grafe S, Comella C, Jankovic J, Truong D, Hanschmann A

• A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.
  

  Jankovic J, Jimenez-Shahed J, Brown LW

• Transcription factor PITX3 in Parkinson's disease.
  

  Le W, Nguyen D, Lin W, Rawal P, Ding Y, Xie W, et al.

• Correlation between Kinesia system assessments and clinical TETRAS scores in patients with essential tremor.
  

  Mostile G, Giuffrida JP, A dam OR, Davidson A, Jankovic J

• 17-AAG protects against rotenone-induced apoptosis in SHSY5Y cells via HSP70 induction.
  

  Pan T, Xie W, Jankovic J, Le W

• Resveratrol, a polyphenol found in red wine, protects against rotenone-induced apoptosis through autophagy induction.
  

  Pan T, Xie W, Le W, Jankovic J

• The course of depressive symptoms in early Parkinson's disease.
  

  Ravina B, Elm J, Camicioli R, Como P, Marsh L, Jankovic J, et al.

• Parkinson's disease — Characteristics of disease onset in a veteran population.
  

  Sarwar AI, Lai EC

• Mood differences between women diagnosed with psychogenic movement disorders and psychogenic seizures.
  

  Strutt AM, Ferrara J, Hill S, York MK, Uber-Zak L, Fogel T, et al.

American College of Sports Medicine (ACSM)
56^th Annual Meeting in Seattle, Wash. (May 27-30, 2009)

• Diagnosis of left ventricular hypertrophy by precordial vs. limb lead criteria in the analysis of ECGs over time in young athlete.
  

  Ananaba I, Damani R, West JJ, Higgins JP

• Prevalence of LVH in athletes classified by race and gender.
  

  Damani R, Ananaba I, West JJ, Higgins JP

Consortium of Multiple Sclerosis Centers (CMSC)
23^rd Annual Meeting in Atlanta, Ga. (May 27-30, 2009)

• Clinical and radiographic improvement of an acutely aggressive case of multiple sclerosis treated with cyclophosphamide.
  

  Avila M, Prieto PG, Robles L, Hutton GJ, Rivera VM

• Prevalence of sleep disorders in multiple sclerosis.
  

  Avila M, Robles L, Prieto P, Bernitsas E, Stosic M, Hutton GJ, et al.

• Spasmodic dysphonia in MS: A rare symptom or a possible association?
  

  Bernitsas E, Hutton GJ, Rivera VM

• Seizures in MS patients: A retrospective study.
  

  Bernitsas E, Stosic M, Hutton GH, Rivera VM

• HALT-MS--Intense immunosuppression and stem cell transplantation for RRMS.
  

  Hutton GJ, Bowen J, Forman S, Frohman E, Griffith L, Kraft G, et al.

• Long-term sc IFN beta-1a treatment in RRMS: Cumulative dose effects.
  

  Jeffery D, Rivera VM

• Continuous vs non-continuous long-term sc IFN beta-1a treatment in RRMS.
  

  Rivera VM, Jeffery D

• Diffuse white matter abnormalities and neurologic manifestations in a patient with anti-ro positive antibodies. Case Report.
  

  Robles L, Prieto P, DeAlvare L, Hutton GJ, Rivera VM

• Occurrence of herpes zoster in multiple sclerosis patients treated with natalizumab.
  

  Robles L, Prieto P, Rivera VM, Hutton GJ

European Stroke Conference (ESC)
18^th Annual Meeting in Stokholm, Sweden (May 26-29, 2009)

• Platelet inhibition may explain results with abciximab in the treatment of acute ischemic stroke.
  

  Mandava P, Anderson J, Dalmeida W, Kent TA

• A method to generate a control population for acute ischemic stroke trials: Validation with NINDS and application to a phase 1 treatment series.
  

  Mandava P, Kent TA

American Academy of Neurology (AAN)
61^st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)

• The written and oral administration of the Symbol Digit Modality Test in Huntington disease.
  

  Adam O, Halton S, Mostile G, Jankovic J

• How well does the ADAS-cog measure the spectrum of Alzheimer's disease severity? An item response theory analysis.
  

  Benge J, Balsis S, Geraci L, Massman P, Doody R

• Polyarteritis nodosa-type vasculitis isolated to the central nervous system: A first case report of a fulminant primary CNS vasculitis variant.
  

  Chern J, Kung D, Kass J

• Efficacy and safety of NT 201 (neurotoxin free from complexing proteins) in cervical dystonia.
  

  Comella C, Jankovic J, Truong D, Hanschmann A, Grafe S

• Age at onset and pre- morbid IQ influence early progression rates in AD.
  

  Doody R, Chan W, Pavlik V, Massman P, Darby E, Rountree S, et al.

• Material specific memory impairment is associated with unilateral cingulum bundle structural integrity in intractable temporal lobe epilepsy.
  

  Dulay M, Verma A, Karmonik C, Xue Z, Strutt A, York M, et al.

• Apocynin decreases consequences of nitric oxide synthase uncoupling in experimental neonatal hypoxia-ischemia.
  

  Fabian R, Kent T

• Efficacy and safety of NT 201 (botulinum neurotoxin free from complexing proteins) in blepharospasm.
  

  Jankovic J, Comella C, Hanschmann A, Grafe S

• A post-hoc analysis of cumulative dose effects of subcutaneous interferon beta-1a on clinical and MRI outcomes in relapsing-remitting multiple sclerosis: Results over the long term.
  

  Jeffery D, Rivera V

• Long-term effects of interferon beta-1a dose on relapse rate in relapsing-remitting multiple sclerosis: Results from a post- hoc analysis of PRISMS study data.
  

  Jeffery D, Rivera V

• Late stent thrombosis following self-expanding intracranial stent placement.
  

  Kansara A, Tiwari A, Rayes M, Rao CV, Jones M, Xavier A

• Stent supported revascularization of acute basilar artery occlusion beyond 8 hours of stroke onset.
  

  Kansara A, Tiwari A, Rayes M, Rao CV, Jones M, Xavier A

• An efficient and robust method for the fractional anisotropy analysis of white matter tracts based on automated template matching in talairach space.
  

  Karmonik C, Dulay M, Verma A, York M, Grossman R

• Toxoplasmosis myopathy as a manifestation of HIV immune reconstitution inflammatory syndrome.
  

  Kung D, Hubenthal E, Shelburne S, Goodman J, Kwan J, Kass J

• ApoE genotype in ALS.
  

  McDowell E, Jawaid A, Poon M, Rice L, Salamone A, Strutt A, et al.

• Rapamycin protects against rotenone-induced apoptosis through autophagy induction in SH-SY5Y cells.
  

  Pan T, Xie W, Rawal P, Jankovic J, Le W

• Covered stent in the treatment of internal carotid arteriovenous fistulae.
  

  Rao CV, Braun C, Jones M, Tiwari A, Kansara A, Steele J, et al.

• Stent without concomitant coil embolization for anterior circulation cerebral aneurysms.
  

  Rao CV, Lee A, Jones M, Tiwari A, Kansara A, Guthikonda M, et al.

• Safety of treatment of more multiple aneurysms in the same session.
  

  Rayes M, Rao CV, Jones M, Tiwari A, Kansara A, Xavier A

• In-stent restenosis on follow-up angiography among patients treated with stenting in acute ischemic stroke.
  

  Tiwari A, Rayes M, Rao CV, Jones M, Kansara A, Xavier A

• Safety of stent supported intracranial revascularization in the setting of acute ischemic stroke.
  

  Tiwari A, Rayes M, Rao CV, Jones M, Kansara A, Xavier A

• A controlled study of the long-term cognitive outcome of bilateral subthalamic nucleus deep brain stimulation.
  

  Williams A, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK

• HALT MS — Phase II clinical trial of high dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation for active relapsing- remitting multiple sclerosis.
  

  Wundes A, Bowen J, Kraft G, Hutton G, Openshaw H, Forman S, et al.

American Heart Association
Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference in Washington, DC (April 23-25, 2009)

• Systematic bias in blood pressure measurement between health care systems - Implications for quality of care research.
  

  Pavlik V, Greisinger AJ, Hyman DJ

American College of Cardiology (ACC)
58^th Annual Scientific Session in Orlando, Fla. (March 29-31, 2009)

• Rates of abnormal screening electrocardiograms differ greatly between U.S. collegiate cohorts.
  

  West JJ, Higgins JP, McPherson DD, Mistry DJ, MacKnight JM, Saliba EN, et al.

Baylor College of Medicine (BCM)
James K. Alexander Research Symposium in Houston, Texas (March 2009)

• Tuberculosis meningitis: Risk factors, treatments and outcomes in a case series.
  

  Walker GV, King C, Nord K, Goldsmith C, Kass J, Shandera W

Association of Academic Physiatrists (AAP)
Annual Meeting in Colorado Springs, Colo. (Feb. 24-28, 2009)

• Optimizing the accuracy and safety of shoulder injection procedures with cross-sectional anatomic schematics.
  

  Harrell JS, Chiou-Tan FC, Kass JS, Taber KH

Texas Scottish Rite Hospital for Children
31^st Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 19-20, 2009)

• Anesthesiologist with muscle cramps.
  

  Ansari S, Smyth S, Harati Y

• A tale of two diseases.
  

  Kung D, Harati Y

• Muscular dystrophy with subacute onset.
  

  Phan CL, Biliciler S, Harati Y

• Another patient with burning feet.
  

  Smyth S, Harati Y

• A case of a painful leg.
  

  Vullaganti M, Harati Y

American Stroke Association
2009 International Stroke Conference in San Diego, Calif. (Feb. 17-20, 2009)

• VWF pathway: A new animal model of lacunar stroke.
  

  Kent TA, Fabian RH, Dalmeida W, Ruidong J, Dong JF

• Restoring balance: A method to adjust for randomization imbalances in stroke clinical trials.
  

  Mandava P, Kent TA

• The optimal coregistered mismatch ratio to predict a favorable clinical response following recanalization varies based on Tmax threshold.
  

  Mlynash M, Olivot J-M, Thijs VN, Lansberg MG, Kemp SM, Purushotham A, et al.

• Foundations for a successful start: lessons learned from site initiation in the antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.
  

  Novitzke JM, Qureshi AI, the ATACH Investigators

• Perfusion/diffusion mismatch salvage is maximal in regions with mild-moderate perfusion deficits and correlates with clinical outcome.
  

  Olivot J-M, Mlynash M, Thijs VN, Lansberg MG, Kemp SM, Purushotham A, et al.

• Reversible acute diffusion lesions appear to be already reperfused on baseline MRI.
  

  Olivot J-M, Mlynash M, Thijs VN, Lansberg MG, Kemp SM, Purushotham A, et al.

• Apparent diffusion coefficient distinguishes ischemic core from reversible diffusion lesions.
  [Oral Presentation]
  

  Purushotham A, Mlynash M, Olivot J-M, Thijs VN, Bammer R, Kemp SM, et al.

• Apparent diffusion coefficient distinguishes penumbra from benign oligemia.
  [Oral Presentation]
  

  Purushotham A, Mlynash M, Olivot J-M, Thijs VN, Bammer R, Kemp SM, et al.

• Effect of systolic blood pressure treatment on perihematomal edema. Results from the antihypertensive treatment of acute cerebral hemorrhage (ATACH) study.
  

  Qureshi AI, Palesch YY, the ATACH Investigators

International Neuropsychological Society (INS)
37^th Annual Meeting in Atlanta, Ga. (Feb. 11-14, 2009)

• A pilot study of executive functions in PTSD.
  

  Benge J, Collins R, Kent T

• Significance of the apolipoprotein E ε2 allele in Alzheimer's patients' memory functioning.
  

  Massman P, Doody RS

• Incentive effects on time-based prospective memory in children and adolescents with traumatic brain injury.
  

  McCauley SR, McDaniel MA, Pedroza C, Levin HS

• Respiratory function is not related to cognitive impairment in patients with amyotrophic lateral sclerosis (ALS).
  

  Strutt AM, Palcic J, Wager JG, Titus C, Harati Y, Schulz PE, et al.

VA's Health Services Research & Development Service (HSR&D)
Quality Enhancement Research Initiative (QUERI) National Meeting in Phoenix, Ariz. (Dec. 10-12, 2008)

• Implementation of patient self-management programs among veterans in VA.
  

  Damush, Anderson J, Bosworth H

American Epilepsy Society (AES)
62^nd Annual Meeting in Seattle, Wash. (Dec. 5-9, 2008)

• Predictors of individual visual memory decline after right anterior temporal lobe resection.
  

  Dulay MF, Levin HS, York MK, Mizrahi EM, Goldsmith IL, Goldman A, et al.

• Systematic screening in a busy clinical setting improves identification of depression in people with epilepsy.
  

  Friedman DE, Kung DH, Kass JS

• Correlation of vitamin D levels and bone mineral density in anti-epileptic induced osteoporosis.
  

  Haneef Z, Dakakni T, Kedzierska K, Sivaraaman K, Jacobson M

• Vitamin D deficiency and compliance with supplementation in anti-epileptic drugs (AED) treatment.
  

  Sivaraaman K, Haneef Z, Kedzierska K, Jacobson M

• Periventricular nodular heterotopia electrical stimulation produces visual hallucinations.
  

  Van Ness P, Agostini M, Diaz-Arrastia R, Whitworth L

• Risk of seizures after spontaneous hemorrhage involving the temporal lobe.
  

  Vendrame M, Alkasem R, Haneef Z, Jacobson M, Azizi S

American Academy of Physical Medicine and Rehabilitation (AAPM&R)
2008 Annual Assembly in San Diego, Calif. (Nov. 20-23, 2008)

• Optimizing electromyography, chemical denervation, and percutaneous procedures of the pelvic floor with magnetic resonance imaging-based schematics.
  

  Kass JS, Chiou-Tan FC, Harrell JS, Miller JS, Taber KH

Society for Neuroscience (SFN)
38^th Annual Meeting in Washington, DC (Nov. 15-19, 2008)

• Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).
  

  Glasscock E, Yoo JW, Noebels JL

• Tissue-specific, functional toxicity of cytostatic and anaesthetic drugs in primary neuronal cell cultures.
  

  Meyer JF, Minney TN, Ilchmann F, Wolf B

National Multiple Sclerosis Society (NMSS)
Tykeson Fellows Conference in Chicago, Ill. (Nov. 4-7, 2008)

• Marburg's disease and neuromyelitis optica in brother/sister.
  

  Bernitsas E, Hutton GJ, Rivera VM

International Symposium on ALS/MND
19^th Annual Meeting in Birmingham, UK (Nov. 3-5, 2008)

• The ALS Cognitive Behavioral Screen (ALS CBS™): Phase II validation.
  

  Woolley S, York MK, Strutt AM, Schulz PE, Katz J

Society of Vascular and Interventional Neurology (SVIN)
2^nd Annual Meeting in Miami, Fla. (Oct. 24-26, 2008)

• Endovascular stent supported coil and onyx glue embolization of carotico-cavernous fistulae.
  

  Rao CV, Braun C, Jones M, Xavier A

• Stent alone treatment for anterior circulation cerebral aneurysms.
  

  Rao CV, Kuruvilla A, Jones M, Lee A, Tiwari A, Xavier A

• Stent without concomitant coil embolization for dissecting external carotid aneurysms.
  

  Rao CV, Lee A, Jones M, Tiwari A, Kansara A, Guthikonda M, et al.

Neurocritical Care Society (NCS)
6^th Annual Meeting in Miami, Fla. (Oct. 23-25, 2008)

• A case of methemoglobinemia after awake fiberoptic intubation following anterior cervical discectomy with fusion (ACDF).
  

  Rao CV, Varelas P, Wellwood J, Seyfried D, Abdelhak T

6^th International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson's Disease and Related Disorders
Dresden, Germany (Oct. 16-19, 2008)

• Voxel-based diffusion tensor imaging and diffusion tensor tractography for the evaluation of cognitive functioning in Parkinson's disease.
  

  York M, Karmonik C, Wilde E, Kakkar E, Yallampalli R, Strutt A, et al.

American Neurological Association (ANA)
133^rd Annual Meeting in Salt Lake City, Utah (Sept. 21-24, 2008)

• Coagulopathy is an independent predictor of inhospital mortality in patients with acute subdural hematoma.
  

  Bershad EM, Farhadi S, Suri MF, Feen ES, Hernandez OH, Selman WR, et al.

• Altered age of onset in Alzheimer's disease with diabetes mellitus.
  

  Shirani P, Salamone AR, Strutt AM, Schulz PE

• Is frontal dysfunction associated with dysarthria in patients with Amyotrophic Lateral Sclerosis (ALS)?
  

  Sterling LE, Salamone AR, Mosnik DM, Appel SH, Strutt AM, Schulz PE

• Progressive DA neuron degeneration induced by targeting administration of proteasome inhibitor in SN.
  

  Xie W, Zhu W, Pan T, Jankovic J, Le W

World Stroke Organization (WSO)
10^th International Symposium on Thrombolysis and Acute Stroke Therapy in Budapest, Hungary (Sept. 21-23, 2008)

• A systematic analysis of intravenous rt-PA vs. endovascular therapy with respect to therapeutic time window in acute ischemic stroke.
  

  Mandava P, Kent TA

• Low-dose intravenous abciximab and heparin for large vessel acute ischemic stroke: Comparison with natural history models.
  

  Mandava P, Kent TA

World Congress on Treatment and Research in Multiple Sclerosis (ACTRIMS + ECTRIMS + LACTRIMS)
Montreal, Quebec, Canada (Sept. 17-20, 2008)

• Menstrual cycle and menopause in patients with multiple sclerosis. How do these affect the symptoms of disease?
  

  Avila M, Suarez GA, Brandt D, Ramirez J, Hutton GJ, Rivera VM

• Longitudinal individualized analysis of computer-based cognitive rehabilitation in multiple sclerosis.
  

  Chaliman RT, Perez FI, Suarez GA, Rivera VM, Hutton GJ

• RENEW study update XVIII: Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis.
  

  Rivera V, Al-Sabbagh A, Bennett R, Coyle P, Elias S, Mikol D, et al.

• Magnetic resonance imaging findings in patients with clinically isolated syndrome suggestive of multiple sclerosis.
  

  Suarez GA, Avila M, Brandt D, Rivera VM, Hutton GJ

Rutgers/UMDNJ-Robert Wood Johnson Medical School
Poster Session in Piscataway, N.J. (August 2008)

• Effects of MiRNA-372 on embryonic rat cortical neurogenesis.
  

  Chu J, Brzustowicz L, Millonig J, DiCicco-Bloom E

American Psychological Association (APA)
116^th Annual Convention in Boston, Mass. (Aug. 14-17, 2008)

• Culturally specific predictors of subjective well-being in urban adolescents.
  

  Vera EM, Moallem BI, Bena K, Blackmon S, Corona R, Dick L, et al.

Mechanisms of Epilepsy and Neuronal Synchronization
Gordon Research Conference in Waterville, Maine (Aug. 3-8, 2008)

• Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).
  

  Glasscock E, Yoo JW, Noebels JL

2008 International Conference on Alzheimer's Disease (ICAD)
Chicago, Ill. (July 26-31, 2008)

• Eighteen-month data from an open-label extension of a one-year controlled trial of dimebon in patients with mild-to-moderate Alzheimer's disease.
  

  Cummings J, Doody RS, Gavrilova S, Sano M, Aisen P, Seely L, et al.

• Interrater reliability between expert and nonexpert physicians in the assessment of amnestic MCI in the community setting.
  

  Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li MC, et al.

• Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study.
  

  Doody RS, Gavrilova S, Thomas R, Aisen P, Bachurin S, Seely L, et al.

• The effects of donepezil on Alzheimer's disease progression monitored by MRI.
  

  Murthy AK, Schuff N, Suhy J, Doody RS, Goldman R

• Persistent antidementia drug treatment and survival in an Alzheimer's disease (AD) cohort.
  

  Rountree S, Pavlik V, Chan W, Doody RS

• The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Effect of atorvastatin on Alzheimer's disease progression by APOE4 genotype.
  

  Sparks L, Kivipelto M, Doody RS, Waters D, Jones RW, Feldman H, et al.

Natural and Medical Sciences Institute (NMI)
6^th International Meeting on Substrate-integrated Microelectrode Arrays in Reutlingen, Germany (July 8-11, 2008)

• Automated multiparametric 24 well neuro screening system.
  

  Ilchmann F,Meyer J, Lob V, Zhang C, Grothe H

• MEA supported cortical cultures as a novel tool in Alzheimer's research.
  

  Meyer JF, Kamp F, Bartels T, Kinney TN, Ilchmann TN, Beyer K, et al.

• Tissue-specific neurotoxicity of cytostatic and anaesthetic drugs.
  [Platform Presentation]
  

  Meyer JF, Kinney TN, Ilchmann F, Wolf B

• Coil design optimization for magnetic stimulation of neural tissue cultures on MEAs.
  

  Nicoletti M, Meyer JF, Weyh T, Kinney TN, Ilchmann TN, Gross GW, et al.

Movement Disorder Society (MDS)
12^th International Congress of Parkinson's Disease and Movement Disorders in Chicago, Ill. (June 22-26, 2008)

• Unusual motor-phonic tic mimicking essential palatal myoclonus (EPM).
  

  Adam OR, Jankovic J

• Correlation between clinical rating of parkinsonian and essential tremor and quantitative assessments.
  

  Aguilar LG, Giuffrida JP, Heldman DD, Jankovic J

• The essential tremor rating assessment scale (TETRAS).
  

  Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos J, et al.

• Spinocerebellar Ataxia 8: Variable phenotype and unique pathogenesis.
  

  Gupta A, Jankovic J

• Evaluation of a Parkinson's disease screening questionnaire for use in a community-based setting.
  

  Hunter CB, Aguilar LG, Nashatizadeh MM, Lay LF, Jankovic J

• The role of dopaminergic medication doses in impulse control disorders (ICD) in Parkinson's disease (PD).
  

  Jimenez-Shahed J, Baker K, Davidson A, Jankovic J

• Expanded study of NURR1 gene expression in patients with Parkinson's disease.
  

  Le WD, Pan T, Xie W, Huang M, Xu P, Zhu W, et al.

• Deep brain stimulation of the subthalamic nucleus for peripherally-induced parkinsonism.
  

  Nashatizadeh MM, Jankovic J

• A randomized, double-blind, placebo-controlled study of atomoxetine for freezing of gait in Parkinson's disease.
  

  Nashatizadeh MM, Jimenez JE, Davidson AL, Jankovic J

• Rapamycin rescues lactacystin-induced dopaminergic neuron injury in vivo.
  

  Pan T, Xie W, Jankovic J, Le WD

• Association between laterality (right or left) of onset of motor symptoms and degree of speech impairment in veterans with Parkinson's disease (PD).
  

  Sarwar AI, Lai EC

• Deep brain stimulation (DBS) parameters and gait in Parkinson's disease (PD).
  

  Sarwar AI, Lai EC

• Neuropsychological functioning of Parkinson's disease patients two years post subthalamic nucleus deep brain stimulation surgery.
  

  Strutt AM, Jankovic J, York MK

• Experience with MRI safety and DBS: Data from the National Parkinson Foundation Centers of Excellence.
  

  Tagliati M, Jankovic J, Koss AM, Pagan F, Okun MS, National Parkinson Foundation DBS Working Group

Consortium of Multiple Sclerosis Centers (CMSC)
22^nd Annual Meeting in Denver, Colo. (May 28-31, 2008)

• Silent MRI white matter lesions in patients with CIS suggestive of multiple sclerosis.
  

  Suarez-Zambrano GA, Ramirez J, Avila M, Brandt D, Escobar BH, Hutton GJ, et al.

European Stroke Conference (ESC)
17^th Annual Meeting in Nice, France (May 13-16, 2008)

• Improved prediction of treatment success in stroke based on pooled control arms.
  

  Mandava P, Kent TA

American Academy of Neurology (AAN)
60^th Annual Meeting in Chicago, Ill. (April 12-19, 2008)